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ABSTRACT 
Tissue engineering, which has emerged as a new discipline that 
amalgamates aspects from biology, engineering, materials science, and medicine, 
aims to produce functional replacement tissues that can be used to restore 
damaged ones. In view of the ageing population and the worldwide shortage of 
donor tissue, tissue engineering are expected to alter the practice of modern 
medicine. 
Recently, embryonic stem cells (ESCs) are considered as potent cell 
source for skeletal tissue engineering due to several biological advantages. 
However, although considerable progress to direct ESC differentiation to specific 
lineages has been made, before ESCs may be used as a suitable cell source in 
cell and tissue therapy, there are still remaining obstacles which have to be 
resolved regarding ESC differentiation: 1) the requirement for more efficient 
methods for increasing the differentiation efficiency to the desired cell type; and 2) 
the requirement of developing time and cost effective culture systems for 
controlling ESC differentiation is essential. 
The overall aim of this thesis was the development of an efficient method 
to control mesodermal differentiation and enhance osteogenic/chondrogenic 
differentiation of mESCs for application to skeletal tissue engineering. The initial 
focus of this thesis was the investigation of the effect of the HepG2 conditioned 
medium on the early differentiation of mESCs to primitive streak/nascent 
mesoderm-like cells, which could be potent progenitor cells of 
osteogenic/chondrogenic differentiation. Next, the focus was to investigate the 
control and enhancement of osteogenic and chondrogenic differentiation from 
mESC-derived primitive streak/nascent mesoderm-like cells by modulating the 
culture conditions and process. Finally, the focus became the development of 
efficient bioprocessing for the three-dimensional (31D) osteogenic and 
chondrogenic differentiation of mESC in alginate hydrogels and the culture in 
HARV bioreactors for the purpose of achieving 3D bone/cartilage-like tissue 
formation, resulting in an efficient and reproducible culture system for bone and 
cartilage tissue engineering applications. 
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CHAPER I 
LITERATURE REVIEW 
1.1. Clinical Needs in Bone and Cartilage Regeneration 
Therapeutic repair of skeletal tissues has received significant interest by 
the scientific community. Advances in reconstructive orthopedic surgery, such as 
total hip replacement, spinal fusion and plastic surgery, resulting from progress in 
surgical procedures and the increase in an ageing population, have lead to a 
demand for bone -and cartilage grafts that exceeds the current available supply. 
Therefore, the loss of bone and cartilage tissue due to congenital defects, trauma 
and following tumour resection represents a major clinical problem. Specifically, 
trauma and diseases of the bones or cartilage, frequently involving structural 
damage to both the subchondral bone and the articular cartilage surface (Figure 1), 
result in pain and disability for millions of people worldwide and affect the quality of 
life of patients [South-Paul JE 2001, Percival M 1999, Bobic V 2000, Buckwalter 
JA 2002]. 
Wom Cartilage 
Normal Bone 
Bone with 
Osteoporosis w 
ft 
G% 
Bone Fracture 
JW 
Figure 1. Bone and cartilage defects 
Furthermore, the deterioration of bone and cartilage tissue due to age 
related degenerative diseases, such as osteoporosis and osteoarthritis, is a major 
public health issue for the elderly [Percival M 1999, Martin A 2002]. However, 
despite recent advances in surgical and non-surgical therapies, the treatment of 
2 
bone and cartilage regions still remains an intractable problem. Therefore, 
regeneration of skeletal tissues represents one of the most promising areas of 
biological repair that could provide a broad spectrum of potential clinical 
applications. 
1.1.1. Bone and Current Approaches to Bone Regeneration 
Bone is rigid substance with an intricate structure. The periosteurn, a 
fibrous membrane, covers the outside of bone. This membrane is rich with 
capillaries, which are responsible for nourishing bone. The outer layer of bone is 
termed compact bone - eighty percent of skeletal bone mass is compact bone 
Compact bone is mainly composed of a hollow, laminated rod of collagen and 
calcium phosphate, which is optimised to handle compressive and bending forces. 
Near the end of the bones, where the stresses become more complex, there is a 
meshwork of cancellous, or spongy bone, which is an inner spongy structure that 
resembles a honeycomb and accounts for 20% of bone mass. The inner bone 
cavities contain bone marrow, where all blood cells are produced [Weiner S 1992]. 
Bone performs several key functions within the body. Being composed of hard 
tissue, bone provides mechanical resistance and structural support to the body; its 
hard matrix mainly composed of calcium salts deposited around protein fibres. 
Minerals provide rigidity to bone whereas proteins, such as collagen, provide 
strength and elasticity. Furthermore, bone is engaged in a continuous cycle of 
remodelling. Bone absorbing cells, termed osteoclasts, break bone down and 
discard worn cells. After a few weeks, the osteoclasts disappear and osteoblasts 
recruite to repair bone (Figure 2). During this cycle, calcium is deposited and 
withdrawn from the blood [Seeman, 2006]. Consequently, bone is capable of 
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maintaining an optimal shape and structure throughout life via this continual 
process of renewal through which it is able to respond to changes in its 
mechanical environment thus maintaining an optimal balance between form and 
function. 
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Figure 2. Bone remodelling (Modified from Seeman 2006) 
Bone defects can occur in a wide variety of situations; their reconstruction 
being important in the patient's rehabilitation. The current golden standard for bone 
regeneration and reconstruction, the autogenous bone graft, works well in many 
circumstances. However, autograft reconstructions, along with the available 
alternatives of allogenous bone graft or bone cement, do not solve all instances of 
bone deficiency. Furthermore, patients with bone disease, such as osteoporosis, 
have poor bone regeneration capacity since the disease deters bone regeneration 
- normal haemostatic remodelling being abrogated in osteoporosis [Hollinger, 
2000]. In addition, clinical treatments for critical-sized defects are problematic and 
often yield poor healing due to the complicated anatomy and physiology of bone 
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tissue. Therefore, although autologous or allogenic bone grafts have been 
employed for many years [Giannoudis PV 2005], a number of disadvantages to 
their use exist, including the failure of complete resorption of autologous bone, 
difficulties in shaping the bone graft to fill the defect, possible immune reaction in 
allograft, and, often, a lack of sufficient available material. In certain instances of 
patients with osteoporosis, cell therapy has been suggested as an effective 
alternative, but this has not been widely accepted for clinical practice due to the 
shortage of donor cells [Betz RR 2002]. Consequently, tissue engineered 
therapies, uniquely tailored to the bone regeneration requirements of individual 
patients, are extremely important. 
1.1.2. Cartilage and Current Approaches to Cartilage Regeneration 
Articular cartilage consists of the cellular component, the matrix-secreting 
chondrocytes, and the extracellular matrix (ECM) they secrete, mainly type 11 
collagen, hyaluronic acid, and chondroitin sulphate, which accounts for the tissue's 
characteristic rigidity and flexibility. Articular cartilage (Figure 3) is typically 
depicted in 4 zones [James CB 2001] - each zone having its own distinct matrix 
region. The superficial zone includes the gliding surface of the joint. This layer of 
cell-free matrix contains fine fibrils with few polysaccharides and is adjoined by a 
layer of elongated chondrocytes organised parallel to the articular surface. The 
next layer is the transitional zone, which includes active chondrocytes. The 
collagen fibrils of this zone are larger than those of the superficial zone. In this 
layer, collagen fibre orientation transitions from parallel to columnar. The deep 
zone contains chondrocytes that are similar to those of the transitional zone but 
are organized in a columnar pattern perpendicular to the joint surface. These cells 
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contain large amounts of intermediate filaments and glycogen granules. 
Furthermore, the largest collagen fibrils of articular cartilage and the highest 
content of proteoglycans are also contained here. The deepest zone of calcified 
cartilage separates the softer cartilage from subchondral bone. 
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Figure 3. Articular cartilage structure (Modified from ref: James CB 2001) 
These components are required for the survival and functionality of the 
cartilage tissue, especially in the joints where cartilage has to endure pressure 
forces caused by movement. Joint pain, often a consequence of joint degeneration 
due to primary osteoarthritis resulting in cartilage loss, is a major healthcare 
problem affecting, in particular, elderly people [Martin A 2002]. The self- 
regeneration capacity of articular cartilage is very limited; attempts to repair 
articular cartilage defects, including transplantation of autologous chondrocyte or 
mesenchymal cells from bone marrow, have been investigated [Hambly K 2006, 
Yoo J 2001]. Recently, autologous chondrocyte implantation (ACI) has been widely 
used to improve cartilage repair. The first step of ACI is to perform an arthroscopic 
surgery to identify the area of cartilage damage, where during the arthroscopic 
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procedure chondrocytes are harvested. The harvested chondrocytes are 
expanded in vitro for approximately 4-6 weeks in order to generate enough cells. 
Following expansion, a second surgery is required where a larger incision is made 
to access the area of cartilage damage. In addition, an incision over the thin bone 
is required in order to harvest periosteurn tissue, which will provide the periosteal 
patch required to cover the cartilage-damaged area. The periosteal patch is sewn 
over the area of damaged cartilage. Once a tight seal is created between the 
patch and the surrounding cartilage, the cultured chondrocytes are injected 
underneath the patch [Hambly K 2006]. However, this approach is limited due to 
the collection of autolougus cartilage tissue, which causes further cartilage defects 
in the peripheral area and suffers from the availability of suitable tissue and cell 
source. As an alternative cell source for autologous cartilage implantation, 
mesenchymal stem cells (MSCs) isolated from the bone marrow have been 
employed due to their potential to differentiate towards the chondrogenic lineage 
[Yoo J 2001]. However, the use of MSCs is also limited since their self-renewal, 
proliferative capacity and population is restricted and decrease with age [Tsuji T 
1990, Dodson SA 1996]. Thus, the search for new cell sources is ongoing. Thus, 
the development of new therapies that involve bone and cartilage regeneration 
has focused on bone and cartilage tissue engineering strategies that may provide 
alternative solutions of "living" constructs that possess the potential to integrate 
with the surrounding native tissue. 
1.2. Principle of Tissue Engineering 
Tissue engineering is a new discipline that combines knowledge and 
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technology from biology, chemical engineering, materials science, and surgery. 
The aim of tissue engineering is the fabrication of functional living tissues to 
replace damaged tissues. Although advances in tissue engineering have been 
rapid, it is acknowledged that research that is more basic is necessary to develop 
its full potential. In recent years, skeletal tissue engineering progress includes 
methods for the harvest, expansion, lineage specific differentiation and 
transplantation of tissue-forming cells, the use of bioactive matrix materials as 
tissue scaffolds, local or systemic delivery of various hormones and growth factors 
or other chemical compounds, and other methods to control the culture 
environment [Petite H 2000, Tamura S 2001, Karen JLB 2001]. In particular, the in 
vitro expansion and differentiation of cells, most commonly in bioreactors and the 
utilisation of appropriate 3-dimensional (31D) polymeric or natural scaffolds has 
been explored [Freed LE 1997]. In general, the general principle of skeletal tissue 
engineering (Figure 4), specifically bone and cartilage tissue engineering, involves 
combining bone and cartilage forming cells, such as osteoblasts and chondrocytes, 
with a natural or synthetic support or scaffold to produce a three-dimensional living 
tissue construct that is functionally, structurally, and mechanically equal to bone or 
cartilage it has been designed to replace [Cancedda R 2003]. 
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Figure 4. PrinciPle of skeletal tissue engineering. 
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Tissue engineered constructs are mainly composed of two components: (i) 
tissue-forming cells, and (ii) a biocompatible carrier scaffold on which these cells 
can grow and differentiate. Numerous cell and scaffold choices are available with 
unique advantages and disadvantages. Research and clinical therapies have 
explored using cells alone, cells in combination with a biomaterial scaffold, and 
biornaterials that induce host cell activities [Yoo J 2001, Tamura S 2001, Karen 
JLB 2000]. The cells are important for the production of new tissue through ECM 
synthesis and are responsible for the long-term stability of this matrix. The scaffold 
material provides mechanical strength of the construct and a template for 3D 
growth. Addition of a cellular component to the scaffold may aid in repairing tissue 
at a faster rate as well as in repairing larger defects. Thus, the interaction of 
scaffolds and cells, cell adhesion on the matrix surface, cell maturation, ECM 
production, and cell proliferation are all important for the success of a tissue 
engineered construct. 
To date, there has been significant progress in developing tissue 
engineered constructs using various scaffolds and cells. For instance, in bone 
tissue engineering, many suitable materials have been generated, including 
synthetic hydroxyapatite/tricalcium phosphates and polyglycolic and polylactic 
acids. Transplants of hydroxyapatite ceramics supplemented with periosteal cells 
or bone marrow cells appear to be effective for forming bone-like tissue [Brook IM 
1991, Mankani MH 2004, Bianco P 2001]. Other commonly used materials, such 
as synthetic polylactic acid or poly L-lactic acid hybridized with natural collagen, 
have been used as porous scaffold to provide suitable environment for osteogenic 
cells growth and function [Hutmacher DW 2000, Suh H 2000, Suh H 2001], and 
some of polymers could be combined with hydrogels, bioglass, or ceramics 
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[Endres M 2003, Blaker JJ 2005, Chen OZ 2006]. 
Similarly, in cartilage tissue engineering, the development of various 
polymeric, such as the biodegradable and biocompatible poly(a-hydroxy esters) - 
namely, polyglycolic acid, polylactic acid, and copolymer poly(lactic-co-glycolic 
acid) (PLGA), has resulted in approval by the US Food and Drug Administration 
(FDA) for clinical use [Li WJ 2006]. Several studies have reported the 
morphological maintenance of chondrocytes and the synthesis of cartilage specific 
ECM by chondrogenic cells in these scaffolds [Vacanti CA 1991, Mahmoudifar N 
2005, Mouw JK 2005]. In addition, hydrogels, which are crosslinked polymer 
networks that have the ability to absorb large amounts of water making these 
materials attractive scaffolds for engineering tissues with high water content, such 
as cartilage. For instance, alginate, a seaweed-derived polysaccharide approved 
by the FDA for medical use [Atala A 2005], has been identified as such a suitable 
candidate and has been used to culture annular chondrocytes in hydrostatic 
loading experiments [Kuo CK 2001, Wenger KH 2005]. However, no clinical 
application has materialised, yet. 
Despite the advances in biornaterials and culture systems for bone/ 
cartilage tissue engineering, identification of an appropriate cell source that is 
easily obtainable, has good expansion ability, and can be differentiated into the 
desired cell type, still remains a significant challenge. 
1.3. Cells for Bone and Cartilage Tissue Engineering 
In vivo, cells are essential for the construction, remodelling, and 
maintenance of tissues. Furthermore, they contribute to tissue repair by various 
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mechanisms, including the secretion of soluble signals and the production of 
matrix molecules. Cells used in tissue engineering applications can be derived 
from numerous sources, including primary tissues as well as cell lines. The ideal 
properties are non-immunogenic, highly proliferative (since large numbers may be 
required), easy to harvest, and able to differentiate into specific cell types with 
specialized functions [Marler JJ, 1998]. Both autologous and allogenic cells have 
been considered as cell sources, including adult differentiated cells, adult stem 
cells and embryonic stem cells (ESCs). 
1.3.1. Adult Differentiated Cells 
The most obvious cell source is the tissue itself; hence, autologous adult 
differentiated cells, such as mature osteoblasts and chondrocytes, have been 
used extensively and are considered the "golden" standard. However, the use of 
human derived osteoblasts has been primarily confined to laboratory studies and 
no clinical application exist yet. In contrast, chondrocytes have been widely used 
as an adult differentiated cell source and currently autologous chondrocyte 
implantation (ACI) is approved by the FDA as a cell-based cartilage repair product 
[Brittberg M 1994, Brittberg M 2001]. 
However, in most cases, differentiated cells released from adult tissues 
exhibit a very limited proliferation capacity, which could be due to the accelerated 
telomere shortening associated with age resulting in replicative senescence of 
cells [Muschler GIF 2004, Harley CB 1990, Martin A 2001]. This presents serious 
limitations to their expansion in culture in order to generate sufficient cell numbers 
for use in the in vitro reconstruction of engineered tissues that are to be 
transplanted back to the patients. In addition, lack of source and the harvesting of 
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adequate numbers of adult differentiated cells for extracorporeal expansion are 
also problematic. Specifically, harvesting osteogenic cells is time consuming and 
relatively few cells are available after dissociation of bone tissue in addition to 
exhibiting relatively low cellular expansion rates [Salgado AJ 2004]. Furthermore, 
even though chondrocytes have already been utilised in ACI, certain limitations 
exist such as the amount of tissue that can be harvested as well as donor site 
morbidity [Temenoff JS 2000, Schreiber RE 2000]. When chondrocytes are 
removed from their native tissue environment and expanded in monolayer, they 
lose their chondrogenic phenotype as evidenced by loss of spherical cell shape, 
production of type I collagen instead of type 11 collagen, and aggrecan gene 
expression chnabel M 2002]. Consequently, ACI is applicable to cartilage 
defects with only small degenerated areas. Therefore, more rapidly proliferating 
cell sources such as foetal, neonatal, genetically manipulated, or stem cells are 
being explored [Vacanti JP 1999]. 
1.3.2. Adult Stem Cells 
Adult stem cells are capable of self-renewal and of differentiating into 
tissue-specific cell lineages as directed by appropriate inducers. Progenitor or 
precursor cells in foetal or adult tissues are partly differentiated cells that divide 
and give rise to fully differentiated cells. Such cells are usually regarded as 
It committed" to differentiation along a particular cellular development pathway. The 
primary function of adult stem cells is to homeostasis and to replace cells that die 
because of injury or disease. Adult stem cells are present in most tissues but the 
capacity to which they contribute to normal homeostasis and repair varies widely 
[Rando TA 2006]. Ideally, adult stem cells are also defined as clonogenic cells 
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where a single adult stem cell generates a line of genetically identical cells, which 
then give rise to all the appropriate, differentiated cell types of the tissue in which 
they reside [Hennessy B 2004]. 
To date, bone marrow cells are the most frequently used cell source in 
bone and cartilage tissue engineering. The marrow (Figure 5) contains 
mesenchymal stem cells (MSCs), which contribute to the regeneration of 
mesenchymal tissues such as bone, cartilage, muscle, ligament, tendon, adipose, 
and stroma [Pittenger MF 1999, Caplan Al 2005]. 
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MSCs have been isolated and expanded in vitro while maintaining their 
ability to differentiate into chondrogenic and osteogenic lineages. Extensive 
research into the in vitro osteogenic and chondrogenic differentiation of 
MSCs for 
the fabrication of tissue engineered bone and cartilage tissue-like structures using 
various three dimensional supporting matrices as well as enhanced culture system 
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such as bioreactors has been conducted. For instance, a recent study reported 
that the combination of perfusion culture system with MSCs seeded on three 
dimensional collagen sponges and self-assembled pepticle-amphiphile (PA) 
nanofibers hybrid scaffold significantly enhanced the in vitro and in vivo osteogenic 
differentiation of MSCs compared with conventional static tissue culture plates 
[Hosseinkhani H 2006]. Others have reported that the osteogenic potential of 
MSCs is affected by the size and microporosity of hydroxyapatite (HA) 
microparticles, which is clinically used as an injectable bone filler, and indicated 
that MSCs-HA particle hybrids may be used for the development of injectable 
formulations of tissue engineered bone constructs [Fisher EM, 2003]. Furthermore, 
MSCs have been harvested from the patient's bone marrow, expanded in vitro, 
and then induced to differentiate towards the osteogenic cell lineage followed by 
mineralised bone formation on three dimensional HA ceramics. These tissue 
engineered bone constructs were then implanted into the original patients 
demonstrating bone healing potential without any side effects [Morishita T 2006]. 
Efficient protocols for directing MSC differentiation towards the 
chondrogenic lineage as well as suitable biornaterials - coated with type 11 
collagen - have been developed. It has been demonstrated that chondrogenic 
differentiation is enhanced using type 11 collagen based three-dimensional 
hydrogel scaffolds in the presence of transforming growth factor P1 (TGF-pl) 
[Bosnakovski D 2006]. One of the widely accepted culture methods for culturing 
chondrocytes is the pellet culture technique since MSCs are able to differentiate 
into chondrocytes resulting in the formation of three dimensional cartilage tissue- 
like structures [Bosnakovski D 2004]. Furthermore, the utilisation of mechanical 
stimuli has been explored to induce MSC differentiation towards the chondrogenic 
lineage [Schumann D 2006] and three-dimensional polymeric scaffolds have been 
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used to produce cartilage-like tissues using MSCs [Wang Y 2005]. 
As described previously, the main three advantages for the clinical use of 
adult stem cells, especially bone marrow derived MSCs, is availability, autologous 
nature, and multi-lineage differentiation capacity. However, in many cases, 
relatively few MSCs are available in BM aspirates, especially from elderly or 
diseased patients. It has been reported that the proportion of MSCs in bone 
marrow is 0.01% to 0.001% [Friedenstein AJ 1982] and Wexlel et al have reported 
a1in3.4 x 104 frequency for these cells [Wexler SA 2003]. In addition, several 
studies have suggested that the number of marrow-derived progenitors declines 
as a function of donor age [Tsuji T 1990. Dodson SA 1996]. Furthermore, it has 
also been reported that in vitro expansion induced rapid aging of MSCs resulting in 
a limited passage capability and loss of their multi-differentiation potential [Bonab 
MM 2006, Baxter MA 2007], which limits their usefulness in treating age-related 
degenerative diseases such as osteoporosis and osteoarthritis. 
1.3.3. Embryonic Stem Cells 
Recently, the use of embryonic stem cells (ESCs) as a potential cell source 
for cell-based therapies has been suggested. The derivation of pluripotent cell 
lines from mouse embryos was reported in 1981 [Evans MJ 1981]. ESCs were 
originally derived from the inner cell mass (ICM) of blastocysts by plating embyros 
at the expanded blastocyst stage, either intact or following immunosurgical 
isolation of lCM, onto a feeder layer. After several days of culture, the epiblast- 
derived cell mass is dissected and disaggregated and then replated onto fresh 
feeders. Various types of differentiated cell colonies arise along with colonies of a 
characteristic undifferentiated morphology [Robertson EJ 1997]. These 
Ir 
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undifferentiated cell colonies are individually dissociated and replated, resulting in 
further expansion and the establishment of ESCs. Mouse ESCs (mESCs) are 
maintained in the undifferentiated (and pluripotent) state in the presence of the 
leukaemia inhibitory factor (LIF). LIF sustains mESCs self-renewal activity in the 
absence of feeders [Smith 1988]. On withdrawal of LIF (or feeders), proliferation 
continues but differentiation is induced and stem cells do not persist beyond a few 
days. Therefore, ESCs are characterized by two unique properties, namely their 
66 unlimited self-renewal capacity" and 66 pluripotency, )) which allows them the ability 
to generate all foetal and adult cell types in vivo and in vitro. These properties 
make ESCs, potentially, an invaluable cell source for diverse, "off-the-shelf tissue- 
engineering and clinical applications. 
Many signalling pathway molecules participate in the control of ESCs self- 
renewal activity and pluripotency. Octamer binding factor 4 (also known as Oct-3, 
Oct-3/4, Pou5f1) is a POU family transcriptional regulator restricted to early 
embryos, germ line cells, and undifferentiated embryonic carcinoma (EC), 
embryonic germ (EG) line cells, and ESCs [Pesce M 1998]. In vivo, zygotic 
expression of Oct-3/4 is essential for the initial development of pluripotential 
capacity in the ICIVI [Nichols J 1998]. In ESCs, continuous function of Oct-3/4 is 
necessary to maintain pluripotency and control differentiation [Niwa H 2000]. 
However, it has been well established that maintenance of Oct-3/4 expression is 
not in itself sufficient to sustain the pluripotent phenotype. Competition and co- 
ordination between various transcriptional complexes involving Oct-3/4 are 
involved in guiding cell determination. These include the transcription factor Oct- 
3/4, signal transducers and activators of transcription (STAT3), stage-specific 
embryonic antigen (SSEA)-1, and alkaline phosphatase (ALPase) [Saito S 2004]. 
It has been demonstrated that potential downstream effectors of the LIF signal in 
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mESCs include kinases of the Src, Jak, and mitogen-activated protein families and 
the signal transducer and transcriptional activator STAT3 [Raz R 1999]. Activation 
of the signal transducer STAT3 via LIF receptor (LIFRP) and glycoprotein (gp)130 
signalling appears to be essential for maintenance of mESC pluripotency [Matsuda 
T 1999]. Therefore, propagation of the pluripotent mESCs phenotype requires both 
the intrinsic activity of Oct-3/4 and the cytokine-induced action of STAT3. In 
addition, it has been recently identified that the homeodomain protein Nanog is 
among the intrinsic regulators of the pluripotency of mESCs. When overexpressed, 
Nanog displays the unique role of maintaining mESC self-renewal activity in the 
absence of the requisite extracellular stimulation by LIF; Nanog overexpression 
can maintain self-renewal of mESCs independently of LlF/gp130/STAT3 signalling 
pathway [Yates A 2005]. However, in contrast to mESCs, recent reports 
demonstrated that STAT3 activation is not sufficient to inhibit human ESCs 
(hESCs) spontaneous differentiation. Loss of the pluripotency markers Nanog and 
Oct-4 was detected in hESCs on the mouse feeder cell layer during gp130- 
dependent signalling, indicating that signalling through this pathway is insufficient 
to prevent the onset of differentiation [Humphrey RK 2004, Dah6ron L 2004]. This 
fact suggests the existence of an unidentified factor from mouse feeder layer cells 
that acts to maintain hESC self-renewal independently of STAT3 signalling 
pathway. Hence, the totality of factors and signalling pathways that regulate self- 
renewal activity and pluripotency in hESCs remain to be elucidated. 
The term pluripotent describes stem cells that can give rise to cells derived 
from all three embryonic germ layers - mesoderm, endoderm, and ectoderm 
(Figure 6). During embryogenesis, ESCs specialize into many derivatives of the 
three germ layers including gut epithelium (endoderm); cartilage, bone, smooth 
muscle and striated muscle (mesoderm); and neural, epithelium, embryonic 
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ganglia, and stratified squamous epithelium (ectoderm) [Suemori H 1990]. In 
contrast to adult stem and differentiated cells, ESCs are able to divide continually 
in culture while maintaining their ability to generate any cell type desired provided 
they are supplied with the proper supplements such as growth factors or cytokines 
and placed in the appropriate culture environment. 
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Figure 6. ESCs pluripotency in embryogenesis [Illustrated by author] 
Although it is possible to direct ESC differentiation towards certain desired 
lineages in vitro, it has been difficult to control ESC growth and differentiation into 
higher order structures that are composed of multiple cell types that grow and 
differentiate together to form an integrated functional tissue. Furthermore, the 
inherent ESC properties of self-renewal and differentiation pose a significant 
problem for their clinical usage in the form of uncontrolled growth and 
differentiation, known as teratogenesis. It has been demonstrated that ESCs form 
complex teratomas when engrafted into an immune-deficient host [Gertow K 2004]. 
Transplanted hESCs into immune-deficient mice form complex teratomas 
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consisting of a range of differentiated somatic tissues, some of which appear 
highly organized and resemble structures normally identified in the embryo and 
adult [Przyborski SA 2005]. 
1.4. In Vivo Osteogenesis and 
Stem Cells 
Chondrogenesis of Embryonic 
1.4.1. In Vivo Mesoderm Formation of ESCs 
During embryogenesis, undifferentiated ESCs from the lCM initiate lineage 
differentiation though gastrulation, which is the process by which the embryo at an 
early stage of development produces the three primary germ layers: ectoderm, 
mesoderm, and endoderm [Lu CC 2001]. Embryogenesis mainly consists of four 
major stages: a) fertilized egg division (cleavage), b) formation of a ball of cells 
(morula), c) development of a cavity (blastocyst stage), and d) formation of the 
three primary germ layers that will give rise to all the cell types of the body 
(gastrula stage) and ultimately generate all the specialized tissues and organs of a 
mature organism [Tam PP 1993]. Prior to gastrulation, the majority of cells in the 
pre-im plantation blastocyst are composed of the trophectoderm and the primitive 
endoderm. The pre-implantation embryo consists of the inner cell mass or epiblast 
cells. Subsequently, three differentiated cell types exist: the trophoblast, the 
epiblast (also called the embryonic ectoderm or primitive ectoderm at this stage), 
and the primitive encloderm. During the developmental step, namely gastrulation, 
the primitive endoderm differentiates into two different types of endoderm, parietal 
and visceral endoderm, in the anterior region, which is essential in regulating 
development during gastrulation (Figure 7). In the next phase, the forward 
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migration of the posterior epiblast cells occurs into the space between the epiblast 
and the visceral endoderm resulting in formation of primitive streak in a specific 
region of the epiblast along the posterior axis of the embryo [Lawson A 2003]. 
Mesendoderm, the precursor of mesoderm and endoderm, is derived from 
primitive streak, as is ectoderm. At this stage, the three primary germ layers that 
will generate the body of the embryo are finally formed [Niederlander C 2001]. 
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Figure 7. In vivo differentiation process for mesoderm formation [modified from 
Ref: Tam PP 2007] 
The developmental process of the mesoderm formation and the role of 
visceral endoderm on mesoderm formation in vivo are relatively well understood. 
Visceral endoderm is an extraembryonic cell layer that appears prior to 
gastrulation and performs critical functions during embryogenesis. The traditional 
role ascribed to the visceral endoderm entails nutrient uptake and transport. 
Besides synthesizing a number of specialized molecules that facilitate uptake, 
digestion, and secretion of nutrients, the extraembryonic visceral endoderm 
n coordinates blood cell differentiation and vessel formation in the adjoi ing 
mesoderm, thereby facilitating efficient exchange of nutrients and gases between 
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the mother and embryo [Bielinska M 1999]. Around day 6.5 of gastrulation in the 
mouse, epiblast cells start to migrate in the space between the epiblast and the 
visceral endoderm, and undergo an epithelial to mesenchyme transition (EMT) 
and form the transient primitive. Molecules secreted by the visceral endoderm are 
required for activation of mesoderm development, but the exact pathways still 
remain undetermined [Lu CC 2001, Tam PP 1993, Lawson A 2003, Bielinska M 
1999]. These complex processes result in the formation of the tissues and organs 
and require the activation/inactivation of specific genes at specific times, highly 
integrated cell-cell interactions, and interactions between cells and the ECM 
[Pfendler KC 2005, Grover A 1995], as shown in Figure 8. 
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Figure 8. In vivo mesodermal differentiation strategy of ESCs [Modified from Ref: 
Raghunath J 2005]. 
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1.4.2. In Vivo Osteogenesis and Chondrogenesis 
Ultimately, morphogenesis of the skeleton is the outcome of the regulated 
differentiation, function, and interactions of its component cell types. Two major 
cell types contribute to the skeleton: the osteoblasts, which deposit bone matrix, 
and chondrocytes, which form cartilage. As stated earlier, they are both of 
mesenchymal origin [Colnot C, 20051. During embryogenesis, osteogenic and 
chondrogenic cells may arise from the sclerotomal cells of the somatic mesoderm, 
the somitomeres of the hindbrain or the mesectodermal cells of the neural crest. 
They are believed to derive from a common embryonic progenitor cell, 
mesodermal progenitor cell/mesenchymal progenitor cell [Colnot C 2005, Poliard 
A 1995]. Cells in these lineages migrate to the locations in the embryo where 
skeletal elements will develop, form characteristic mesenchymal condensations of 
high cell density, and differentiate into osteoblasts or chondrocytes [Hall BK1 992]. 
The process of bone development involves four distinct phases: (i) 
migration of mesenchymal cells with osteogenic potential to the site of future 
skeletogenesis, (ii) followed by mesenchymal-epithelial interactions that lead to, 
(iii) condensation (or aggregation) of mesenchymal cells, and (iv) subsequent 
differentiation into the osteogenic lineage [Heng BC 2004]. Descriptive embryology 
and anatomy distinguish two types of bone development: intramembranous and 
endochondral. Intramembranous ossification occurs when mesenchymal precursor 
cells differentiate directly into bone forming osteoblasts, a process employed in 
generating the flat bones of the skull as well as in adding new bone to the outer 
surfaces of long bones. In contrast, endochondral bone formation entails the 
conversion of an initial cartilage template into bone and is responsible for 
generating most bones in the skeleton [Colnot C 2005]. 
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Chondrogenesis (Figure 9) results in the formation of the cartilage 
intermediate, anlagen, and leads to endochondral ossification during skeletal 
development. It occurs in stages beginning with mesenchymal cell recruitment and 
migration, proliferation, and condensation, which are regulated by mesenchymal- 
epithelial cell interactions [Hall BK 2000, Tuan IRS 2004]. The aggregation of 
chondroprogenitors from mesenchymal cells into precartilage condensations 
represents one of the earliest events in chondrogenesis. The differentiation of 
chondroprogenitors is required for subsequent stages of skeletogenesis and is 
characterized by the deposition of cartilage matrix containing collagen types 11, IX, 
and XI as well as aggrecan. Subsequently, the differentiated chondrocytes can 
then proliferate and undergo the complex process of hypertrophic maturation. 
Finally, the development of long bones from the cartilage anlagen occurs by a 
process termed endochondral ossification, which involves terminal differentiation 
of chondrocytes to the hypertrophic phenotype, cartilage matrix calcification, 
vascular invasion, and ossification [Goldring MB 2006]. 
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Figure 9. The process of chondrogenesis (Modified from Ref: Goldring MB, 2006). 
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The molecular and cellular mechanisms underlying the sequential 
differentiation of mesodermal cells into osteogenic and chondrogenic lineages 
have been the object of numerous studies. Studies have identified several factors 
that influence these processes, such as Insulin-like growth factor I (IGF-1), BMP-2, 
-4, and -5 and the TGF-p superfamilies [Erlebacher A 1995, Baker J 1993, 
Wozney JM 1992, Kingsley DM 1992]. Furthermore, at the molecular level certain 
cellular transcription factors are closely associated to skeletal lineage 
differentiation, such as the sry-related transcription factor Sox-9 and the runt- 
related transcription factor Runx-2 [Frank Eamesa B 2004]. However, despite the 
identification of several factors involved in skeletal lineage differentiation of ESCs 
in vivo, the precise mechanism still remains to be fully elucidated. 
1.5. Aims and Objectives 
Aims: The use of ESCs in bone and cartilage tissue engineering and 
regeneration necessitates the development of a well-defined and efficient protocol 
for selectively directing ESC differentiation towards the osteogenic or 
chondrogenic lineages in vitro. The overall objectives of this thesis are the 
development and evaluation of a culture process for enhancing and controlling 
lineage specific differentiation of ESCs, especially into osteoblasts and 
chondrocytes, and the development of three dimensional bone and cartilage 
constructs within a bioreactor culture system. Specifically, this can be achieved 
through enhanced mesoderm formation by investigating the effect of human 
hepatocarcinorna cell line (HepG2) conditioned medium on early differentiation of 
mESCs to primitive streak/nascent mesoderm cells. Subsequently, the focus 
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would be on the development of an integrated, single step culture process for 
direct osteogenic and chondrogenic differentiation of mESC by encapsulation in 
alginate hydrogels and culture in bioreactors, resulting in an efficient and 
reproducible culture system for bone and cartilage tissue engineering applications. 
The specific objectives are: 
m Development of the in vitro protocol for the generation of a specific cell 
population with high osteogenic and chondrogenic potential from mESCs: 
Enhancement of mesoderm formation. 
m Enhancement and control of in vitro osteogenic and chondrogenic differentiation 
of mESCs 
m Establishment of an 2D efficient single-step culture system for direct 
differentiation of mESCs into osteogenic and chondrogenic lineages 
n Development of 3D bone and cartilage tissue like constructs through a 3D 
single-step culture system using alginate encapsulation and culture in the 
Horizontal Aspect Ratio Vessel (HARV) bioreactor. 
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CHAPER 11 
MATERIALS AND METHODS 
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2.1. Overview of Experiment 
The pivotal element of the proposed experiment was divided into four main 
phases; Phase 1: Early differentiation of murine embryonic stem cells (mESCs) into 
primitive streak/nascent mesoderm like cell. Phase 11: In vitro osteogenic and 
chondrogenic differentiation of murine embryonic stem cells through Embryoid 
body (EB) formation. Phase III: In vitro direct osteogenic and chondrogenic 
differentiation of murine embryonic stem cells without EB formation process. 
Phase IV: Bioprocessing for three dimensional bone and cartilage tissue like 
construct formation using alginate encapsulated murine embryonic stem cells and 
HARV bioreactor 
2.2. Basic Materials and Common Assay Techniques 
2.2.1. Media 
2.2.1.1. mESC maintenance medium 
Dulbecco's Modified Eagles Medium (DMEM; Gibco, UK) high glucose / no 
sodium pyruvate was supplemented with 10% foetal bovine serum (FBS; Gibco), 
and 100 units/ml penicillin and 100 ýtg/ml streptomycin, 2 mM L-glutarnine (all 
supplied by GibcO, UK), 0.1 mM P-Mercaptoethanol (Sigma, UK) and 1000 
U/ml 
EsgroTm LIF (Chemicon, UK). 
2.2.1.2. HepG2 maintenance medium 
DMEM high glucose / no sodium pyruvate was supplemented with 10% 
FIBS, 2 mM L-glutarnine and 100 units/ml penicillin and 100 ýtg/rnl streptomycin 
(all 
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supplied by Gibco, UK). 
2.2.1.3. EB formation medium 
Alpha Minimal Essential Medium ((x-MEM; Gibco, UK) was supplemented 
with 15% FIBS, and 100 units/ml penicillin and 100 ýtg/rnl streptomycin. 
2.2.2. Cell Culture 
2.2.2.1. mESC maintenance and expansion 
Prior to mESCs culture, tissue culture plastics were coated with 0.1 % 
gelatin (Sigma, UK) in phosphate buffered saline (PBS; Gibco, UK). mESCs 
(E14/TG2a cell line) was routinely cultured and passaged on 0.1% gelatin coated 
tissue culture plastic at 370C in a 5%CO2 humidified incubator.. Undifferentiated 
mESCs (<p20) were passaged every two or three days and fed everyday with 
fresh mESC maintenance medium. To detach the mESCs from the flasks, 0.5% 
(v/v) trypsin-ethylenediaminetetraacetic acid (Trypsin-EDTA; Gibco, UK) was 
administrated to the mESCs for 5 minutes at 370C, after medium aspiration and a 
single wash with pre-warmed 1X PBS. 
2.2.2.2. HepG2 maintenance and expansion 
Human hepatocarcinoma cell line (HepG2; ATCC HB-8605) were cultured 
on tissue culture plastic at 370C in a 5%CO2 humidified incubator. HepG2 cells 
were passaged every three or four days and fed every 2 days with HepG2 
maintenance medium. 
2.2.2.3. Collection of HepG2 conditioned media 
HepG2 cells were cultured in tissue-culture flasks in a 
5%CO2 humidified 
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incubator using HepG2 maintenance medium at a seeding density of 5.0 x 104 
cel IS/CM2 . The conditioned medium (CM) was collected after three or four days of 
culture, and the collected media was filter-sterilised through a 0.22 ýtm filter unit 
(Nalgene, UK), and then filtered conditioned media was supplemented with 0.1 
mM P-mercaptoethanol (Sigma, UK), and stored at -200C prior to use. 
2.2.3. Common Assay Techniques 
2.2.3.1. Immunocytochernical staining 
Immunocytochernical staining was generally done according to following 
protocol throughout all experiment. Firstly, cells in 4 or 8 well chamber slides were 
fixed with 4% paraformaldehyde (Sigma, UK) for 30 minutes, washed three times 
with 1X PBS, followed by permeabilisation with 0.2% triton X-100 (Sigma, UK), 
and blocking of non-specific binding by incubation with 10% (V/V) 
rabbit/goat/mouse serum (Vector Laboratory, USA), which serum was selected 
according to the origin of primary antibodies. The primary antibodies (diluted to 
proper concentration with bovine serum albumin (BSA)/Azide solution) were 
incubated overnight at 40C. Following a wash with PBS, the secondary 
fluorescent-conjugated antibodies were incubated for 1 hr at room temperature 
which secondary antibodies were selected according to the origin of primary 
antibodies. The cells were counter-stained with 4', 6 diamidino-2-phenylindole 
(DAPI) or Propidium iodide (PI) (Vector Laboratory, USA) to visualize the cell 
nucleus and were observed using epi-fluorescence on a BX-60 microscope and 
images were captured using a Zeiss Axiocam digital camera and analysed using 
KS-300 software. 
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2.2.3.2. Ribonucleic acid (RNA) extraction 
For the analysis of gene expression profile, firstly total RNA was extracted 
from each cell culture or sample using the total RNA isolation kit (Quiagen Ltd, UK) 
according to manufacturer's instruction. Briefly, each sample was kept in ice 
throughout the whole process and was dissolved by 350 or 600ýtl Lysis buffer 
containing 10ýtl/ml P-mercaptoetanol, which volume of Lysis buffer depends on the 
sample amount. Following vigorous vortexing until no visible sign of cell clumps, 
sample solution was transferred to purple column and was centrifuged at max 
speed for 2 min. Equal volume of 70% ethanol was added to sample solution, 
gently mixed and then transferred into pink isolation column. After following 
centrifuge at 15000 rpm for 15 sec, solution was discarded and RNA could be 
present on the membrane of column. 700ýtl RW1 buffer was added into pink 
column and then centrifuged at max speed for 15 sec. After discarding solution, 
pink column was transferred to 2ml new tube and then 500ýtl RIPE solution was 
added into pink column and centrifuged at max speed for 15 sec. After discarding 
solution, 500ýLl RIPE solution was added again into pink column and centrifuged at 
15000 rpm for 2 min. The pink column was transferred to a new tube and then 
30ýtl RNase free water added in the middle of membrane carefully, and then 
centrifuged at max speed for 1 min. Finally, extracted RNA was diluted 20 times 
and then the concentration of RNA was measured UV spectrophotometer 
(Eppenclorf BioPhotometer, Germany). Samples were stored at -80 'C until further 
use. 
2.2.3.3. Reverse transcription (RT) 
1 lig RNA was used as a template for AMV reverse transcriptase. RNA was 
reversed transcribed into complementary deoxynucleic acid (cDNA) using the 
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reverse Transcription System (Promega, UK) according to the manufacturer's 
recommendations. Single-stranded clDNA synthesis was performed with total RNA 
in the presence of 5 mMMgC12,1 mM of dNTP mixture, 1 unit/ýd recombinant 
RNasin ribonuclease inhibitor, 15 units/ýtl AMV reverse transcriptase and 0.5 ýtg/ý, l 
random primers in a total volume of 20 [tl per reaction. Diluted RNA samples were 
heated at 70 OC for 10 min, briefly centrifuged and cooled on ice for 5 min. The 
Mastermix + RNA was incubated at 22 'C for 1 Omin, reverse transcription was 
performed at 42 OC for 40 min, followed by denaturation at 99 OC for 5 min and a 
cooling step at 4 'C for 5 min using a thermocycler (Eppendorf Mastercycler, 
Germany). Samples of cDNA were diluted 5-fold to a final volume of 100 ýtl and 
stored at -20 'C until further use. 
2.2.3.4. Polymerase chain reaction (PCR) amplification 
10 ýLl of the diluted cDNA samples were used for PCR amplification in 20 ýtl 
reactions. PCRs consisted of 1 xAmplitaq Gold Buffer, 1.5 mMMgC12,200 ýM each 
dNTP, 0.2 units of Amplitaq DNA polymerase (PE biosystern) and 0.5 ýM of each 
of 'forward' and 'reverse' primers (Invitrogen custom primers, UK). Reactions were 
incubated in a thermocycler (Eppendorf Mastercycler, Germany) as follows; at 94 
'C for 10 min for one cycle, then 94 OC (30 sec); specific primer annealing 
temperature (30 sec), 72 'C (60 sec) for optimal cycles, and/or with a final 10 min 
extension at 72 OC. The number of amplification cycles used was optimised to 
ensure that product concentration was within the exponential part of the 
amplification reaction. Products were then held at 4 OC. 
2.2.3.5. Agarose gel electrophoresis 
After amplification, PCIR products were analyzed by electrophoresis. 
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Aliquots of 9.6 ýtl of amplified CDNA were mixed with 2.4 ýtl of 6x loading buffer 
and electrophoresed on a 1.5% (w/v) agarose gel (made up with 1 OX TAE buffer 
from Invitrogen, UK; 0.4 M Tris acetate, 10 mM EDTA, pH 8.3), containing 0.001 
ýtg/ml- ethiclium bromide (EtBr). When exposed to Ultraviolet (UV) illumination, the 
gel showed a single band when the mRNA was expressed. Images of the gel were 
captured digitally using a BioRad Fluor-S multi-imager (BioRad/Zeiss, UK). 
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2.3. Early Differentiation of Murine Embryonic Stem Cells into 
Primitive Streak/Nascent Mesoderm Like Cells 
2.3.1. mESCs Expansion and Characterisation 
As a test for characterising the undifferentiation stage prior to the induction 
of early differentiation, mESCs were expanded in mESC maintenance medium at 
370C and 5%CO2and were immuno-stained for Oct-4, CD9 and E-cadherin, and 
expression of alkaline phosphatase (ALPase) was evaluated. Prior to antibody 
reaction, the fixed cells were then incubated with 10% (v/v) blocking goat or rabbit 
serum (Vector Laboratories) for 30 min at room temperature. The primary 
antibodies, goat anti E-cadherin (diluted 1: 50 with BSA/Azide solution; Santa Cruz 
Biotechnology, UK), rabbit anti Oct 4 (diluted 1: 50 with BSA/Azide solution; Santa 
Cruz Biotechnology, UK) and rat anti CID 9 (diluted 1: 50 with BSA/Azide solution; 
Research Diagnostics, USA) were incubated overnight at 4 OC. In secondary 
antibody reaction, the secondary Fluorescein isothiocyanate (FITC)-conjugated 
anti-goat immunoglobulin G (IgG) (Santa Cruz Biotechnology, UK) or Texas Red 
(TR)-conjugated anti-rabbit IgG (Santa Cruz Biotechnology, UK) or Rhodamine 
(R)-conjugated anti-rat IgG (Chernicon, USA) antibodies were incubated for 1 hr at 
room temperature. The cells were counter-stained with DAR to visualize the cell 
nucleus, and other procedure was done according to previously described method 
in the section of 2.2.3.1. Immunocytochernical staining. 
The assessment of alkaline phosphatase (ALPase) expression was done 
using Alkaline Phosphatase Detection Kit (Chernicon, USA). Briefly, the cells were 
fixed with 4% paraformalclehyde (Sigma, UK) for 1 min followed by three washes 
with 1X TBST buffer (20mM Tris-HCI, 0.15M NaCl and 0.05% Tween-20, pH 7.4). 
The fixed cells were stained with Naphtal/Fast Red Violet solution, which was 
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prepared according to manufacturer's instruction, for 15 min in dark and then 
washed with 1X PBS. Images of stained cells were captured using Leica inverted 
microscope (Leica, UK) equipped with Olympus DP50 digital camera (Olympus 
Optical Co, Tokyo, Japan) and analyzed using analySISO imaging software (Soft 
Image System GmbH, Germany). 
In addition, in order to establish the optimal condition for mESC expansion, 
the mESC growth in accordance with initial cell seeding density was evaluated 
using the CeIlTiter 960 AQueous non-radioactive cell proliferation assay (Promega, 
UK). mESCs were seeded on 0.1% (v/v) gelatin coated 24 well plates with initial 
cell seeding density of 7500,15000 and 30000 ce IIS/CM2 , and cultured in mESC 
maintenance medium for 1,2,3,4, and 5 days at 370C in a 5%CO2 incubator. 
After culture, unattached cells were removed by thoroughly washing 3 times with 
1X PBS. Cell proliferation were evaluated by quantifying the metabolically active 
adherent or proliferating cells by measuring the level of the endogenous 
mitochondrial clehydrogenase by addition of 200 ýtl/well of DMEM without phenol 
red (Gibco, UK) and 40 ýtl/well of mitochondrial dehydrogenase substrate 
(Promega, UK). Following 2 hrs incubation, mitochondrial dehydrogenase activity 
was stopped by addition of 50 ýtl/well 10% (w/v) sodium dodecyl sulfate (SIDS; 
Sigma, UK) in 1X PBS. The plates were read at a 490 nm wavelength using an 
ELISA reader (MRX 11, Dynex Technology, USA). A standard curve (Appendix 1) 
was generated by measuring the level of the enclogenous mitochondrial 
dehydrogenase of mESCs after 4 hrs of seeding in accordance with serial cell 
seeding density using the same protocol above mentioned in order to determine 
the number of adherent or proliferating cells. Data were expressed as number of 
cells/cm 
2. 
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2.3.2. Induction of mESCs Early Differentiation by HepG2 Conditioned Media 
For the early differentiation of mESCs, mESCs were cultured for three 
days in tissue-culture flasks coated with 0.1% (v/v) gelatin using a 1: 1 mixture 
containing the HepG2 conditioned medium (CM) and the standard mESC 
maintenance medium containing LIF described earlier. CM treated mESCs is 
denominated as CM-mESCs in further experimental protocol. 
2.3.3. Embryoid Body (EB) Formation 
Prior to establishment of EB formation process, two different EB formation 
medium were tested to provide suitable environment for efficient EB formation of 
undifferentiated mESCs and CM-mESCs; DMEM with high glucose/no sodium 
pyruvate was supplemented with 15% FIBS, and 100 units/ml penicillin and 100 
ýtg/ml streptomycin or (x-MEM was supplemented with 15% FBS, and 100 units/ml 
penicillin and 100 ýtg/rnl streptomycin. 
The CM-mESCs and undifferentiated mESCs were trypsinised to detach 
cells from flasks; trypsinisation was stopped through addition of prewarmed serum 
containing medium before the dispersion of single cells became apparent. The cell 
colonies were very gently centrifuged for 10 sec and re-suspended in pre-warmed 
EB formation medium. The re-suspended cells were plated onto non-tissue culture 
treated petri dishes and cultured at 370C in a 5%CO2 humidified incubator. The 
cultures were fed every two days by replacing with fresh medium. 
2.3.4. Characterisation 
2.3.4.1. Morphological observation 
After culture of mESCs in mESC maintenance medium or 50% of CM and 
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EB culture in EB formation media, cells and EBs morphology were observed 
routinely using an inverted phase microscope (Olympus IX70, UK) equipped with 
analysisD soft imaging system (Soft imaging system GmbH, Germany). The 
change of mESCs and ElBs morphology was captured. 
2.3.4.2. Cell adhesion and proliferation assay 
The cell adhesion and proliferation activity of mESCs in standard mESC 
maintenance culture medium and in 50% HepG2 CM were compared as follows: 
24-well tissue culture polystyrene plates were coated with 0.1 % (v/v) gelatin for 30 
min. For cell adhesion studies, mESCs were seeded onto the plates at the density 
of 3.0 X 104 cel IS/CM2 and allowed to adhere for 1,2, and 4 hr in standard mESC 
culture medium or 50% HepG2 conditioned medium at 370C in a 5% C02 
humidified incubator. For cell proliferation studies, mESCs were seeded onto the 
plates at the density of 3.0 x 104 ce IIS/CM2 and cultured for 1,2,3,4, and 5 days in 
standard mESC maintenance culture medium or 50% HepG2 conditioned medium 
at 37'C in a 5%CO2 humidified incubator. Unattached cells were removed by 
thoroughly washing 3 times with 1X PBS. Cell adhesion and proliferation were 
evaluated using the CeIlTiter 960 AQueous non-radioactive cell proliferation assay 
according to previously described method in the section of 2.3.1. 
2.3.4.3. ALPase expression and ALPase activity 
The undifferentiation/differentiation stage of mESCs in 50% HepG2 
conditioned medium was evaluated by assessing AI-Pase expression and AI-Pase 
activity in cOmParison with undifferentiated mESCs in mESC maintenance medium. 
rnESCs were seeded onto the plates at the density of 3.0 x 
104 cel IS/CM2 and 
cultured for 3 days in standard mESC maintenance culture medium or 50% 
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HepG2 conditioned medium at 370C in a 5%CO2humidified incubator. Unattached 
cells were removed by thoroughly washing 3 times with 1X PBS. After 1 and 3 
days of culture, the assessment of ALPase expression was done with same 
protocol as previously described in the section of 2.3.1. Images of stained cells 
were captured using Leica inverted microscope (Leica, UK) equipped with 
Olympus DP50 digital camera (Olympus Optical Co, Tokyo, Japan) and analyzed 
using analySISO imaging software (Soft Image System GrnbH, Germany). 
In the parallel experiment of AI-Pase expression, the AI-Pase activity for 
mESCs in 50% HepG2 conditioned medium or mESC maintenance medium was 
determined at day 3 of culture, in order to capture the temporal nature of AI-Pase 
activity. Briefly, unattached cells were removed by gentle washing with1X PBS. 
The cells were then incubated with pre-warmed 150 ýtl/well of ALPase buffer 
(Sigma) and 150 ýtl/well of a p-nitrophenyl phosphate solution (Sigma) for 30 min 
in a 5%CO2 humidified incubator at 37 OC. The reaction was stopped by adding 
200 ýLl/well of 0.5N NaOH solution. The production of p-nitrophenol was 
determined by absorption at 405 nm using an ELISA reader (MRX 11, Dynex 
Technology). A calibration curve (Appendix 2) was generated using standard p- 
nitrophenol solution (Sigma, UK) and the amount of total p-nitrophenol produced 
from cultured cells was enumerated from the calibration curve. In addition, the 
content of cellular protein in culture was evaluated at each experimental time point 
using Lowry or Bicinchoninic acid (BCA) method. Calibration curves (Appendix 3) 
were generated using bovine serum albumin (Sigma, UK) and Bio-Rad DC protein 
assay kit (Bio-Rad, USA) and BCATm protein assay kit (Pierce, USA) according 
to 
the manufacturer's instruction, and the amount of total protein produced 
from 
cultured cells was enumerated from the calibration curve. Finally, the enzyme 
activity was expressed as micromoles of reaction product (p-nitrophenol) per 
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minute per mg of total cellular protein. 
2.3.4.4. Immunocytochemistry 
The effect of HepG2 conditioned media on mESCs early differentiation was 
evaluated by specific staining for Oct-4 and E-cadherin. mESCs were cultured in 
mESC maintenance medium and 50% HepG2 conditioned medium at 370C in a 
5%CO2 humidified incubator and were immuno-stained for Oct-4 and E-cadherin. 
Prior to antibody reaction, the fixed cells were then incubated with 10% (v/v) 
blocking goat or rabbit serum (Vector Laboratories) for 30 min at room 
temperature. The primary antibodies, goat anti E-cadherin (diluted 1: 50 with 
BSA/Azide solution; Santa Cruz Biotechnology, UK), and rabbit anti Oct 4 (diluted 
1: 50 with BSA/Azide solution; Santa Cruz Biotechnology, UK) were incubated 
overnight at 40C. In secondary antibody reaction, the secondary FITC-conjugated 
anti-goat IgG (Santa Cruz Biotechnology, UK) or TR-conjugated anti-rabbit IgG 
(Santa Cruz Biotechnology, UK) antibodies were incubated for 1 hr at room 
temperature. The cells were counter-stained with DAR to visualize the cell 
nucleus and were observed using epi-fluorescence on a BX-60 microscope and 
images were captured using a Zeiss Axiocam digital camera and analysed using 
KS-300 software, and other procedure was done according to previously 
described method in the section of 2.2.3.1. 
2.3.4.5. Reverse transcription and polymerase chain reaction (RT-PCR) 
For evaluating the change of gene expression profile in CM-mESCs and its 
derived EBs in comparison with undifferentiated mESCs and its derived EBs, 
mESCs were cultured in standard mESC culture medium or 
50% HepG2 
conditioned medium at 370C in a 5% C02 humidified incubator 
for 3 days. 
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Following monolayer culture, HepG2 conditioned medium treated mESCs (CM- 
mESCs) were trypsinised to detach cells from flasks; trypsinisation was stopped 
through addition of serum containing medium before the dispersion of single cells 
became apparent. The cell colonies were very gently centrifuged for 10 sec and 
re-suspended in pre-warmed EB formation medium. The re-suspended cells were 
plated onto non-tissue culture treated petri dishes and were allowed to form EBs 
for 1-day (CM-mESC-EBl), 3-days (CM-mESC-EB3), or 5-days (CM-mESC-EB5) 
in suspension culture at 370C in a 5%CO2 humidified incubator . The cultures 
were fed every two days by replacing with fresh medium. Non-treated mESCs 
were allowed to form EB for 5 days as control group After culture, total RNA was 
extracted from cells of each test group, and RNA extraction and RT-PCR 
procedure was done according to previously described method in the sections of 
2.2.3.2-2.2.3.5. Primers which used in this experiment and the expected product 
size are detailed in Table 1 
Table 1. Oligonucleoticle primers for RT-PCR analysis for mESCs early 
differentiation 
Gene Sequence Product (bp) 
mBrachyury sense 5'-AAGGAACCACCGGTCATC-3' 319 
antisense 5-GTGTCGTCAGTGGTGTGTAATG-3' 
mGoosecoid sense 5'-GCACCATCTTCACCGATGAG-3' 523 
antisense 5'-AGGAGGATCGCTTCTGTCGT-3' 
mNodal sense 5'-TGTGTCTATCCAGGGAGCAGAA-3' 195 
antisense 5-CAAGCAGTTCATAAACCCTATTTCC-3' 
mCritpo-1 sense 5'-GTCCCTGATAGTCTCTGATATTC-3' 240 
antisense 5'-GAAATGTAAGAGAAGTCATGGG-3' 
mGAPDH sense 5'-CATCACCATCTTCCAGGAGC-3' 500 
antisense 5'-ATGCCAGTGAGCTTCCCGTC-3' 
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2.3.4.6. Reversibility of early differentiation and characterisation 
The reversible differentiation of CM-mESCs to undifferentiated mESCs was 
tested by morphological observation and immuno-staining with several markers 
indicating undifferentiation/differentiation stage. mESCs were cultured in various 
conditions at 370C in a 5%CO2humidified incubator; Four experimental groups 
were set-up. Group 1 is mESCs culture in standard mESC maintenance medium 
(denominated as mESC), Group 2 is mESCs culture in 50% HepG2 conditioned 
medium for 3 days (denominated as CM-mESC), Group 3 is mESCs which were 
replated and cultured in mESC maintenance medium following HepG2 conditioned 
medium treatment for 3 days (denominated as CM-mESC-rr), and Group 4 is 
mESCs which were cultured in mESC maintenance media following HepG2 
conditioned media treatment for 3 days with direct media replacement without 
replating (denominated as CM-mESC-rd). 
After culture, morphological change of each groups were observed using 
an inverted phase microscope (Olympus IX70, UK) equipped with analysislD soft 
imaging system (Soft imaging system GmbH, Germany). 
In addition, as a test for characterising the undifferentiation/differentiation 
stage of mESCs in various culture conditions in molecular level, each groups were 
immuno-stained for Oct-4, CD9 and E-cadherin. Prior to antibodies reaction, the 
fixed cells were then incubated with 10% (v/v) blocking goat or rabbit serum for 30 
min at room temperature. The primary antibodies, goat anti E-cadherin (diluted 
1: 50 with BSA/Azide solution), rabbit anti Oct 4 (diluted 1: 50 with BSA/Azide 
solution) and rat anti CID 9 (diluted 1: 50 with BSA/Azide solution) were 
incubated 
overnight at 40C. In secondary antibody reaction, the secondary 
FITC-conjugated 
anti-goat IgG or TR-conjugated anti-rabbit IgG or 
R-conjugated anti-rat IgG 
antibodies were incubated for 1 hr at room temperature. 
The cells were counter- 
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stained with DAR to visualize the cell nucleus, and other procedure was done 
according to previously described method in the section of 2.2.3.1. 
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2.4. In Vitro Osteogenic and Chondrogenic Differentiation of 
Murine Embryonic Stem Cells through EB Formation 
2.4.1. Osteogenic and Spontaneous Cardiogenic Differentiation 
2.4.1.1. Osteogenic Media 
a-MEM was supplemented with 15% FBS, and 100 units/ml penicillin and 
100 ýtg/ml streptomycin containing 50 ýtg/ml ascorbic acid (Sigma, UK) in 1X PBS 
and 10 mM P-glycerophosphate (Sigma, UK) in 1X PBS. After 14 days of culture, 
the medium was further supplemented with 1 ýM clexamethasone (Sigma, UK) in 
1X PBS. 
2.4.1.2. Experimental groups 
Three experimental groups and one control group were set-up. The 
experimental groups consisted of CM-mESCs allowed to form EBs for 1 -day (CM- 
mESC-EB1), 3-days (CM-mESC-EB3), or 5-days (CM-mESC-EB5), followed by a 
further 21 days of culture in the osteogenic medium detailed above. The control 
group (EB5) consisted of mESCs maintained for 3 days in the standard mESC 
maintenance medium, followed by EB formation for 5 days. The control group 
represents the standard protocol for development of mesoderm required for 
skeletal cell lineage differentiation, which EB formation for 5 days is generally 
accepted method to induce spontaneous mesoderm formation for further 
mesodermal lineage differentiation [Nakayama N 2003, Kramer J 2000 & 2005, 
Kawaguchi J 2005, Tanaka H 2004, Buttery LD 2001, Xu C 2002], prior to being 
cultured for a further 21 days in the osteogenic medium previously described. 
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2.4.1.3. Osteogenic differentiation 
After EB formation, the EBs of each test group were very gently 
centrifuged and then trypsinised to release single cells; trypsinisation was stopped 
through addition of serum containing medium before the dispersion of single cells 
became apparent. The single cell dispersion was centrifuged at 1000 rpm for 10 
min and re-suspended, and then re-suspended cells were plated in tissue culture 
plates at a cell density of 30,000 ce IIS/CM2 in our previously described basic 
osteogenic medium. The cultures were maintained at 37 OC in a 5% C02 
humidified incubator and fed every two days up to 21 days. 
2.4.1.4. Beating colony formation and quantification 
During the culture, spontaneous cardiogenic differentiation was evaluated. 
Beating colonies were counted at day 11,16, and 21 of culture using an inverted 
phase microscope (Olympus IX70) equipped with a Nikon CoolPix 950 digital 
camera. Data were expressed as number of beating colonies/well in each well of a 
6-well plate. 
2.4.1.5. Bone nodule formation and quantification (Alizarin Red-S staining) 
Bone nodule formation was evaluated at day 11,16, and 21 of osteogenic 
culture. After culture, cells in each test group were fixed with 4% 
paraformalclehyde (Sigma, UK) for 20 min followed by three washes with 1X PBS. 
The fixed cells were stained with 40 mM Alizarin Red S (ARS; Sigma, UK) solution 
(pH4.2) for 20 min at room temperature and then washed with 1X PBS three times 
and with tap water. Bone nodules were counted using an inverted epi-fluorescence 
microscope (BX-60, Olympus, Japan) and images were captured using a Zeiss 
Axiocarn digital camera and analysed using KS-300 software (imaging Associates, 
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UK). Only bone nodules fluorescent were counted as positive when AIRS stained 
area was exposed to filtered UV light (excitation at 530-560 nm and emission at 
580 nm) to exclude non-specific staining. 
2.4.1.6. Immunocytochernical staining 
Osteogenic and spontaneous cardiogenic differentiation in molecular level 
was characterised by immunostaining for OB-cadherin, and sarcomeric (x-actinin 
and tropornyosin, respectively. Prior to antibodies reaction, the fixed cells were 
then incubated with 10% (v/v) blocking goat or mouse serum (Vector Laboratories) 
for 30 min at room temperature. The primary antibodies, goat anti OB-cadherin 
(diluted 1: 50 with BSA/azide solution; Santa Cruz Biotechnology, UK), mouse anti 
sarcomeric (x-actinin (diluted 1: 800 with BSA/Azide solution; Sigma), and mouse 
anti tropomyosin (diluted 1: 50 with BSA/Azide solution; Sigma) were incubated 
overnight at 4'C. In secondary antibodies reaction, the secondary FITC- 
conjugated goat anti-mouse IgG (Jackson Immunoresearch laboratory, USA) or 
FITC-conjugated rabbit anti-goat IgG (Santa Cruz Biotechnology) antibodies were 
incubated for 1 hr at room temperature. The cells were counter-stained with DAR 
to visualize the cell nucleus and were observed using epi-fluorescence on a BX-60 
microscope and images were captured using a Zeiss Axiocam digital camera and 
analysed using KS-300 software, and other procedure was done according to 
previously described method in the section of 2.2.3.1. 
2.4.1.7. Reverse transcription and polymerase chain reaction (RT-PCR) 
For evaluating the change of gene expression profile in osteogenic 
differentiation and spontaneous cardiogenic differentiation of each test groups, 
after 11 days of culture, total RNA was extracted from cells of each test group, and 
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RNA extraction and RT-PCR procedure was done according to previously 
described method in the sections of 2.2.3.2-2.2.3.5. Primers which used in this 
experiment and the expected product size are detailed in Table 2. 
Table 2. Oligonucleoticle primers for RT-PCR analysis for osteogenic and 
spontaneous cardiogenic differentiation through EB formation 
Gene Sequence Product (bp) 
sense 5'- CATGGTGGAGATCATCGC -3' 
mCbfal/ Runx2 
antisense 5'- ACTCTTGCCTCGTCCACTC -3' 285 
sense 5'- TGGCGTCGGGGACTTGAAC -3' 
mNkx-2.5 
antisense 5'- AGGCTACGTCAATAAAGTGG -3' 259 
sense 5'-CATCACCATCTTCCAGGAGC-3' 
mGAPDH 
antisense 5'-ATGCCAGTGAGCTTCCCGTC-3' 500 
2.4.1.8. Colorimetric quantification of ALPase activity 
ALPase activity for each test group was determined at day 6,11,16 and 21 
of osteogenic culture, in order to capture the temporal nature of AI-Pase activity. 
Briefly, unattached cells were removed by gentle washing with 1X PBS. Following 
AI-Pase activity assay was done according to previously described method in the 
sections of 2.3.4.3. 
2.4.2. Chondrogenic Differentiation 
2.4.2.1. Chondrogenic media 
a-MEM was supplemented with 15% FBSI 100 units/ml penicillin and 
100 
ýtg/rnl streptomycin, 0.4 mM L-proline (Sigma, 
UK), 1X Non essential amino acid 
(Gibco, UK), 4500 mg/L glucose, 1X insulin-transferrin-selenium (ITS; Sigma, UK), 
50 ýtg/ml ascorbic acid (Sigma, UK), 1 ýM dexamethasone 
(Sigma, UK) and 50 
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ng/ml insulin like growth factor (IGF-1, Sigma, UK). 
2.4.2.2. Experimental groups 
Three experimental groups and one control group were set-up. The 
experimental groups consisted of CM-mESCs allowed to form ElBs for 1-day (CM- 
mESC-EB1), 3-days (CM-mESC-EB3), or 5-days (CM-mESC-EB5), followed by a 
further 15 days of culture in the chondrogenic medium detailed above. The control 
group (EB5) consisted of mESCs maintained for 3 days in the standard mESC 
maintenance medium, followed by EB formation for 5 days. 
2.4.2.3. Micromass culture for chondrogenesis 
For high cell density micromass culture, after EB formation, the CM-mESC- 
EBs and control EBs were gently centrifuged and then trypsinized to release single 
cells; trypsinisation was stopped by addition of serum-containing EB formation 
medium before the dispersion of single cells became apparent. The single cell 
dispersion was centrifuged and resuspended at density of 10 x 106 cells/ml and 20 
ýtl drops (2 x 105 cells: 380000 ce IIS/CM2) spotted onto 24 well plates. In addition, 
for RT-PCR and immunocytochernistry, cells were plated in 6 well plates and 8 
well chamber slides at a cell density of 380000 ce IIS/CM2 . After 30 min, wells were 
flooded with 2 ml chondrogenic medium. The cultures were fed everyday by 
replacing half the volume with fresh medium and maintained in a 5% C02 
humidified incubator. 
2.4.2.4. Measurement of Alcian blue-stained areas 
Cartilage nodule formation in chondrogenic culture was evaluated at day 
15 of culture by the measurement of GAG-specific Alcian blue stained area. Cells 
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were fixed with 4% paraformaldehyde for 20 min, washed in 1X PBS, and stained 
with 1% (w/v in 3% Acetic acid, pH 2.5) Alcian blue 8 GX (Sigma, UK) for 20 min 
and then washed with 1X PBS. Stained cartilage nodules were observed using an 
inverted microscope (BX-60, Olympus, Japan). The area of stained nodule was 
calculated from randomly taken pictures using Photoshop program (Adobe, USA). 
The area of the stained region was expressed relative to the whole area of the 
picture including stained region. 
To exclude the possibility that any Alcian blue-stained region derived from 
bone or other cell colonies rather than cartilage, we performed dual staining with 
Alcian blue and Alrizarin red-S. After Alcian blue staining, the nodules were stained 
with 40 mM Alizarin Red S (ARS) solution (pH4.2) for 20 min at room temperature 
and then washed with 1X PBS. The stained cell cultures were observed using an 
inverted epi-fluorescence microscope (BX-60, Olympus, Japan) and images were 
captured using a Zeiss Axiocam digital camera and analysed using KS-300 
software (Imaging Associates, UK) 
2.4.2.5. Measurement of sulfated GAG content (1,9-Dimethimethylene Blue 
(DMMB) assay) and DNA content 
To measure sulfated glycosaminoglycans (GAG) produced by cells, DMMB 
assay was performed as documented in [Barbosa 1 2003] with a slight adaptation. 
Briefly, after culture for chondrogenic differentiation, all cell cultures were digested 
with Proteinase K solution (50 ýtg/rnl proteinase K in 100 mM K2HP04 (pH 8.0), 
Sigma, UK) at 370C overnight with shaking in a C02 incubator. After digestion, 
samples were transferred to 1.5 ml centrifuge tubes, and then proteinase K activity 
was inactivated by heating at 90 'C for 10 min. After centrifugation at 12,000g for 
0 min, supernatant was collected to use in GAG quantification and DNA content 
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measurement. 100 ýtl Proteinase K-treated samples solution were reacted with 1.4 
ml DMMB solution (Sigma) through vigorous vortexing for 30 min resulting in 
complexation of GAG with DMMB- After centrifugation at 12,000g for 10 min, 
precipitates of insoluble GAG-DMMB complex were dissolved with 1 ml DMMB 
clecomplexation solution with vortexing for 10 min, and the OD650 of the solution 
was measured using an ELISA Plate Peader (MRX 11, Dynex Technology, Finland). 
A calibration curve (Appendix 4) was generated using the chondroitin sulfate 
solution (Sigma, UK), and the amount of total GAG produced from cultured cells 
was enumerated from the calibration curve. 
From the Proteinase K-treated samples solution, 100ýtl of the sample 
supernatant was placed in a DNA/RNA free eppendorf tube along with 100ýtl of 
Hoescht 33258 solution (2 ýtg/ml; Sigma, UK) and vortexed for 2-3 min. An aliquot 
(100ýLl) of the solution was then read using a microtiter plate fluorometer (MFX, 
Dynex Technology, Finland) with the excitation wavelength being at 365 nm and 
the emission wavelength at 460 nm. A calibration curve (Appendix 5) was 
generated using highly polymerised calf-thymus DNA (Sigma, UK) and the amount 
of total DNA produced from routinely cultured cells was enumerated from the 
calibration curve. 
For the final data analysis, GAG values were normalized to total values of 
DNA content determined by Hoechst 33258 assay. The GAG content was 
expressed as relative GAG content at each culture time to GAG content at 
0 day 
culture of each test group. 
2.4.2.6. Immunocytochernical staining 
Chondrogenic differentiation in molecular level was evaluated by 
immunostaining for type 11 collagen. Prior to antibodies reaction, the fixed cells 
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were then incubated with 10% (v/v) blocking goat serum (Vector Laboratories) for 
30 min at room temperature. The primary antibodies, goat anti type 11 collagen 
(diluted 1: 50 with BSA/Azide solution; Santa Cruz Biotechnology, UK) were 
incubated overnight at 40C. In secondary antibodies reaction, the secondary FITC- 
conjugated rabbit anti-goat IgG (Santa Cruz Biotechnology) antibodies were 
incubated for 1 hr at room temperature. The cells were countered stained with 
DAR to visualize the cell nucleus. 
2.4.2.7. Reverse transcription and polymerase chain reaction (RT-PCR) 
For evaluating the change of gene expression profile in chondrogenic 
differentiation of CM-mESC-EB1, after 5,10 or 15 days of culture, total RNA was 
extracted from cells of each test group, and RNA extraction and RT-PCR 
procedure was done according to previously described method in the sections of 
2.2.3.2-2.2.3.5. Primers which used in this experiment and the expected product 
size are detailed in Table 3. 
Table 3. Oligonucleoticle primers for RT-PCR analysis for chondrogenic 
differentiation through EB formation 
Gene Sequence Product (bp) 
mcol 11 sense 5'-GCGCTCACGCCGCGGTCCTA-3' 
antisense 5'-AGGGGTACCAGGTTCTCCATC-3' 
mcol X sense 5'-CCTGGGTTAGATGGAAAA-3' 
antisense 5'-AATCTCATAAATGGGATGGG-3' 
mAggrecan sense 5'-AGGGTGAGAAGGTAAGGGGT-3' 
antisense 5'-GAGGCGAAGTAACCAACCAT-3' 
MSOX-9 sense 5'-GTGGCAAGTATTGGTCAA-3' 
antisense 5'-GAACAGACTCACATCTCT-3' 
mGAPDH sense 5'-CATCACCATCTTCCAGGAGC-3' 
463(IIA) 
222(11B) 
579 
102 
320 
500 
antisense 5'-ATGCCAGTGAGCTTCCCGTC-3' 
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2.5. In Vitro Osteogenic and Chondrogenic Differentiation of 
Murine Embryonic Stem Cells without EB Formation 
2.5.1. Direct Osteogenic Differentiation without EB Formation 
2.5.1.1. Direct osteogenic differentiation 
For in vitro direct osteogenesis, mESCs were directly plated at a cell 
density of 10,000 ce IIS/CM2 , and were cultured for 3 days in the culture condition of 
a 1: 1 (v/v) mixture of HepG2 CM and the standard mESC maintenance medium in 
a same manner with the section of 2.3.2. Induction of mESCs early differentiation 
by HepG2 conditioned media. After 3 days, the conditioned media was directly 
replaced by osteogenic medium previously described in the section of 2.4.1.1. The 
cultures were maintained at 370C in a 5%CO2 humidified incubator and fed every 
2 days up to 21 days. As a comparative control group, mESCs were cultured in 
mESC maintenance medium for 3 days, and then cultured in osteogenic medium 
up to 21 days. 
2.5.1.2. Bone nodule formation (ARS staining) and AIRS quantification 
Bone nodule formation assay was done by mineralised nodule specific 
Alizarin red S (ARS) staining and the quantification of extracted ARS from stained 
bone nodules using cetylpyridiniurn chloride (CPC) extraction method [Gregory CA 
2004] with a slight adaptation. After 6,11,16, and 21 days of osteogenic culture, 
each test group were fixed with 4% paraformaldehyde for 20 min followed by three 
washes with 1X PBS, and then were stained with AIRS in a same way previously 
described in the section of 2.4.1.5. These AIRS stained bone nodules were 
captured were captured using a Zeiss Axiocam digital camera in an inverted epi- 
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fluorescence microscope (BX-60, Olympus, Japan). In addition, for the 
quantification of bone nodule formation, AIRS from stained bone nodules in 6 well 
plates were extracted with 2ml CPC buffer (10% (w/v) CPC in 10mM Na2PO4 (pH 
7.0)) for 1 hr with shaking at 370C, and then 20041 aliquots were transferred to a 
96-well plate and the OD550 of the solution was measured using an microplate 
reader (ELx 808, Bio-Tek Instrument, USA). 
2.5.1.3. ALPase expression and ALPase activity 
Direct osteogenic differentiation of mESCs and CM-mESCs was evaluated 
by assessing ALPase expression and ALPase activity. mESCs were seeded onto 
the 48 well plates at the concentration of 1.0 x 104 cel IS/CM2 and cultured for 3 
days in standard mESC maintenance culture medium or 50% HepG2 conditioned 
medium and then were induced to differentiate osteogenic lineage in osteogenic 
medium for 21 days at 370C in a 5%CO2humidified incubator. At day 6,11,16, 
and 21 of culture, AI-Pase expression and its activity was measured using the 
same method as previously described in the section of 2.3.4.3. 
2.5.1.4. Immunocytochernical staining 
Direct Osteogenic differentiation in molecular level was characterised by 
immunostaining for type I collagen and osteopontin, respectively. Prior to antibody 
reaction, the fixed cells were then incubated with 10% (v/v) blocking goat serum 
(Vector Laboratories) for 30 min at room temperature. The primary antibodies, 
goat anti type I collagen (diluted 1: 50 with BSA/azide solution; Santa Cruz 
Biotechnology, UK), and goat anti osteopontin (diluted 1: 50 with BSA/Azide 
solution; Sigma) were incubated overnight at 40C. In secondary antibody reaction, 
the secondary FITC-conjugated rabbit anti-goat IgG (Santa Cruz Biotechnology) 
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antibodies were incubated for 1 hr at room temperature. The cells were counter- 
stained with DAR to visualize the cell nucleus and were observed using epi- 
fluorescence on a BX-60 microscope and images were captured using a Zeiss 
Axiocam digital camera and analysed using KS-300 software, and other procedure 
was done according to previously described method in the section of 2.2.3.1. 
2.5.1.5. Reverse transcription and polymerase chain reaction (RT-PCR) 
For evaluating the change of gene expression profile in direct osteogenic 
differentiation of mESCs and CM-mESCs, after 6,11,16 and 21 days of culture, 
total RNA was extracted from cells of each group, and RNA extraction and RT- 
PCR procedure was done according to previously described method in the 
sections of 2.2.3.2-2.2.3.5. Primers which used in this experiment and the 
expected product size are detailed in Table 4. 
Table 4. Oligonucleotide primers for RT-PCR analysis for direct osteogenesis 
Gene Sequence Product(bp) 
mOsteocalcin sense 5'-CGGCCCTGAGTCTGACAAA-3' 50 
antisense 5'-ACCTTATTGCCCTCCTGCTT-3' 
mCbfal/Runx2 sense 5'- CATGGTGGAGATCATCGC -3' 285 
antisense 5'-ACTCTTGCCTCGTCCACTC-3' 
mOsterix sense 5'-CAGGCATCCACGCAGGCATCTC-3' 398 
antisense 5'-TGGGGCAGTCGCAGGTAGAACG-3' 
mGAPDH sense 5'-CATCACCATCTTCCAGGAGC-3' 500 
antisense 5'-ATGCCAGTGAGCTTCCCGTC-3' 
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2.5.2. Direct Chondrogenic Differentiation without EB Formation 
2.5.2.1. Chondrogenic medium 
cc-MEM supplemented with 15% (v/v) FIBS, 100 units/ml penicillin and 100 
ýtg/rnl streptomycin, 0.4 mM L-proline (Sigma), 1X non essential amino acid 
(Gibco), 4.5 g/L glucose (Sigma), 1X insulin-transferrin-selenium (ITS; Sigma, UK), 
50 ýtg/ml ascorbic acid (Sigma), 1 ýM dexamethasone (Sigma) and 50 ng/ml 
transforming growth factor-pl (TGF-pl; Sigma, UK) were added. TGF-pl was 
reconstituted in 4 mM HCI, which activates TGF-P1 from its latent form, containing 
1 mg/ml of bovine serum albumin, prior to the addition of the TGF-01 to the 
medium. 
2.5.2.2. Direct chondrogenic differentiation 
For in vitro direct chondrogenesis, mESCs were directly plated at a cell 
density of 30,000 cel IS/CM2, and were cultured for 3 days in the culture condition of 
a 1: 1 (v/v) mixture of HepG2 CM and the standard mESC maintenance medium in 
a same manner with the section of 2.3.2. After 3 days, the conditioned media was 
directly replaced by chondrogenic medium previously described in the section of 
2.5.2.1. The cultures were maintained at 370C in a 5%CO2 humidified incubator 
and fed everyday up to 15 days. As a comparative control group, mESCs were 
seeded at a cell density of 30,000 ce IIS/CM2 , and cultured 
in mESC maintenance 
medium for 3 days, and the conditioned media was directly replaced by 
chondrogenic medium previously described in the section of 2.5.2.1., and cultured 
in chondrogenic medium upto 15 days. 
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2.5.2.3. Morphological observation 
During the direct chondrogenic differentiation, morphological change of 
mESCs and CM-mESCs were observed routinely using an inverted phase 
microscope (Olympus IX70, UK) equipped with analysislD soft imaging system 
(Soft imaging system GmbH, Germany). The change of mESCs and CM-mESCs 
morphology was captured. 
2.5.2.4. Measurement of Alcian blue-stained areas 
Cartilage nodule formation in the culture for direct chondrogenic 
differentiation was evaluated at day 15 of culture by the measurement of GAG- 
specific Alcian blue stained area. After culture, mESCs and CM-mESCs were fixed 
with 4% paraformaldehyde for 20 min, washed in 1X PBS, and stained with 1% 
(w/v in 3% Acetic acid, pH 2.5) Alcian blue 8 GX for 20 min and then excessive 
staining was washed with 1X PBS several times. Stained cartilage nodules were 
observed using an inverted microscope (BX-60, Olympus, Japan). The area of 
stained nodule was calculated from randomly taken pictures using Photoshop 
program (Adobe, USA). The area of the stained region was expressed relative to 
the whole area of the picture including stained region. 
2.5.2.5. Measurement of sulfated GAG content (1,9-Dimethimethylene Blue 
(DMMB) assay) and DNA content 
After 5,10,15 days of culture for direct chondrogenic differentiation, the 
content of sulfated glycosaminoglycans (GAG) produced by mESCs and CM- 
mESCs and DNA content was measured using DMMB assay method and Hoechst 
33258 DNA assay method previously described in the section of 2.4.2.5. GAG 
values were normalized to total values of DNA content determined by Hoechst 
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33258 assay. 
2.5.2.6. Measurement of collagen content and DNA content 
In addition to the measurement of GAG content, after 5,10,15 days of 
culture for direct chondrogenic differentiation, collagen content was quantified 
using the collagen detection kit (Sircol Collagen Assay S 1000, Biocolor Ltd, 
Ireland) according to manufacturer's instruction. Briefly, following chondrogenic 
differentiation for 5,10 and 15 days, non-attached cells were removed by washing 
with 1X PBS, and all cultures were digested with 0.5 ml (starting volume) of pepsin 
(Sigma, UK) solution (2 mg/ml dissolved in 0.05M acetic acid) at 4'C overnight 
with gentle mixing on a rotator. After pepsin digestion, 1/10 the starting volume of 
1OX TSB (1. OM Tris-2. OM NaCI-5OmM CaC12, pH 7.8 - 8.0) was added and mixed 
vigorously, and then 1/10 the starting volume of pancreatic elastase (Sigma, UK) 
(1 mg/ml dissolved in 1X TSB, pH 7.8 - 8.0) was added and incubated at 350C for 
30 min with gentle mixing on a rotator. Finally, digested samples were centrifuged 
at 10,000 rpm for 5 min at room temperature. After centrifuge, only supernatant 
was acquired for assay for collagen content with the collagen detection kit (Sircol 
Collagen Assay S 1000, Biocolor Ltd, Ireland), and then 200ýtl aliquots were 
transferred to a 96-well plate and the OD540of the solution was measured using an 
ELISA Plate Peader (MRX 11, Dynex Technology, Finland). A calibration curve 
(Appendix 6) was generated using the supplied reference collagen standard 
solution, and the amount of total collagen produced from cultured cells was 
enumerated from the calibration curve. 
In addition, the DNA content was measured using Hoechst 33258 DNA 
assay method previously described in the section of 2.4.2.5. Collagen values were 
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normalized to total values of DNA content determined by Hoechst 33258 assay. 
2.5.2.7. Immunocytochernical staining 
Chondrogenic differentiation in molecular level was evaluated by 
immunostaining for type 11 collagen and sox-9. Prior to antibody reaction, the fixed 
cells were then incubated with 10% (v/v) blocking goat serum (Vector 
Laboratories) for 30 min at room temperature. The primary antibodies, goat anti 
type 11 collagen (diluted 1: 50 with BSA/Azide solution; Santa Cruz Biotechnology, 
UK) or goat anti Sox-9 (diluted 1: 50 with BSA/Azide solution; Santa Cruz 
Biotechnology, UK) were incubated overnight at 40C. In secondary antibody 
reaction, the secondary FITC-conjugated rabbit anti-goat IgG (Santa Cruz 
Biotechnology) or Alexa Fluor 350-conjugated donkey anti-goat IgG (Invitrogen, 
UK) antibodies were incubated for 1 hr at room temperature. The cells were 
counter-stained with PI to visualize the cell nucleus and were observed using epi- 
fluorescence on a BX-60 microscope and images were captured using a Zeiss 
Axiocam digital camera and analysed using KS-300 software, and other procedure 
was done according to previously described method in the section of 2.2.3.1. 
2.5.2.8. Reverse transcription and polymerase chain reaction (RT-PCR) 
For evaluating the change of gene expression profile in direct chondrogenic 
differentiation of mESCs and CM-mESCs, after 5,10 and 15 days of culture, total 
RNA was extracted from cells of each group, and RNA extraction and RT-PCR 
procedure was done according to previously described method in the sections of 
2.2.3.2-2.2.3.5. Primers which used in this experiment and the expected product 
size are detailed in Table 5. 
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Table 5. Oligonucleotide primers for RT-PCR analysis for direct chondrogenesis 
Gene Sequence Product (bp) 
mcol 11 sense 5'-GCGCTCACGCCGCGGTCCTA-3' 463 
antisense 5'-AGGGGTACCAGGTTCTCCATC-3' 
mAggrecan sense 5'-AGGGTGAGAAGGTAAGGGGT-3' 102 
antisense 5'-GAGGCGAAGTAACCAACCAT-3' 
mLink-protein sense 5'-TTCTGGGCTATGACCGCTG-3' 80 
antisense 5'-AGCGCCTTCTTGGTCGAGA-3' 
MSOX-9 sense 5'-GTGGCAAGTATTGGTCAA-3' 320 
antisense 5'-GAACAGACTCACATCTCT-3' 
mScleraxis sense 5'-GTGGACCCTCCTCCTTCTAATTCG-3' 376 
antisense 5'-GACCGCACCAACAGCGTGAA-3' 
mGAPDH sense 5'-CATCACCATCTTCCAGGAGC-3' 500 
antisense 5'-ATGCCAGTGAGCTTCCCGTC-3' 
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2.6. Bioprocessing for Three Dimensional (3D) Bone and Cartilage 
Tissue Like Construct Formation Using Alginate Encapsulated 
Murine Embryonic Stem Cells and HARV Bioreactors 
2.6.1.3D mESC Encapsulation 
After expansion on T75 tissue culture flasks, undifferentiated mESCs were 
trypsinised, counted, and resuspended in 0.2pm sterile filtered 1.1% (w/v) low 
viscosity alginic acid (Sigma, UK) and 0.1% (v/v) porcine gelatin (Sigma, UK) (all 
dissolved in 1X PBS, pH 7.4) solution at room temperature. With a peristaltic pump 
(Model P-1, Amersham Biosciences, UK), a flow rate producing single droplets, a 
drop height of 30 mm (tubing autoclaved and then sterilised with 1M NaOH for 30 
min and washed three times with sterile 1X PBS) the cell-gel solution was passed 
through the peristaltic pump and dropped using a 25-gauge needle (Becton 
Dickinson, UK) into sterile alginate gelation solution which is composed of 100 mM 
calcium chloride solution (CaC12; Sigma, UK), 10 mM N-(2-hydroxyethyl) 
piperazine-N-(2- ethane sulfonic acid) (HEPES; Sigma, UK), and 0.01% Tween 
(Sigma, UK) in distilled water at pH 7.4, at room temperature with stirring. The cell- 
gel solution gelled immediately on contact with the CaC12 solution, forming 
spherical beads resulting in encapsulating cells. The beads remained in gently 
stirred CaC12 solution for 6-10 min at room temperature. The beads were washed 
three times in 1X PBS and placed into a 1: 1 (v/v) mixture of HepG2 CM and the 
standard mESC maintenance medium. 
For the 3D osteogenic differentiation, 25000 cells were encapsulated in 
each alginate beads through the cell suspension at the approximate cell density of 
3.9 0x 107 cells/ml alginate solution, which was calculated from that the 
approximate volume of a drop of alginate solution passing though needle is 6.4 ýd 
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for making an alginate bead. 
For the 3D chondrogenic differentiation, 50000 cells were encapsulated in 
each alginate beads through the cell suspension at the approximate cell density of 
7.81 X 107 cells/ml alginate solution, which was calculated from that the 
approximate volume of a drop of alginate solution passing though needle is 6.4 ýAl 
for making an alginate bead. 
2.6.2. Operation of Single-Step Bioprocess Using HARV Bioreactors 
Undifferentiated mESCs encapsulated in alginate beads were cultured for 
3 days in a 1: 1 (v/v) mixture of HepG2 CM and the standard mESC maintenance 
medium in 50 ml horizontal aspect ratio vessel (HARV) bioreactors (Synthecon, 
USA) with daily refreshment of medium to induce early differentiation. Each vessel 
contained 600 beads and was rotated anticlockwise at 25 rpm throughout the 
whole culture period. 
To initiate 3D osteogenic differentiation, the 50% HepG2 conditioned 
medium was replaced in the HARV with osteogenic medium which was described 
previously in the section of 2.4.1 A. on day 3 until day 24 of culture and changed 
every 2 days. 
To initiate 3D chondrogenic differentiation, the 50% HepG2 conditioned 
medium was replaced in the HARV with chondrogenic medium which was 
described previously in the section of 2.5.2.1. on day 3 until day 18 of culture and 
changed everyday. 
2.6.3. Characterisation of 3D Osteogenesis and Chondrogenesis 
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2.6.3.1. Observation of cell viability (Live/Dead assay) 
Time course cell viability within alginate beads during 3D osteogenic and 
chondrogenic culture in 3D single step culture system was visualized using a two- 
colour fluorescence cell viability assay, EthD-1/ Calcein AM live/dead assay 
(Molecular Probes, UK), that is based on the simultaneous determination of live 
and dead cells that measure intracellular esterase activity and plasma membrane 
integrity. Membrane permeable 3', 6'-Di(O-acetyl)-2', 7'-bis[N, N-bis(carboxymethyl) 
arninomethyl] fluorescein, tetraa cetoxym ethyl ester (Calcein AM) is cleaved by 
intracellular esterases to brightly label live cells with green fluorescence. Ethidium 
homodimer (EthD-1) enters cells that have lost plasma membrane integrity, 
producing bright red fluorescent labelling of dead cells. This assay was done 
according to the manufacturer's instruction. Briefly, a4 mM EthD-1 and 2 mM 
calcein AM solution diluted in 1X PBS was added to 1X PBS washed, cells 
encapsulated by alginate were incubated at room temperature for 30 min, in the 
dark. After incubation, the solution was aspirated and washed with 1X PBS and a 
small amount of 1X PBS was added to the cells to prevent dehydration. The cells 
were then photographed, within 30 min using a BX-60 microscope and images 
were captured using a Zeiss Axiocarn digital camera and analysed using KS-300 
software to visualise the proportion of live and dead cells. 
2.6.3.2. Bioprofiling 
Following live and dead assay, the consumption of nutrient by cells within 
alginate beads in the osteogenic and chondrogenic media in a HARV bioreactor 
was evaluated by measuring time-course concentration of glucose, ammonia, 
lactate and by detecting pH of media during whole culture. Media samples of 1.5 
ml were collected every two days during the duration of cultures. Glucose, 
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ammonia, lactate concentrations, and pH were measured using a BioProfile 
Analyser 200 (Nova Biomedical, USA). In this study, the osteogenic and 
chondrogenic media was refreshed every two days just after measuring the 
concentration of nutrients in cultured media. As a control, osteogenic medium and 
chondrogenic medium was collected at day 0 and glucose, ammonia, lactate 
concentrations, and pH were measured in the same way. 
2.6.3.3. Reverse transcription and polymerase chain reaction (RT-PCR) 
For extracting RNA from encapsulated cells, after osteogenic and 
chondrogenic culture, around 100 alginate beads were collected and then alginate 
beads containing cells were dissolved in a sterile depolymerisation buffer 
consisting of 50 rnM tri-sodium citrate dihydrate (Fluka, UK), 77 mM sodium 
chloride (BDH Laboratory supplies, UK) and 10 mM HEPES. The dissolution buffer 
(Ca 2+ -depletion) was added to 1X PBS washed beads for 15-20 min while stirring 
gently. The solution was centrifuged at 400g for 10 min and the pellet was washed 
with 1X PBS and centrifuged again, at 300g for 3 min. These cell pellets were 
stored at -80'C prior to use for the extraction of RNA. Total RNA was extracted 
from these cell pellets, and RNA extraction and RT-PCR procedure was done 
according to previously described method in the sections of 2.2.3.2-2.2.3.5. 
Primers which used for evaluating gene expression profile of 3D 
osteogenic differentiation in HARV bioreactor culture system and the expected 
product size are detailed in Table 6. 
Primers which used for evaluating gene expression profile of 3D 
chondrogenic differentiation in HARV bioreactor culture system and the expected 
product size are detailed in Table 7. 
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Table 6. Oligonucleoticle primers for RT-PCR analysis for 3D osteogenesis 
Gene Sequence Product (bp) 
mOsteocalcin sense 5'-CGGCCCTGAGTCTGACAAA-3' 50 
antisense 5-ACCTTATTGCCCTCCTGCTT-3' 
mCbfal/Runx2 sense 5'- CATGGTGGAGATCATCGC -3' 285 
antisense 5'- ACTCTTGCCTCGTCCACTC -3' 
mOsterix sense 5'-CAGGCATCCACGCAGGCATCTC-3' 398 
antisense 5'-TGGGGCAGTCGCAGGTAGAACG-3' 
mOct4 sense 5'-TGGAGACTTTGCAGCCTGAG-3' 798 
antisense 5'-TGAATGCATGGGAGAGCCCA-3' 
mBrachyury sense 5'-GTGTGCGTCAGTGGTGTGTAATC-3' 299 
antisense 5'-AAGGAACCACCGGTCATC-3' 
mGATA-4 sense 5'-CTCCTACTCCAGCCCCTACC-3' 590 
antisense 5'-GTGGCATTGCTGGAGTTACC-3' 
mNestin sense 5'-CGGCCCACGCATCCCCCATCC-3' 253 
antisense 5'-AGCGGCCTTCCAATCTCTGTTCC-3' 
mGAPDH sense 5'-CATCACCATCTTCCAGGAGC-3' 500 
antisense 5'-ATGCCAGTGAGCTTCCCGTC-3' 
Table 7. Oligonucleoticle primers for RT-PCR analysis for 3D chondrogenesis 
Gene Sequence Product (bp) 
mcol 11 sense 5'-GCGCTCACGCCGCGGTCCTA-3' 463 
antisense 5'-AGGGGTACCAGGTTCTCCATC-3' 
mAggrecan sense 5'-AGGGTGAGAAGGTAAGGGGT-3' 102 
antisense 5'-GAGGCGAAGTAACCAACCAT-3' 
mLink-protein sense 5'-TTCTGGGCTATGACCGCTG-3' 80 
antisense 5'-AGCGCCTTCTTGGTCGAGA-3' 
MSOX-9 sense 5'-GTGGCAAGTATTGGTCAA-3' 320 
antisense 5'-GAACAGACTCACATCTCT-3' 
mScleraxis sense 5'-GTGGACCCTCCTCCTTCTAATTCG-3' 376 
antisense 5'-GACCGCACCAACAGCGTGAA-3' 
mOct4 sense 5'-TGGAGACTTTGCAGCCTGAG-3' 798 
antisense 5'-TGAATGCATGGGAGAGCCCA-3' 
mBrachyury sense 5'-GTGTGCGTCAGTGGTGTGTAATC-3' 299 
antisense 5'-AAGGAACCACCGGTCATC-3' 
mGATA-4 sense 5'-CTCCTACTCCAGCCCCTACC-3' 590 
antisense 5'-GTGGCATTGCTGGAGTTACC-3' 
mNestin sense 5'-CGGCCCACGCATCCCCCATCC-3' 253 
antisense 5'-AGCGGCCTTCCAATCTCTGTTCC-3' 
mGAPDH sense 5'-CATCACCATCTTCCAGGAGC-3' 
500 
antisense 5'-ATGCCAGTGAGCTTCCCGTC-3' 
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2.6.3.4. Staining of paraffin embedded section of alginate beads 
2.6.3.4.1. Paraffin embedding of alginate beads 
After culture for 3D osteogenic and chondrogenic differentiation, the 
alginate beads were fixed with 10% (w/v) PFA for 30 min at room temperature and 
then placed in 1X PBS for 15 min prior to dehydration. The beads were 
dehydrated by placing in a sequential series of increasing ethanol concentrations 
to remove all the water. The ethanol was then completely replaced with increasing 
xylene concentration, finally 100% xylene, followed by incubation with paraffin 
saturated xylene at room temperature overnight. The beads in paraffin saturated 
xylene were then placed in an oven (60 OC) for 20 min. The xylene was then 
completely replaced with pre-warmed liquid paraffin. The beads were then serially 
sectioned (4 pm) and left at room temperature overnight to adhere to 
Vectabonded TM (Vector Laboratories, UK) glass slides. 
For staining, the paraffin was completely removed from the sections by 
immersion in xylene, decreasing ethanol concentrations and then by washing with 
tap water. 
For immuno-staining, the deparaffinised sections were immersed in pre- 
heated antigen retrieval reagent (R&D systems, USA) and allowed to cool in order 
to retrieve the antigens. 
2.6.3.4.2. Haernatoxylin & Eosin staining 
The slides of sectioned alginate beads were dipped in haernatoxylin 
(Harris' solution; BDH Laboratory Supplies, UK) for 30 sec following fixation. The 
slides were washed in running tap water for 2-3 min and examined 
for sufficient 
staining. Excess stain was removed by decolourising in 0.5-1% 
HCI in 70% 
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ethanol for a few seconds and then washed in tap water for 5 min. The slides were 
finally dipped in 1% eosin (BDH Laboratory Supplies, UK) for 2 min and washed 
briefly in tap water. The tissue was dehydrated by dipping in ethanol (70% (v/v) 
once and anhydrous or 100% twice), cleared in xylene and mounted in 1 3-diethyl- 
8-phenylxanthine mountant (DPX; BDH Laboratories, UK), and examined using 
Leica inverted microscope (Leica, UK) equipped with Olympus DP50 digital 
camera (Olympus Optical Co, Tokyo, Japan) and analyzed using analySISO 
imaging software (Soft Image System GmbH, Germany). 
2.6.3.4.3. Alizarin Red S staining (3D osteogenesis) 
The sections of alginate beads from 3D culture for osteogenic 
differentiation were immersed in a 2% (w/v) Alizarin Red S (ARS), (Sigma, UK) 
solution (pH4.2) for 5 min at room temperature, and excessive staining was 
washed in tap water, rinsed once in distilled water, and the stained slides were 
dipped in acetone 20 times and then in 1: 1 acetone/xylene for 20 times, followed 
by clearing in xylene and mounting with DPX solution. The slides were 
counterstained with Mayer's haernatoxylin, and examined using Leica inverted 
microscope (Leica, UK) equipped with Olympus DP50 digital camera (Olympus 
Optical Co, Tokyo, Japan) and analyzed using analySISO imaging software (Soft 
Image System GmbH, Germany). 
2.6.3.4.4. Alcian Blue and Safranin 0 staining (313 chondrogenesis) 
The sections of alginate beads from 3D culture for chondrogenic 
differentiation were pre-treated with 3% (v/v) acetic acid and then were stained 
with 1% Alcian blue at pH 2.5 for 2 hr at room temperature and excessive staining 
was washed in tap water, rinsed once in distilled water, and the stained slides 
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were dipped in acetone 20 times and then in 1: 1 acetone/xylene for 20 times, 
followed by clearing in xylene and mounting with DPX solution. The slides were 
counterstained with Mayer's haernatoxylin, and examined using Leica inverted 
microscope (Leica, UK) equipped with Olympus DP50 digital camera (Olympus 
Optical Co, Tokyo, Japan) and analyzed using analySISO imaging software (Soft 
Image System GrnbH, Germany). 
Alternatively, the sections of alginate beads from 3D culture for 
chondrogenic differentiation were stained with 0.1% safranin 0 solution (Sigma, 
UK) for 5 min at room temperature. and excessive staining was washed in tap 
water, rinsed once in distilled water, and the stained slides were dipped in acetone 
20 times and then in 1: 1 acetone/xylene for 20 times, followed by clearing in 
xylene and mounting with DPX solution. The slides were counterstained with 
Mayer's haernatoxylin, and examined using Leica inverted microscope (Leica, UK) 
equipped with Olympus DP50 digital camera (Olympus Optical Co, Tokyo, Japan) 
and analyzed using analySISO imaging software (Soft Image System GmbH, 
Germany). 
2.6.3.4.5. Immuno-staining (3D osteogenesis and chondrogenesis) 
Immuno-staining was performed on sections using goat polyclonal 
antibodies to type I collagen (diluted 1: 50 with BSA/Azide solution; Santa Cruz 
Biotechnology, UK), osteocalcin (diluted 1: 50 with BSA/Azide solution; Santa Cruz 
Biotechnology, UK) for the characterisation of 3D osteogenic differentiation and 
type 11 collagen (diluted 1: 50 with BSA/Azide solution; Santa Cruz Biotechnology, 
UK) for the characterisation of 3D chondrogenic differentiation. Briefly, the slides 
were immersed in 0.3% (v/v) H202 for 15 min to quench endogenous peroxidase 
activity from sectioned tissues on slides. Sections were then placed in 10% (v/v) 
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goat serum (Vector laboratory, USA) for 30 min at room temperature to block non- 
specific staining. The primary antibodies were applied and allowed to react for 
overnight at 40C. Sections were then incubated with biotinylated antibodies to goat 
IgG (R&D systems, USA). After colour development using ant-goat HRP-AEC Cell 
Tissue Staining kit (R&D systems, USA) according to the manufacturer's 
instruction, the slides were counterstained with Mayer's haematoxylin, and 
examined using Leica inverted microscope (Leica, UK) equipped with Olympus 
DP50 digital camera (Olympus Optical Co, Tokyo, Japan) and analyzed using 
analySISO imaging software (Soft Image System GrnbH, Germany). 
2.6.3.4.6. Physicochernical and mechanical characterisation of alginate 
beads (3D osteogenesis) 
2.6.3.4.6.1. Scanning Electron Microscope - Energy Dispersive X-ray 
Spectroscopy (SEM-EDS) analysis 
The cross-section of alginate beads from the 3D culture for osteogenic 
differentiation were fixed with 10% PFA, thoroughly washed with distilled water, 
and then freeze-dried. Specimens were mounted and sputter-coated with gold 
using an ion coater and observed at an accelerating voltage of 20kV. In order to 
characterise the morphology and the chemical composition of mineralized nodules 
within alginate beads, Energy-dispersive X-ray Spectroscopy (EDS) analysis on 
cross sections of alginate beads was carried out with a LEO Gemini Field 
Emission Gun-Scanning Electron Microscope (FEG -SEM, Carl Zeiss, 
Hertfordshire, UK). Samples for SEM analysis were either imaged directly. 
2.6.3.4.6.2. Micro attenuated total reflection - Fourier transformed infrared 
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(ATR-FTIR) analysis 
The cross-section of alginate beads from the 3D culture for osteogenic 
differentiation was further characterized by the micro attenuated total reflection - 
Fourier transformed infrared (ATR-FTIR) spectroscopy. FT-IR images were 
collected with a system described previously [Chan KLA 2003]. The FT-IR images 
were collected with a Bruker Optics imaging spectrometer (Bruker Optics Inc, 
Germany). The whole system is made up of an IFS 66/S step scan FT-IR 
spectrometer, an infrared microscope (IRscope 11) with a Ge ATR objective, and a 
64 X 64 focal-plane array (FPA) detector. In this configuration, the field of view of 
the image was 500 X 700 ýtM2 . All images were taken with a nominal spectral 
resolution of 8 cm-1 in the range 4000 - 900 cm-1 using 20 scans. The cross- 
sections were supported on a BaF2window and the background was taken with 
the same window without the sample. The chemical images were obtained by 
attributing a color to each pixel according to the absorbance of a spectral band 
characteristic of a given compound. 
2.6.3.4.6.3. Compression study 
A micro-deformation apparatus, developed in Dr. Williams' earlier work 
[Andrei DC 1996, Briscoe BJ 1998], was used to measure the force-displacement 
characteristics of the alginate hydrogels that are compressed between two rigid 
parallel plates. The alginate hydrogels were prepared with one test group and two 
control groups (Test group: 3D bone construct: alginate hydrogels encapsulating 
mESCs-derived osteogenic cells by osteogenic culture for 21 days in HARV 
bioreactor, Control group 1: pure alginate hydrogels, Control group 2; alginate 
hydrogels encapsulating undifferentiated mESCs with the cell density of 
approximate 1800,000 cells, which are almost identical to the cell number in 3D 
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bone construct). A detailed description of the micro-deformation apparatus is 
presented elsewhere [Andrei DC 1996, Briscoe BJ 1998, Liu KK 1998]. The 
apparatus permits continuous and simultaneous measurements on the responsive 
force (measured with a cantilever transducer of 10 ýA resolution) and the applied 
displacement (monitored by the computer with a resolution of 0.1 ýtm). During the 
experiment, the alginate hydrogels are fully immersed in cc-MEM supplemented 
with 15% FIBS, and 100 units/ml penicillin and 100 ýLg/rnl streptomycin. The 
alginate hydrogels were subjected to a maximum deformation of up to 20%, and 
were continuously monitored by a high-resolution video camera during 
manipulation and deformation to ensure that the alginate hydrogels were not 
damaged. Deformation measurements were carried out immediately on the 
alginate hydrogels after harvest to minimise effects on the alginate hydrogel 
compliance due to swelling. At least eight force-displacement measurements were 
taken for each type of alginate hydrogels, and all experiments were conducted 
under ambient conditions (T = 20 ±2 OC). 
2.7. Statistical Analysis 
The results were expressed as mean ± standard deviation (SID) and 
analysed using a Student's unpaired two-tailed Mest, comparing all data pairs. 
Statistical significance was considered at P <0.05. 
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CHAPER III 
EARLY DIFFERENTIATION OF MURINE 
EMBRYONIC STEM CELLS INTO PRIMITIVE 
STREAK / NASCENT MESODERM LIKE 
CELLS 
69 
3.1. INTRODUCTION: Current Approaches to In Vitro Differentiation of 
Embryonic Stem Cells into Mesoderm 
Induction of mesoderm formation has been identified as the early 
differentiation step required for further specific lineage differentiation towards the 
haernatopoietic, cardiogenic, osteogenic, and chondrogenic lineages with various 
conditions having been established for the efficient and reproducible induction and 
differentiation into mesoderm in vitro. 
3.1.1. EB-mediated in vitro spontaneous early differentiation 
Undifferentiated mESCs can be induced to differentiate in vitro by removal 
of the feeder-cell layer and LIF, and subsequent transfer into suspension culture 
[Eldor JI 2000]. Under these conditions, ESCs undergo differentiation into spheroid 
structures termed embryoid bodies (EBs). Currently, the most established 
methodology for ESC differentiation requires the formation of EBs. EB formation is 
considered to mimic the differentiation in the blastocyst in vivo. Much of our 
current understanding on mesoderm induction is dependent on EBs recapitulating 
several aspects of early development, displaying regional-specific differentiation 
processes into derivatives of all three embryonic germ layers, namely ectoderm, 
encloderm and mesoderm [Eldor JI 2000]. Consequently, EB formation has been 
utilised as a basic step in a wide range of studies aimed at differentiating ESCs 
into specific and desired cell types. Formation of EBs represents several phase of 
differentiation (Figure 10). Within 2-4 days in suspension culture, endoderm forms 
a rim on the surface of the inner cell mass cells, giving rise to three dimensional 
spheroid structures. Around day 4 or 5, differentiation of a columnar epithelium 
with a basal lamina and formation of a central cavity occurs. Upon continued in 
vitro culture of EBs, mesodermal cells appear, and subsequently a variety of the 
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early embryonal lineages develop [Eldor JI 2000, Tanaka H 2004, Buttery LID 2001, 
Mummery C 2002]. 
In Vitro 
Embryonic stem 
cells 
Day 0 
a 
Embrycid Body 
Day 3-5 
Primitive Early Embryoid Body Embryoid Body Day 3-5 
Ectoderm Day 2 Prunitive 
Day I Streak 
AOL 
Figure 10. In vitro skeletal lineage differentiation of ESCs. 
Differentiation studies have suggested that structural organization and the 
dynamics of developmental processes are maintained during EB formation. The 
first two days of EB formation are equivalent to the period between implantation 
and beginning of gastrulation in mouse embryos. Gastrulation-related cell types 
appear to be present in the EBs between days 3 and 5. It has been well known 
that early organogenesis is stretched out during EB formation between days 3 and 
8 [Leahy A 1999]. Therefore, differentiation of ESCs through EB formation in 
suspension culture provides a powerful in vitro system for studying early lineage 
determination during mammalian development. Consequently, most protocols for 
skeletal lineage differentiation require EB formation for approximately 5 days 
followed by replating of the EB-derived cells onto tissue culture dishes and 
terminal differentiation induction into the various specialized cells, such as 
osteoblasts, chondrocytes and cardiomyocytes, using the appropriate culture 
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conditions [Tanaka H 2004, Buttery LD 2001, Mummery C 20021. 
3.1.2. In vitro early differentiation using exogenous cytockines and growth 
factors 
The use of growth factors has been investigated in order to develop defined 
culture media for directing the mesodermal differentiation of ESCs or EB-derived 
cells. A promising candidate for inducing mesoderm formation is the transforming 
growth factor beta (TGF-P) family of cytokines. Specifically, Activin A was shown 
to mediate dorsoanterior mesoderm differentiation and bone morphogenetic 
protein 4 (BMP-4; also known as BMP-2b or DVR-4) was shown to mediate 
mesoderm formation of a more ventral character, including hematopoietic cells 
[Valdimarsdotter G 2005, Huber BTL 1998, Johansson BM 1995]. In addition, it 
has been well reported that Nodal plays a role of inducing mesoderm formation 
during the development of embryos [Jones CM 1995, Vincent SID 2003, Pfendler 
KC 2005]. In addition to the TGF-P superfamily, it has been demonstrated that 
binding of IGF-11, a member of insulin-like growth factor (IGF) family, to its 
signalling receptor, IGR R, at the surface of mesoderm precursor cells increased 
mesoderm formation [Morali OG 2000]. 
Although several growth factors have been identified to influence mesoderm 
formation in vivo and in vitro, the reports in literature are conflicting. Hence, activin 
A also functions to maintain ESCs undifferentiation [Beattie GM 2005] and the self- 
renewal activity of ESCs was sustained by BMP-4 addition to the ESC 
maintenance medium by inhibiting both the extracellular receptor kinase (ERK) 
and p38 m itoge n -activated protein kinase (MAPK) pathways [Qi X 2004]. 
Furthermore, Johansson et al demonstrated that members of both the TGF-p and 
the fibroblast growth factor (FGF) families, such as TGF-pl, -P2, and -P3, acidic 
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FGF, and basic FGF, when applied individually, did not produce any marked 
consistent increase in the expression of the mesoderm markers. They suggested 
that these factors normally operate in conjunction with others [Johansson BM 
1995]. These observations are consistent with the fact that mesoderm formation 
and subsequent development involve multiple dynamic, overlapping signals that 
progressively give rise to pattern formation [Kimelman D 1992, Wolpert L 1969]. 
3.1-3. In vitro early differentiation using conditioned media 
An alternative strategy for inducing mesoderm formation or other early 
differentiation of ESCs is the use of conditioned culture media. Recently, it has 
been shown that visceral endoderm plays a critical role in establishing anterior- 
posterior polarity in the mouse embryo and the primitive streak followed by 
mesoderm formation during embryogenesis [Lu CC 2001]. Furthermore, 
similarities between liver cell lines and visceral endoderm in their biological 
functionality and gene expression profiles were observed [Rathjen J 1999]. These 
observations have resulted in the use of the human hepatocarcinoma cell line 
(HepG2)-conditioned medium [Rathjen J 1999, Lake J 2003] or of the visceral 
endoderm-like cell line, END-2 [Mummery C 2000], in studies of early ESC 
differentiation, suggesting that these conditioned media recapitulate the visceral 
endoderm-like signalling. In particular, HepG2 conditioned medium treatment 
induced mESC early differentiation into a primitive ectoderm like cell, termed the 
early primitive ectoderm like cell (EPL), as evidenced by the gene expression 
profile of conditioned medium-treated ESCs that was similar to primitive ectoderm. 
Furthermore, they also reported a restricted repertoire of cell types comprising of 
mainly mesodermal cell types and parietal endoderm [Rathjen J 1999, Lake J 
2003]; mesoderm consisting up to 90% of EBs. In contrast, others have shown 
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that treatment of hESCs with HepG2-conditioned medium directed differentiation 
to a cell type with a gene expression profile resembling that of primitive 
streak/nascent mesoderm-stage cells while retaining the pluripotency markers 
[Calhoun JD 2004]. Although there are conflicting reports on the cell type 
generated by treatment with the HepG2 conditioned medium, mesoderm formation 
was certainly enhanced. Similarly, Mummery and colleagues reported that when 
ESCs were cultured on the visceral endoderm-like cell line (END-2), they 
aggregated and spontaneously differentiated to card iornyocyte-forming beating- 
heart muscle colonies. This spontaneous differentiation towards cardiornyocytes 
was induced not only by co-culture with the END-2 cells but also by the END-2 
conditioned medium suggesting that soluble factors secreted by END-2 cells can 
act as cues for cardiac differentiation [Mummery C 2000]. In addition, it has been 
reported that avian precardiac explant-conditioned medium induces cardiornyocyte 
differentiation presumably by mimicking the cues from the explanted 
endoderm/mesoderm [Rudy-Reil D 2004]. The utilisation of conditioned media has 
highlighted an efficient methodology for inducing mesoderm formation as the 
primary potent cell source for terminal skeletal lineage differentiation with 
concomitant reduction in the formation of other contaminating lineages. 
3.2. Objectives 
Despite progress in developing efficient strategies for osteogenic or 
chondrogenic differentiation of ESCs, little has been achieved in establishing 
optimal conditions for the efficient induction of mesoderm. Hence, the focus of this 
chapter is on the development of an in vitro protocol for the generation of a 
specific cell population with high osteogenic and chondrogenic potential from 
mESCs by investigating the effects of the HepG2 conditioned medium on early 
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differentiation of mESCs to primitive streak/nascent mesoderm cells, which could 
be potent progenitor cells for osteogenic and chondrogenic differentiation. 
3.3. Experimental Process 
In this chapter, prior to osteogenic or chondrogenic differentiation, mESCs 
were treated with 50% HepG2 conditioned medium, which was collected by 
culturing the HepG2 cells for 3 days. Following HepG2 exposure, the conditioned 
medium-treated mESCs were allowed to form EBs to achieve spontaneous 
differentiation. The experimental and control groups (untreated mESCs) were 
evaluated for change in morphology, gene expression, AI-Pase activity, EB 
formation capacity as detailed in chapter 11. In brief, the overall experimental 
process is illustrated in Figure 11. 
HepG2 CoU Line 
Human Hopalocwckvxna 
dw 
Mouse Embryonic Stem CeNs 
(mESCs) 
ýApr 
ýw 
50% HepG2 or 
Conditioned 
Media (CM) 
CM Treatment 
PrirT*ive Streak/ 
Nascent Mesoderm 
Like Cells (CM-fnESCs) 
Figure 11. Schematic diagram of experimental process for the generation of 
primitive streak/nascent mesoderm like cells from mESCs. 
3.4. Results 
3.4.1. mESCs expansion and maintenance 
The maintenance and expansion of undifferentiated mESCs, while 
retaining their Pluripotency, is an important step since it provides the starting 
material for osteogenic and chondrogenic differentiation. Pluripotent ESCs can be 
characterized by high level expression of the Oct3/4 transcription factor (POU 
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domain, class 5, transcription factor 1, Pou5fl) [Niwa H 20001, and CD9 [Oka M 
2002] and E-cadherin [Bloor DJ 2002] cell-surface makers. Oct3/4 expression is 
required to sustain stem-cell pluripotency and its expression is down-regulated as 
cells differentiate [Niwa H 2000]. E-cadherin plays a role in cell colony and EB 
formation of ESCs; constitutive expression of E-cadherin in early stage embryo is 
down-regulated as the cells differentiate [Bloor DJ 2002, Dang SM 2004]. mESCs 
showed typical three dimensional colony formation with colony size increasing 
during the culture. Furthermore, Oct-4, CD9 and E-cadherin were strongly 
expressed in the nucleus and periphery of cells in the cell colonies (Figure 12A-C). 
In addition, high expression of AI-Pase was observed in mESC colonies (Figure 
12D). 
Ab 100 4m 
Figure 12. Assessment of undifferentiation marker expression of mESCs in 2D 
expansion. mESCs expressed Oct-4 (pink) (A), CD9 (Orange/red) (B), and E- 
cadherin (Green) (C) with DAR counterstaining (nuclear staining, blue). mESCs 
expressed ALPase as well (D). 
i 
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In addition, in order to establish the optimal conditions for mESC 
expansion, mESC growth was correlated to initial cell seeding density. As shown 
in Figure 13, high initial cell seeding density of approximately 30,000 ce IIS/CM2 
showed rapid growth rate resulting in achieving 80% confluent cell density within 3 
days of culture in comparison with medium (15,000 cel IS/CM2 ) and low (7,500 
ce s/cm 2) cell densities. Consequently, the high cell seeding density was used in 
all further studies. 
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Figure 13. mESC growth kinetics as a function of cell seeding density. Each value 
represents the mean±SD cel IS/CM2 in six samples. 
3.4.2. mESCs morphology studies 
The morphology of untreated mESCs (control group) was compared to 
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those treated with the HepG2 conditioned medium (experimental group). Control 
mESC cultures formed colonies with typical morphology of round multi-layers with 
tight phase bright boundaries. Individual cells were difficult to identify within the 
colonies of undifferentiated mESC (Figure 14A). In contrast, mESCs grown in 
conditioned medium exhibited a more flattened morphology with relatively larger 
nucleoli. Individual cells were clearly visible within the colonies (Figure 14B). 
(A) (B) 
Figure 14. Morphological evaluation of mESCs and conditioned medium-treated 
mESC (CM-mESC) under light microscopy. (A) mESCs in conventional 
maintenance medium after 1 day of culture and (B) CM-mESCs in 50% of HepG2 
conditioned medium after 1 day of culture 
3.4.3. Cell adhesion and growth 
The cell adhesion and proliferation capacity were evaluated. Specifically, 
adhesion was rapid - 67% of the cells adhered in 1 hr and 95% in 2 hrs (P < 0.05) 
- in the CM-mESC group as compared to the control mESC group where 10% of 
the cells adhered in 1 hr and 40% in 2 hrs (Figure 15). After 4 hrs the difference 
was less marked, with 95% of mESCs in CM adhering as compared with 80% of 
control mESCs. 
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Figure 15. mESC adhesion in HepG2 conditioned medium (CM) and normal 
maintenance medium (BM). (A) mESC morphology in BM after 1hr of seeding. (B) 
mESC morphology in CM after 1hr of seeding. (C) Cell adhesion assay: each 
value represents the mean±SD cel IS/CM2 in six samples. (*: significantly different 
compared to the control BM, P<0.05). 
Similarly, cell proliferation, as determined by the 3-(4,5- dimethylthiazol-2- 
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yl)-5-(3-ca rboxymethoxyphenyl)-2-(4-su Ifophe nyl)-2 H-tetrazol ium; MTS) assay, 
[Ber S 2005] was more rapid in the CM-MESC group as compared with control 
mESCs early in the culture (days 1 and 2), as shown in Figure 16. Specifically, the 
cell proliferation rate of mESCs exposed to CM was almost two fold higher (P 
0.05) than that of the control mESCs at day 1 of culture. As culture time increased, 
no significant difference in the cell proliferation could be observed, and at day 5 
both reached the same cell density. 
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Figure 16. mESC proliferation in HepG2 conditioned medium (CM) and normal 
maintenance medium (BM). Each value represents the mean±SD cel IS/CM2 in six 
samples. (*: significantly different compared to the control BM, P<0.05). 
3.4.4. ALPase expression 
The undifferentiated/differentiated state of the embryonic stem cells is 
characterized by a high level of expression of alkaline phosphatase (ALPase), one 
of the classical markers of pluripotent ESCs [Thomson A 1998]. Expression levels 
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of AI-Pase decrease following stem cell differentiation. As shown in Figure 17, 
mESCs expressed high AI-Pase activity whereas CM-mESCs showed relatively 
weak AI-Pase expression at day 3 of culture. 
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Figure 17. Assessment of AI-Pase Expression using the Alkaline Phosphatase 
Detection Kit (Chemicon, USA). (A) and (B): mESCs at day 3 of culture, (C) and 
(D): CM-mESCs at day 3 of culture. 
The expression of ALPase was supported by the quantification of ALPase 
activity using the colorimetric assay. Consistent with expression, CM-mESCs 
showed relatively low level of AI-Pase activity in comparison with mESCs at day 3 
of culture, indicating the early differentiation stage of CM-mESCs (Figure 18). 
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Figure 18. Colorimetric assay for assessing AI-Pase activity. (*: significantly 
different compared to mESCs, P<0.05). 
3.4.5. Molecular expression relating with ESCs pluripotency and early 
differentiation 
To determine development stage of the mESCs treated with the HepG2 
conditioned medium, immunostaining for undifferentiation and early differentiation 
cellular markers was performed (Figure 19). Control mESCs showed typical three 
dimensional colonies with strong expression of Oct-4 and E-cadherin at both days 
1 and 3 culture, as well as Oct-4 transcription factor, which was localised in the 
nucleus. Similarly, CM-mESCs, after 1 day of culture, expressed Oct-4 and E- 
cadherin strongly, even though some of the cells displayed a relatively more flat 
and elongated morphology. However, after 3 days of culture, very few cells in the 
large CM-mESCs colonies expressed weak Oct-4 and E-cadherin, with most 
confluent CM-mESC colonies not expressing Oct-4 and E-cadherin. 
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Figure 19. Immunostaining of mESCs and conditioned media treated mESCs 
(CM-mESC). (A) and (B) mESCs after 1 day of culture with the use of anti E- 
cadherin (Green) and anti Oct-4 (pink) antibodies and DAR (nuclear staining, 
blue); X400 magnification. (C) and (D) mESCs after 3 days of culture with the use 
of anti E-cadherin (Green) and anti Oct-4 (pink) antibodies and DAR (nuclear 
staining, blue); X400 magnification. (E) and (F) CM-mESCs after 1 day of culture 
with the use of anti E-cadherin (Green) and anti Oct-4 (pink) antibodies and DAR 
(nuclear staining, blue); X400 magnification. (G) and (H) CM-mESCs after 3 days 
of culture with the use of anti E-cadherin (Green) and anti Oct-4 (pink) antibodies 
and DAR (nuclear staining, blue); X 400 magnification. (1) and (J) Negative 
staining with the use of anti E-cadherin and Oct-4 antibodies and DAPI. 
3.4.6. EB formation capacity 
EB formation, where ESCs spontaneously differentiate into multi-lineage 
cells as tissue-like spheroids in suspension culture, is the most accepted practice 
in inducing ESC differentiation. Recently, it has been shown that EB formation is 
driven by cell to cell adhesion of undifferentiated ESCs through E-cadherin 
interactions [Dang SM 2004]. The EB formation capacity of mESCs and CM- 
mESCs was evaluated; their EB formation capacity could be influenced by 
different culture media and supplements (Figure 20A-F & A-F'). Specifically, three 
different culture media were evaluated: DMEM containing 15% FBS, DMEM 
containing 15% FBS and 50 ýtg/ml ascorbic acid (same as that of (x-MEM), and (x- 
MEM containing 15% FBS. Based on morphology, the EB formation capacity of 
mESCs was not influenced by the different culture conditions with the EBs 
displaying spherical shape with smooth surfaces. However, CM-mESCs 
demonstrated different EB formation capabilities dependent on the culture media 
used. Specifically, CM-mESCs could not form EBs efficiently in the DMEM and 
DMEM containing ascorbic acid media. In contrast, in (x-MEM, CM-mESCs 
displayed high EB formation capacity with EBs assuming spherical shape, albeit 
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with a relatively rough surface. Following 5 days of EB formation, agglomeration 
was observed by the mESC-derived EBs resulting in larger EBs with either 
spherical or rod shapes in all culture media. However, agglomeration was not 
prevalent in EBs generated by the CM-mESCs derived EB formation; only a few 
EB agglomerates were detected in a-MEM and EB agglomeration was hardly 
detected in DMEM and DMEM containing ascorbic acid. 
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Figure 20. Morphological evaluation of mESC and conditioned media treated 
mESC (CM-mESC) derived EBs under light microscope. (A) and (A) mESC 
derived EBs for 1 day and for 5 days in DMDM containing 15% FBS; (B) and (B') 
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mESC derived EBs for 1 day and 5 days in DMDM containing 50 ýtg/ml ascorbic 
acid and 15% FBS; (C) and (C') mESC derived EBs for 1 day and 5 days in (X- 
MEM containing and 15% FBS. (D) and (D') CM-mESC derived EBs for 1 day and 
for 5 days in DMDM containing 15% FBS; (E) and (E') CM-mESC derived EBs for 
1 day and 5 days in DMDM containing 50 ýtg/ml ascorbic acid and 15% FBS; (F) 
and (F) CM-mESC derived EBs for 1 day and 5 days in (x-MEM containing 15% 
FIBS. (A, B, C, D, E, F) X100 magnification under light microscope. (A', B', C', D', 
F) F) X40 magnification under light microscope. 
3.4.7. Gene expression 
Differential gene expression, indicative of primitive streak/nascent 
mesoderm of CM-ESCs as well as different time points of EB formation was 
evaluated by RT-PCR analysis (Figure 21). A much higher level of brachyury 
expression, which is restricted to the primitive streak and nascent mesoderm 
[Wilkinson DG 1990], was detected from day 0 to day 3 of CM-mESC-derived EBs; 
thereafter it gradually decreased. In contrast, brachyury expression in control 
mESCs was not detected and mESC-derived EBs expressed brachyury temporally 
from day 1 to day 5 with a distinct increase at day 3 yet at relatively lower levels 
than the CM-mESC-derived EBs. Consistent with brachyury expression, TDGF1 
(cripto) expression, a gene essential for ante rio r-posterio r axis and mesoderm 
formation in mouse embryos and a key component of the TGF-Pl/Nodal signalling 
pathway [Dono R 1993], was observed at high levels in CM-mESCs, which 
remained constant throughout EB formation. On the contrary, cripto expression in 
control mESCs was hardly detected and increased gradually from day 3 to day 5 
in mESC-derived EBs. Nodal was continuously transcribed at high levels in both 
CM-mESCs and mESC-derived EBs, whereas it was expressed at lower levels in 
rnESCs and was present throughout mESC-derived EB cultivation with an 
apparent high expression at day 3. Goosecoid, a gene that is expressed as an 
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immediate early response to mesoderm induction [Niehrs C 1994], was present in 
CM-mESCs though not in mESCs. Goosecoid expression was observed in EBs 
derived from both mESCs and CM-mESCs. 
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Goosecoid 
Nodal #f4, w 
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Figure 21. Molecular analysis (RT -PCR). Lane M: EZ Load 100 bp Molecular 
Ruler. Lane 1: CM-mESC. Lane 2: CM-mESC derived EB for 1 day (CM-mESC- 
EB1). Lane 3: CM-mESC derived EB for 3 days (CM- mESC-EB3). Lane 4: CM- 
mESC derived EB for 5 days (CM-mESC -EB5), Lane 5: mESC, Lane 6: mESC 
derived EB for 1 day (EB1), Lane 7: mESC derived EB for 3 days (EB3), Lane 8: 
mESC derived EB for 5 days (EB5). 
3.4.8. Reversibility of early differentiation 
The results thus far suggest that the CM-mESCs represent a cell 
population with characteristics similar to primitive streak/nascent mesoderm. 
Furthermore, when CM-mESCs were cultured in mESC maintenance medium, a 
reversal in morphology to undifferentiated mESCs was observed (Figure 22), as 
evidenced by the distinct colony morphology of round multilayer with tight phase 
bright boundaries, which is considered as typical morphology of undifferentiated 
rnESCs with variations in their colony size. 
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Figure 22. Morphological observation of mESCs in various culture conditions: (A) 
normal mESC (B) CM-mESC: HepG2 conditioned medium treated mESC. (C) CM- 
mESC-rr: mESCs were replated and cultured in mESC maintenance medium 
following HepG2 conditioned media treatment for 3 days. (D) CM-mESC-rd: 
mESCs were cultured in mESC maintenance media following HepG2 conditioned 
media treatment for 3 days. 
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(D) 
Figure 23. Immunostaining: (A) and (B): normal mESCs at day 3 expressing E- 
cadherin (Green), CD9 (pink), and DAR (nuclear staining, blue). (C) and (D): CM- 
mESCs: HepG2 conditioned medium-treated mESC after 3 days of culture 
expressing E-cadherin (Green), CD9 (pink), and DAR (nuclear staining, blue). (E) 
and fl: CM-mESC-rr: CM-mESCs were replated and cultured in mESC 
maintenance medium at day 3 expressing E-cadherin (Green), CD9 (pink), and 
DAR (nuclear staining, blue). (G) and (H): CM-mESC-rd: CM-mESCs were 
cultured in mESC maintenance medium without replating at day 3 expressing E- 
cadherin (Green), CD9 (pink), and DAR (nuclear staining, blue). 
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This reversible differentiation or cledifferentiation was further characterised 
by the expression of the E-cadherin and CD9 pluripotency markers. Consistent 
with previous data, mESCs showed well developed CD9 and E-cadherin molecular 
expression with typical colonies at day 3 (Figure 23 A&B). In contrast, CM-mESCs 
did not express expression (or faintly expressed) E-cadherin and CD9 at day 3 of 
culture (Figure 23 C&D). However, when the CM-mESCs were replated and 
cultured in mESC maintenance medium, the strong expression of CD9 and E- 
cadherin was detected, similar to the undifferentiated mESCs (Figure 23 E&F). 
However, when CM-mESCs were cultured in mESC maintenance medium without 
replating, the partial expression of CD9 and E-cadherin was detected in the 
colonies (Figure 23 G&H). 
3.5. Discussion 
mESCs are permanent cell lines that can be maintained indefinitely in the 
undifferentiated state in the presence of LIF while remaining pluripotent. Upon 
withdrawal of LIF and/or feeder support, mESCs start to differentiate 
spontaneously [Eldor JI 2000]. This unique property of ESCs has allowed studying 
differentiation in early development, understanding the underlying molecular 
mechanisms that control cell growth and differentiation in vitro, and for further 
applications to regenerative medicine and tissue engineering. However, 
standardisation is critical and it is essential to maintain the undifferentiation stage 
and self-renewal activity of ESCs while maintaining pluripotency and to develop 
defined culture conditions for specific differentiation into homogenous populations. 
Whether the ESCs undergo self-renewal or differentiation is likely to depend on 
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the state of the cells - sternness is maintained by suppressing lineage commitment. 
Assessment of the conserved, self-renewal-related transcription factors, such as 
OcK CD9, E-cadherin and AI-Pase is important in evaluating the quality of the 
starting mESC material. Our results illustrated that undifferentiated mESCs highly 
expressed Oct4, CID 9 and E-cadherin, and AI-Pase with typical three dimensional 
colony formation, which is in agreement with literature data [Niwa H 2000, Oka M 
2002, Bloor DJ 2002, Dang SM 2004]. Hence, our results confirm that mESCs in 
expansion remained undifferentiated without losing their pluripotency. 
Currently, the most accepted method to induce early differentiation is EB 
formation, since in vitro EB formation resembles early differentiation during 
embryogenesis [Leahy A 1999]. Specifically, osteogenic differentiation of mESCs 
has been demonstrated following spontaneously formation of EBs [Buttery LID 
2001]. Recently, an alternative method of inducing mesoderm progenitors has 
been proposed that utilises conditioned media [Rathjen J 1999, Lake J 2003, 
Calhoun JD 2004, Mummery C 2000]. Several examples of the successful 
application of conditioned media for directing ESC differentiation exist in the 
literature. For instance, the use of conditioned medium from the visceral 
endoderm-like cell line, END-2, resulted in enhanced cardiogenic differentiation, 
when the ESCs were cultured in the conditioned medium and allowed to form ElBs 
[Mummery C 2000]. In another approach, Rathjen and colleagues induced early 
differentiation of mESCs into an apparently homogenous cell population with a 
high capacity of forming mesoderm in EBS by treatment with conditioned medium 
derived from human hepatocellular carcinoma cell line, HepG2, which resulted in 
an increase in the number of beating colonies [Rathjen J 1999]. Rathjen's results 
showed that the HepG2 conditioned medium-treated mESCs can generate 
mesoderm in EBs more rapidly, almost two or three times faster than normal 
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mESC-derived EBs [Rathjen J 1999], which is agreement with our results. Our 
results on mesoderm stimulation were in agreement with Rathjen's. However, the 
full characterisation of the early differentiated cell population generated using the 
HepG2 condition medium, whether it is primitive ectoderm- or primitive 
streak/nascent mesoderm-like cells [Rathjen J 1999, Calhoun JD], is still pending. 
Upon treatment of mESCs with HepG2 conditioned medium, enhanced cell 
adhesion and proliferation activity along with a flattened morphology and 
decreased expression of Oct4, E-cadherin, and ALPase were observed in 
comparison with untreated mESCs. During ESC colony formation, cell-cell 
adhesion via E-cadherin plays a key role in undifferentiated ESC colony formation 
[Bloor DJ 2002, Dang SM 2004]. Furthermore, E-cadherin expression by ESCs is 
down-regulated as the cells differentiate [Dang SM 2004]. These reports are in 
agreement with our results of the CM-mESCs with their flattened morphology and 
down-regulated E-cadherin, suggesting that certain factors produced by the 
HepG2 cell line influence cell adhesion and affect cell differentiation. Furthermore, 
the EB formation capacity of the CM-ESCs was also influenced, which can be 
attributed to the down-regulation of E-cadherin, plays a key role in cell aggregation 
during EB formation and differentiation [Dang SM 2004]. This also is in agreement 
with the fact that reduced initial endodermal layer formation in EBs gives rise to EB 
disorganization, since it has been demonstrated that disruption of endoderm 
formation leads to EB disorganization. According to Rathjen's research, HepG2 
conditioned medium-treated ESCs have lost ability to form visceral endoderm 
during EB formation and are just restricted to form parietal endoderm [Rathjen J 
1999]. However, these finding require further investigation. 
Visceral endoderm plays a critical role in establishing ante rior-poste no r 
polarity in the mouse embryo and the primitive streak followed by mesoderm 
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formation [Lu CC 2001]. Recently, cell lines, with visceral endoderm functionally, 
have been used to induce mesodermal lineage differentiation [Rathjen J 1999, 
Lake J 2003, Mummery C 2000]. However, full characterisation of the cell 
population produced by treatment with the conditioned medium remains 
unresolved with two different pathways of early ESC differentiation being 
suggested. Rathjen's group showed that conditioned medium induced FGF 5 gene 
up-regulation and Rex-1 gene down-regulation, similar to the gene expression 
pattern of primitive ectoderm, while retaining the marker of pluripotency, Oct-4 
[Rathjen J 1999]. In contrast, Calhoun presented evidence that treatment of 
hESCs with HepG2-conditioned medium resulted in up-regulation of TDGF1 
(cripto), a gene essential for primitive streak and mesoderm formation in mouse 
embryos and a key component of the TGF-01/Nodal signalling pathway. 
Consequently, their work suggested differentiation into primitive streak stage cells 
as further evidenced by DNA micro-array and real time RT-PCR analyses. Our 
results are in agreement with the primitive streak/nascent mesoderm differentiation 
pathway due to the up-regulation of Nodal and Cripto expression, which are key 
genes regulating primitive streak or nascent mesoderm formation [Calhoun JD]. 
The brachyury and goosecoid expression marked up-regulation observed further 
supports the primitive streak/nascent mesoderm pathway since during early 
development brachyury expression is restricted to the primitive streak and nascent 
mesoderm in the region that will define the posterior part of the embryo [Herrmann 
BG 1991]. It has been well documented that the early primitive streak is the origin 
of the migrating cells that form the extraembryonic mesoderm, where the 
epithelium-mesenchyme transition is temporally associated with the up-regulation 
of brachyury [Kispert A 1994]. In addition, mesenchyme differentiation is marked 
by the down-regulation of Oct3/4 [Flechon JE 2004] and expression of E-cadherin 
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[Burdsal CA 1993], which is in agreement with our results showing the temporal 
up-regulation of brachyury, goosecoid, nodal, and cripto expression and partial 
down-regulation of Oct4 and E-cadherin expression. 
The differentiation of the undifferentiated mESCs into primitive 
streak/nascent mesoderm cell population following treatment with the HepG2 
conditioned medium was reversible when the CM-mESCs were replated and 
cultured in ESC maintenance medium. These observations are supported by 
Rathjen's work demonstrating reversible differentiation of early differentiated 
mESCs into undifferentiated mESCs [Rathjen J 1999]. Furthermore, others have 
reported that reverse pathway from early mesoderm -specified progenitors to 
undifferentiated ESCs is regulated by Nanog expression [Suzuki A, 2006]. 
However, to date, the precise mechanism has not been fully elucidated. 
3.6. Conclusion 
We have demonstrated that the conditioned medium from the human 
hepatocarcinorna cell line HepG2 induced transition of mESCs a specific cell type 
with primitive streak/nascent mesoderm profile resulting in enhanced mesoderm 
formation during EB formation. Hence, this strategy for generating a specific cell 
population with high capacity of mesoderm formation could prove useful in skeletal 
tissue engineering application due to the potent cell source it produces. However, 
from a clinical application perspective, it requires the identification of the active 
factors within the conditioned medium and the formulation of a defined medium. 
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CHAPER IV 
IN VITRO OSTEOGENIC AND 
CHONDROGENIC DIFFERENTIATION OF 
MURINE EMBRYONIC STEM CELLS USING 
EB FORMATION 
915 
4.1. Introduction: Current Approaches for the In Vitro EB-Mediated 
Osteogenic and Chondrogenic Differentiation of Embryonic Stem Cells 
The vast majority of the current methodologies for in vitro osteogenic and 
chondrogenic differentiation rely on EB formation, which results in the 
spontaneous formation of the precursor germ layers as a prerequisite for terminal 
differentiation towards the osteogenic and chondrogenic lineages (Figure 24). 
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Figure 24. Current in vitro culture strategy for osteogenic and chondrogenic 
differentiation through EB formation. 
A number of molecules have been applied in in vitro skeletal lineage 
differentiation to control mesodermal cell fates towards the terminal differentiation 
of ESCs into the desired specific cell lineage [Tanaka H 2004, Buttery LID 2001, 
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Mummery C 2002, Kawaguchi J 2005]. However, despite the progress made and 
the increased understanding of the biological mechanisms of growth factors or 
other supplements on ESC differentiation, the challenge remains in developing 
scalable and clinically suitable processes for the therapeutic application of ESCs in 
skeletal tissue engineering - mainly due to the much higher degree of plasticity 
possessed by ESCs compared with adult stem cells. 
Currently, the vast majority of protocols for in vitro osteogenesis of ESCs 
employ EB formation for around 5 days in suspension followed by replating of the 
EB derived cells onto tissue culture dishes and differentiation to osteoblasts by the 
addition of osteogenic supplements [Kawaguchi J 2005, Woll NL 2006, Bielby RC 
2005]. Specifically, it has been shown that addition of supplements such as p- 
g lyceroph osp hate, ascorbic acid, dexamethasone, retinoic acid, and 1,25-hydroxy 
vitamin D3, factors that have all previously been used for the growth and 
differentiation of primary osteoblasts and mesenchymal stem cells, results in 
increased differentiation of ESCs along the osteogenic pathway [Buttery LID 2001, 
Kawaguchi J 2005, Woll NL 2006, Bielby RC 2005]. Similarly, for in vitro 
chondrogenesis, ESCs are allowed to form EBs for approximately 5 days followed 
by terminal differentiation into chondrocytes in three different culture environments 
through the addition of various chondrogenic supplements. One of culture 
methods is micro mass culture technique, which requires high cell density in order 
to form the cell condensation necessary for initial chondrogenesis [Tanaka H 2004, 
Nakayama N 2003]. Another technique is the pellet culture method, where cell 
aggregation for cell condensation is achieved by placement in conical tubes 
[Nakayama N 2003]. The final method is to plate whole ElBs in tissue culture plates 
(EB plating method) [Kawaguchi J 2005, Kramer J 2005] and induce 
chondrogenesis by replacing the EB formation medium with chondrogenic media. 
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The chondrogenic supplements most commonly employed include BMP-2 and 
BMP-4 [Kramer J 2000], TGF-P3 [Kawaguchi J 2005], and dexamethasone 
[Tanaka H 2004]. Specifically, it has been reported that BMP-2 and BMP-4 
promote chondrogenic differentiation using the direct EB plating culture method 
when added during day 3-5 of EB differentiation [Kramer J 2000]. Others have 
shown that retinoic acid treatment of EBs (to primarily induce mesoderm 
formation) followed by addition of TGF-P3 was sufficient to induce chondrogenesis 
from ESCs [Kawaguchi J 2005]. Furthermore, macroscopic cartilage formation has 
been demonstrated from EB cultures derived from fluorescence activated cell 
sorting (FACS) sorted-mesodermal progenitor cells by supplying a cocktail of IGF-I, 
TGF-P3, BMP-4 and platelet derived growth factor-BB (PDGF-BB) [Nakayama N 
2003]. 
Therefore, for in vitro osteogenesis and chondrogenesis, the majority of 
approaches utilize the EB culture system where undifferentiated ESCs are allowed 
to form EBs for approximately 5 days followed by terminal osteogenic and 
chondrogenic differentiation using various supplements. However, EB based 
culture methods suffer certain disadvantages, mainly because controlling the 
spontaneous differentiation during EB formation is difficult - the precise 
mechanisms have not yet been identified - resulting in limited intact mesoderm in 
EBs and, consequently, a low yield for terminal differentiation. Furthermore, once 
mesoderm is formed, osteogenic and chondrogenic differentiation is in competition 
(or possibly even suppressed) by spontaneous cardiornyocyte differentiation. 
Hence, the need for novel methods that control and enhance osteogenic and 
chondrogenic differentiation more efficiently is enormous. 
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4.2. Objectives 
The focus of this study was the investigation and development of an in vitro 
protocol for controlling and enhancing osteogenic and chondrogenic differentiation 
from mESC-derived primitive streak/nascent mesoderm-like cells by modulating 
the culture conditions and process, specifically the EB formation time. 
4.3. Experimental Plan 
Previously, we have demonstrated that HepG2 conditioned medium 
induced early differentiation of mESCs to a specific cell type with a gene 
expression similar to primitive streak/nascent mesoderm transient-stage cells, 
which showed an elevated expression of primitive streak/nascent mesoderm 
marker. Herein, we address whether the mESC-derived primitive streak/nascent 
mesoderm stage cells are also capable of efficiently differentiating into the 
osteogenic lineages. Specifically, the dissociated CM-mESCs derived-EB cells 
from different EB formation time points (day 1,3 and 5) were subjected to 
osteogenic or chondrogenic supplements such as P-glycerophosphate, ascorbic 
acid and dexamethasone (osteogenic) or ascorbic acid, dexamethasone and 
TGFP1 (chondrogenic). As the control group, the dissociated untreated ESC 
derived-EB cells day 5 of EB formation were used. Since during osteogenic and 
chondrogenic induction, spontaneous cardiogenic differentiation of mESCs can be 
detected unexpectedly with beating colonies present, spontaneous cardiogenic 
differentiation was also evaluated in 
card iogenic/osteogen ic/chondrogen ic differentiation 
th is study. Therefore, 
was investigated using 
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beating colony formation assay, bone nodule formation assay, cartilage nodule 
formation assay, immunocytochernical characterization, RT-PCR, expression of 
specific ECM proteins, and lineage specific enzyme activity evaluation, as 
described in CHAPTER 11. In brief, the overall experimental plan is illustrated in 
Figure 25. 
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Figure 25. Schematic diagram of experimental process for EB-mediated 
osteogenic and chondrogenic differentiation of mESCs 
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4.4. Results 
4.4.1. In vitro EB-mediated cardiogenic differentiation 
The differentiation and maturation of mESC-derived cardiornyocytes as 
influenced by the use of HepG2 conditioned medium and EB formation time in 
order to suppress selectively cardiogenic differentiation in favour of 
osteogenic/chondrogenic differentiation was evaluated. 
4.4.1.1. Morphology of beating colonies 
During osteogenic/chondrogenic differentiation of mESCs, beating colonies 
could be observed in both the experimental and control groups (CM-mESC-EB5 
and EB5), which confirmed the spontaneous cardiogenic differentiation of mESCs 
even in specified osteogenic/chondrogenic culture conditions. Spontaneous 
cardiomyocyte differentiation has been observed in both human and murine ESC 
lines [Xu C 2002, Kehat 1 2002, Doevenclans PA 2000, Boheler KR 2002]. 
Cardiornyocytes were readily identifiable due to their spontaneous contractions 
within days following plating. With continued differentiation (longer EB formation 
time), the number of beating foci increased and certain groups, such as CM- 
mESC-EB5 and EB5, could possibly contain localized beating cells. During early 
stages of differentiation, cardiornyocytes within beating colonies were small and 
round. With maturation, some of the ESC-derived cardiomyocytes expressed an 
elongated shape and beating cells were primarily mononucleated and rod-shaped 
with tight cell-cell contact (as shown in Figure 26), consistent with those observed 
in cardiornyocytes developing in the heart [Westfall MV 1997]. 
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Figure 26. Morphology of beating colony. (A) and (B) Beating colonies after 16 
days of culture. 
4.4.1.2. Beating colony formation 
In this study, mESCs and HepG2 conditioned medium-treated mESCs 
(CM-mESCs) were allowed to form EBs for 1,3 or 5 days in EB formation medium 
(a MEM containing 15% FBS) followed by EB dissociation and subsequent culture 
in osteogenic or chondrogenic media for an additional 21 days. As shown in figure 
27, enhanced mesoderm formation through the use of HepG2 conditioned medium 
resulted in a 3-4 fold increase (P<0.05) in the number of beating colonies in CM- 
mESC-EB5 as opposed to the EB5 control group for all culture times, where the 
number of beating colonies were 16.3 ± 5.1,38.5 ± 5.8,27.5 ± 10.2 colonies/well 
in CM-mESC-EB5 and 5.5 ± 3.1,8.8 ± 3.0,8.8 ± 4.6 colonies/well in EB5 at day 11, 
16 and 21. In contrast, reducing the EB formation time resulted in the absence of 
beating colonies. Specifically, no beating colonies were observed for the CM- 
mESC-EB1 group as well as the CM-mESC-EB3 group at 21 days of culture 
(Figure 27). 
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Figure 27. Effect of EB formation time on beating colony formation. Control group 
(EB5) represents mESCs maintained in conventional maintenance medium then 
allowed to form EBs for 5 days and then directed to the spontaneous cardiogenic 
differentiation for 21 days. The experimental groups were mESCs treated for 3 or 
4 days with 50% HepG2 conditioned media followed by 1 -day (CM-mESC-EB1), 3- 
day (CM-mESC-EB3), or 5-day (CM-mESC-EB5) EB formation period, and then 
directed to the spontaneous cardiogenic differentiation for 21 days. Data are 
shown as mean number of beating colonies ± SID (n = 4; *p < 0.05 compared to 
EB 5). 
4.4.1.3. Immuno-staining for cardiogenic differentiation 
One of the earliest steps in card iornyogenesis is the assembly of 
contractile proteins into organized structures capable of contraction, which 
requires the polymerization and assembly of several different proteins into three 
types of filaments that interact with one another and become organized into 
sarcomeric units that comprise the myofibrils [Du A 2003]. The formation of a 
myofibril involves the precise ordering of multiple subunits into a linear array of 
sarcomeres. Myofibril formation begins at the spreading edges of the 
cardiomyocytes with the formation of premyofibrils that subsequently fuse at the 
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level of the Z-bodies to form mature myofibrils [Dabiri GA 1997]. Figure 28 shows 
the highly developed bundles of myofibrils and sarcomeres in cardiomyocytes from 
CM-mESC-EB5 cultures and also sarcomeric a-actinin and tropornyosin staining 
with elongated rod shapes in cardiornyocytes. Adjacent cardiomyocytes often 
show different degrees of myofibrillar organization. Some myofibrils were sparse 
and irregularly organized, whereas others contained parallel bundles of myofibrils. 
During cardiogenic differentiation stages, densely packed well organized bundles 
of myofibrils could be observed, and the sarcomeres had clearly defined Z bands, 
which could be detected at a high magnification. 
Figure 28. Immunocytochemical staining for sarcomeric a-actinin and tropomyosin 
in the CM-treated mESCs. (a) and (b): Sarcomeric a-actinin expression (green) 
and nuclear staining (DAPI; blue) at day 16 of culture. (c) and (d): Tropomyosin 
expression (green) and nuclear staining (DAPI; blue) at day 16 of culture. The 
insets (a') and (c') show negative controls for non-specific binding of the primary 
antibodies. 
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4.4.1.4. Cardiogenic gene expression 
A murine Nkx-2.5 homeobox gene was identified as one of the important 
factors in the activation of cardiac (x-actin and myosin heavy chain gene in 
cardiogenic differentiation [Chen CY 1996]. In mouse embryos, Nkx-2.5 transcripts 
were localized to early cardiac cell progenitors, prior to cardiogenic differentiation 
and continued to be expressed in cardiac myocytes throughout development [Lints 
TJ 1993]. Herein, at gene expression level, cardiogenic differentiation was 
characterised by evaluating the expression of Nkx-2.5 mRNA. RT-PCR analysis 
confirmed the high expression of transcription factor Nkx2.5 at day 11 of culture in 
the CM-mESC-EB5 and EB5 groups (Figure 29). In contrast, in CM-mESC-EB1 
and CM-mESC-EB3 NKx2.5 expression was extremely weak. These results are in 
agreement with the beating colony assay and immunocytochernistry results 
demonstrating the correlation between cardiornyocyte beating colonies and 
cardiomyocyte marker and gene expression. 
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Figure 29. RT-PCR analysis of cardiogenic (Nkx-2.5) gene expression at day 11 
of culture. GAPDH gene expression was used at the housekeeping control Lane 
M: 100 bp DNA ladder; Lane 1: CM-mESC-EB 1; Lane 2: CM-mESC-EB 3; Lane 
3: CM-mESC-EB 5; Lane 4: EB 5. 
4.4.2. In vitro EB-mediated osteogenic differentiation 
In this study, in vitro osteogenic differentiation was characterised by 
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morphological observation, bone nodule formation assay, alkaline phosphatase 
ac ivity assay immunocytochernical staining and RT-PCR. 
4.4.2.1. Morphology of mineralised bone nodules 
It has been well documented that mineralized bone nodules form when 
cells are grown in the presence of ascorbic acid and P-g lycerophosp hate 
[Tenenbaum HC 1982], and formation of mineralized nodules is enhanced by 
clexamethasone [Buttery LID 2001]. The bone nodule formation assay permits the 
specific assessment of bone-forming cells and a relative measure [Tenenbaum HC 
1982]. In this study, mineralised nodules could be easily detected as very dark 
spots using a light microscope in all culture groups, indicating the osteogenic 
differentiation of mESCs. As shown in figure 30, mineralised bone nodules usually 
formed at the centre of cell colonies with various intensities. 
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Figure 30. Morphology of mineralised bone nodule. (A) and (13): Mineralised bone 
nodules after 21 days of culture. Under light microscope. 
4.4.2.2. Bone nodule formation 
Osteogenic differentiation was assessed by staining with Alizarin Red in 
order to visualize mineralization (Figure 31). Quantification of mineralization was 
achieved by counting the mineralised bone nodules only if they were fluorescent 
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when exposed to UV light (excitation at 530-560 nrn and emission at 580 nm), as 
shown in figure 32. This was done in order to exclude non-specific staining of cell 
aggregates, such as alizarin red S stained cell clusters formed by beating colonies 
or other cell types [Midura RJ 2004, Chang YL 2000]. Our results show that, with 
differentiation and maturation, the number of stained bone nodules increased in 
the conditioned medium-treated groups such as CM-mESC-EB1 and CM-mESC- 
EB3, and the size of bone nodules also increased in accordance with culture time 
and differentiation. 
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Figure 31. Alizarin red S stained bone nodules in a light microscope. Control 
group (EB5) represents mESCs maintained in conventional maintenance medium 
then allowed to form EBs for 5 days and then directed to osteogenic differentiation 
for 21 days. The experimental groups were mESCs treated for 3 or 4 days with 
50% HepG2 conditioned media followed by 1-day (CM-mESC-EB1), 3-day (CM- 
mESC-EB3), or 5-day (CM-mESC-EB5) EB formation period, and then directed to 
osteogenic differentiation for 21 days. 
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Figure 32. Alizarin red S stained bone nodules under UV light. Mineralised 
nodules shows red/orange fluorescence and non-specific stained area does not 
show fluorescence. 
As shown in figure 33, a significantly higher number (P<0.05) of stained 
bone nodules was achieved by reducing the time the mESCs treated with 
conditioned medium were allowed to form EBs. Specifically, at days 11 and 16 of 
culture a1 0-fold increase in the number of bone nodules formed in the CM-mESC- 
EB1 cultures as compared to the control EB5 group, where the number of bone 
nodules were 330 ± 59 and 563 ± 70 bone nodules/well in CM-mESC-EB1 and 18 
6 and 64 ±7 bone nodules/well in EB5 at day 11 and 16, respectively. 
Subsequently, at day 21 an approximately 5-fold increase in the number of bone 
nodules formed by the CM-mESC-EB1 group as opposed to the control EB5 group 
was observed, where the number of bone nodules were 694 ± 61 bone 
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nodules/well in CM-mESC-EB1 and 192 ± 11 bone nodules/well in EB5 at day 21, 
respectively. Throughout the culture period, the CM-rnESC-EB5 group showed no 
difference in bone nodule formation compared to the EB5 group. 
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Figure 33. Bone nodule formation. Control group (EB5) represents mESCs 
maintained in conventional maintenance medium then allowed to form EBs for 5 
days and then directed to osteogenic differentiation for 21 days. The experimental 
groups were mESCs treated for 3 or 4 days with 50% HepG2 conditioned media 
followed by 1-day (CM-mESC-EB1), 3-day (CM-mESC-EB3), or 5-day (CM- 
mESC-EB5) EB formation period, and then directed to osteogenic differentiation 
for 21 days. Data are shown as mean number of bone nodules ± SD (n = 4; *p 
0.05 compared to EB 5). 
4.4.2.3. Immuno-staining for osteogenic differentiation 
Osteoblast differentiation is controlled by the extracellular environment. 
One aspect of this environment is cell to cell interaction, which is particularly 
mediated by cadherins. Cadherin-mediated cell to cell adhesion is essential for the 
development and survival of multi-cellular tissues. In osteoblasts, the expression 
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CM-mESC-EB5 
EB5 
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of N-cadherin, cadherin-1 1, R-cadherin, and an isoform of K-cadherin has been 
reported [Mbalaviele G1998, Cheng SL 1998, Kawaguchi J 2001]. In osteoblast 
differentiation, cadherin-1 1 (also called as OB-cadherin), is constitutively 
expressed by the osteoblastic lineage [Kii 12004]. In this study, as shown by figure 
34, at day 16 of culture OB-cadherin was very strongly expressed in the CM- 
mESC-EB1 group. In particular, OB-cadherin immunostaining was well developed 
in the periphery of neighbouring cells, which maintained cuboidal shapes. In 
contrast, OB-cadherin-immunoreactive cells could hardly be observed in the CM- 
mESC-EB5 and E135 groups at day 16 of osteogenic culture. 
Figure 34. Immunocytochernical staining for OB-cadherin in CM-treated mESC- 
derived cultures. Expression of OB-cadherin (green) and nuclear staining (DAPI; 
blue) at day 16 of culture in the CM-mESC-EB1 -derived osteogenic cells. Inset (a') 
shows negative control for non-specific binding of the primary antibody. 
4.4.2.4. Alkaline phosphatase activity 
Alkaline phosphatases (orthophosphoric-monoester phosp hohyd ro lase, 
alkaline optimum, EC 3.1.3.1. ) are cell surface glycoproteins that hydrolyze a 
variety of monophosphate esters. The bone isoenzyme has long been thought to 
play a role in the mineralization of bone [Wuthier RE 1985] and is widely used as a 
marker of mineralization and as a marker of the osteoblast phenotype. As shown 
in figure 35, alkaline phosphatase activity was enhanced 3-fold (P<0.05) in the 
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CM-mESC-EB1 and 2-fold in the CM-mESC-EB3 group in comparison with the 
control EB5 group at day 11 of the osteogenic culture - 377.7 ± 32.0 
PNPýM/rnin/rng in the CM-mESC-EB1,209.3 ± 22.8 PNPýM/rnin/rng in the CM- 
mESC-EB3, and 116.3 ± 16.5 PNPýM/rnin/rng in the EB5, respectively. No 
statistical difference in enzyme activity was observed between the CM-mESC-EB5 
and EB5 groups. Furthermore, enzyme activity showed a time-dependent 
behaviour with a marked increase at day 11 and then a decrease to background 
levels from day 16 onwards. This temporal increase of alkaline phosphatase 
activity in CM-mESC-EB1 and CM-mESC-EB3 correlates with the increased bone 
nodule formation. 
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Figure 35. Alkaline phosphatase activity. Control group (EB5) represents mESCs 
maintained in conventional maintenance medium then allowed to form EBs for 5 
days and then directed to osteogenic differentiation for 21 days. The experimental 
groups were mESCs treated for 3 or 4 days with 50% HepG2 conditioned media 
followed by 1-day (CM-mESC-EB1), 3-day (CM-mESC-EB3), or 5-day (CM- 
mESC-EB5) EB formation period, and then directed to osteogenic differentiation 
for 21 days. Data are shown as mean enzyme activity ± SD (n = 6; *p < 0.05 
compared to EB 5). 
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4.4.2.5. Osteogenic gene expression 
It is well established that core binding factor Cbfal/Runx2 is an essential 
transcription factor required for osteoblast recruitment and differentiation, and 
bone formation [Banerjee C 2001]. In this study characterisation of osteogenic 
differentiation was performed by examining expression of Cbfa 1/Runx 2 using RT- 
PCR after 11 days of culture, at which point the highest expression of bone 
nodules was observed. As shown in figure 36, bands for Cbfa 1/Runx 2 were 
present in the CM-mESC-EB1 and CM-mESC-EB3 groups. In contrast, the CM- 
mESC-EB5 and EB5 groups showed extremely weak (almost non-existent) 
expression of Cbfal/Runx2. These results are in agreement with the bone nodule 
formation assay and OB cadherin immunostaining results demonstrating the 
correlation between mineralised bone nodule formation and osteogenic marker 
expression and osteoblast related gene expression. 
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Figure 36. RT-PCR analysis of osteogenic (Cbfal/Runx2) gene expression at 
day 11 of culture. GAPDH gene expression was used at the housekeeping control 
Lane M: 100 bp DNA ladder; Lane 1: CM-mESC-EB 1; Lane 2: c CM-mESC-EB 3; 
Lane 3: CM-mESC-EB 5; Lane 4: EB 5. 
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4.4.3. In vitro EB-mediated chondrogenic differentiation 
The changes associated with the in vitro chondrogenic capacity of mESC 
as influenced by the use of HepG2 conditioned medium and EB formation time 
were studied. In vitro chondrogenic differentiation was characterised by 
morphological observation, cartilage nodule formation assay, GAG assay 
immunocytochernical staining and RT-PCR. 
4.4.3.1. Morphology of cartilage nodule 
Chondrogenic differentiation is triggered in pre-cartilage condensations 
and ultimately cartilage forms. In micromass cultures, dissociated cells with 
chondrogenic capacity interact to first form small aggregates, then bigger clusters 
and finally cartilage nodules [Lee YS 1998]. Such micromass cultures [Lee YS 
1998, Ahrens 1977, Daniels 1996], have been an excellent model for analyzing the 
mechanisms of chondrogenesis. It has been also well documented that synthetic 
dexamethasone (DEX) increased the number of cartilage nodules formed in a 
dose-dependent manner [Grigoriadis AE 1998]. In addition, treatment with insulin- 
like growth factor-1 (IGF-1) also produced cell clustering and cartilage nodule 
formation, which are indicative of chondrogenesis with an increase in type 11 
collagen and aggrecan mRNA that was time- and con centration-dependent 
[Mierisch CM 2002]. In this study, the dissociated EB cells from different EB 
formation times were subjected to the high cell density micromass culture with 
chondrogenic supplements such as dexamethasone, ascorbic acid and IGF-I. 
Distinct cartilage nodule like structures could be observed in all cultures, albeit 
with different frequency (Figure 37). Specifically, the nodules exhibited a distinct 
structure comprising of round-shaped cells separated by extracellular matrix 
surrounded by a circular arranged fibrillar matrix that was easily detected by light 
113 
microscopy, which is in agreement with the reported typical structure of ESC- 
derived chondrocytes [Kramer J 2000]. Positive staining of the nodules with alcian 
blue indicated cartilage-like extracellular matrix accumulation. In the cartilage 
nodules, most of cells showed round shape with tight contact between cells, and 
peripheral space of cells stained positive for GAG, as indicated by the alcian blue 
and neutral red staining (Figure 37). 
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Figure 37. Morphology of cartilage nodules. (A). cartilage nodule in a light 
microscope. (13): Alcian blue stained bone nodules in a light microscope. (C)-. 
Double stained cartilage nodule with Alcian blue and Neutral Red. (D). Highly 
magnified feature of double stained cartilage nodule. 
4.4.3.2. Cartilage nodule formation 
Following morphological observation and alcian blue staining of the 
cartilage nodules, the extent (area) of the stained nodules was quantified. 
Specifically, the size of the alcian blue stained portions (dark blue) of cartilage 
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nodules was determined in relation to the total observed area. At day 15, CM- 
mESC-EB1 showed a 2.5 fold higher relative stained areas than other test groups; 
the other test groups showed no significant difference in the alcian blue stained 
area (25.70 ± 4.55 % in the CM-mESC-EB1,10.61 ± 6.67% in the CM-mESC-EB3, 
8.60 ± 5.36 % in the CM-mESC-EB5 and 8.47 ± 2.56% in the EB5, respectively). 
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Figure 38. Quantification of the Alcian blue stained areas of cartilage nodules. (A): 
Representative images of cartilage nodules formed by CM-mESC-EB1 cells. (B): 
Representative images of cartilage nodules formed by CM-mESC-EB3. (C): 
Representative images of cartilage nodules formed by CM-mESC-EB5. (D): 
Representative images of cartilage no dules formed by EB5. Data shown as mean 
relative stained area ± SD (n=4, * P<0. 005 compared to EB5). 
In addition, to determine whether Alcian blue staining was due to the 
cartilage nodules or other cell aggregates, such as bone nodules, a dual staining 
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with Alcian blue and Alrizarin red-S was performed. As shown in figure 39, the dark 
blue stained region, which was considered as cartilage nodules and frequently 
found in the CM-mESC-EB1 group, was not stained by Alizarin red S, confirming 
that these strong ly-stained areas were derived from cartilage nodule. In contrast, 
some light blue stained nodules, which could be found in the other test groups, 
showed mineralised calcium deposit as indicated by the presence of fluorescence 
from Alizarin red S staining. 
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Figure 39. Alcian blue and Alizarin red-S double staining. (A) Representative 
image of well stained cartilage nodules of CM-mESC -EB1. (N) High power image 
of nodules and confirmation of mineralization by UV fluorescence (inset). (B) 
Representative images of mineralised nodules in CM-mESC -EB3. (B) High power 
image of minerlaised nodules by UV fluorescence (inset). (C) Representative 
image of other cell colonies in CM-mESC-EB5. (C') High power image of 
minerlaised nodules by UV fluorescence (inset). (D) Representative images of 
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other cell colonies in EB5. (D') High power image of minerlaised nodules bY UV 
fluorescence (inset). 
4.4.3-3. Glycosaminoglycan (GAG) synthesis 
Cartilage is particularly rich in specialised extracellular matrix, with matrix 
making up 90% of the dry weight of the tissue [Poole AR 2001]. ECM has dense 
collagen and proteoglycan networks that determine mechanical and functional 
properties of the tissue [Poole AR 2001, Knudson CB 2001]. ECM molecules in 
cartilage cooperate with growth factors to regulate chondrogenic differentiation 
and cartilage development. Proteoglycan interactions with collagen fibrils and 
growth factors have been implicated in the regulation of ECM assembly and 
growth factor functions [Knudson CB 2001]. The major components of 
proteoglycans are glycosaminoglycans, which are involved in cell-cell and cell- 
matrix interactions during chondrogenic differentiation [Maleski MP 1996]. In this 
study, the analysis of alcian blue staining was accompanied by measuring the 
sulfated GAG content produced by chondrogenic cells using DMMB assay method. 
As shown in figure 40, the relative matrix sulfated GAG amount in the CM-mESC- 
EB1 group was detected at a much higher level (2 fold to 2.5 fold) throughout the 
culture period - increasing at day 5 and 10 and then slightly decreasing at day 15. 
The CM-mESC-EB3 group showed the distinct temporal increase of GAG content 
at day 5 followed by rapid decrease during the subsequent culture time. In contrast, 
the CM-mESC-EB5 and EB5 groups showed a relatively constant sulfated GAG 
production at relatively low levels throughout the culture period, which was not 
significantly different. The higher content of sulfated GAG in the CM-mESC-EB1 
group is in agreement with the high alcian blue stained area observed. 
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Figure 40. Quantification of relative matrix sulfated GAG amount produced by 
culture. The experimental and control groups are as follows: The experimental 
groups were mESC treated for 4 days with 50% HepG2 conditioned media (CM- 
mESC) followed by 1-day (CM-mESC-EB1), 3-day (CM-mESC-EB3), or 5-day 
(CM-mESC-EB5) EB formation period. Finally, CM-mESC-EB cultures were 
directed to the chondrogenic lineage for 15 days, similar to the control group, 
using chondrogenic medium. Control group represents mESCs maintained for 3 
days in conventional maintenance medium then allowed to form EBs for 5 days 
(EB5) and then directed to the chondrogenic lineage for 15 days using the 
chondrogenic medium. Data shown as mean relative GAG content at each culture 
time to GAG content at 0 day culture of each test group ± SD (n=6 * p<0.005 
compared to EB5). 
4.4.3.4. Immuno-staining for chondrogenic differentiation 
One of the distinct ECM proteins in cartilaginous matrix is type 11 collagen, 
which plays an important role in modulating the mechanical and structural 
properties of cartilage; type 11 collagen interacts with the minor collagens IX and XI 
to form heterotypic fibrils [Poole AR 2001]. As shown in figure 41, at day 15 of 
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culture, small islands of type 11 collagen matrix (green stain) were observed in both 
the cells and the matrix in the peripheral space around the cells in the CM-mESC- 
EB1 group. 
Figure 41. Immunostaining of cartilage nodules with type 11 collagen antibody. (A), 
(B) and (C) cartilage nodules after 15 day of culture with the use of anti type 11 
collagen (Green) and DAR (nuclear staining, blue); X 40, X 100, and X 400 
magnification. (D) Negative staining with the use of anti type 11 collagen antibodies 
and DAPI. 
4.4.3.5. Chondrogenic gene expression 
The genotypic profiling of the chondrogenic markers using RT-PCR at 
different culture time points is shown in figure 42. Type 11 collagen can be 
expressed in two forms by alternative splicing; the pre-chondrogenic splice variant 
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(collagen IIA) and the adult splice variant (collagen 1113) [Sandell LJ 1991]. Type 11 
collagen RNA expression for both variants was observed at substantial levels in 
the CM-treated mESCs with reduced EB formation time (CM-mESC-EBl). In 
particular, expression of the adult variant (collagen 1113) was prominent and 
constant during chondrogenic differentiation in CM-mESC-EB1. Consistent with 
type 11 collagen RNA expression, we observed that aggrecan expression, one of 
the major structural components of cartilage [Watanabe H 1998], was constant in 
the CM-mESC-EB1 group throughout the culture time. Finally, Sox-9 expression, a 
major transcription factor controlling chondrogenic differentiation [Kulyk KM 2000], 
appeared to be increasing with culture time during chondrogenic differentiation in 
the CM-mESC-EB1 group. In contrast, expression of type X collagen, a matrix 
protein expressed mainly in hypertrophic chondrocytes [Schmid TM 1985], was not 
detected in the CM-mESC-EB1 group. 
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Figure 42. Molecular analysis (RT-PCR) of type 11 collagen, aggrecan, sox-9 and 
type X collagen gene expression with GAPDH control lanes. Lane M: EZ Load 100 
bp Molecular Ruler. Lane 1,2 and 3: CM-mESC -EB1 cells were cultured in 
chondrogenic media for 5,10 and 15 days. 
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4.5. Discussion 
ESC differentiation can be induced by removal of LIF and subsequent 
culture in suspension to generate the three germ layers, namely mesoderm, 
endoderm, and ectoderm, through the EB mediated spontaneous differentiation. 
This culture strategy has been generally accepted as the conventional way to 
induce further differentiation, including skeletal lineage differentiation such as 
cardiogenic, osteogenic and chondrogenic differentiation [Tanaka H 2004, Buttery 
LD 2001, Mummery C 2002, Kawaguchi J 2005]. However, this approach faces 
several limitations. First, the fact that all three germ layers are formed results in 
the competition of mesoderm formation with endoderm and ectoderm formation, 
thus limiting the available pool of cells and producing a heterogeneous cell 
population. Furthermore, once mesoderm is formed, osteogenic and chondrogenic 
differentiation is in competition (or even suppressed) by spontaneous cardiogenic 
differentiation within the intact mesoderm. Therefore, control of the desired 
differentiation, including at the EB formation process, is required for the enhanced 
and exclusive ESC differentiation to our desired specific cell type. In the previous 
chapter we have demonstrated that a specific cell population with high capacity to 
form mesoderm was generated from mESCs through HepG2-CM treatment. In this 
chapter, we have evaluated the osteogenic and chondrogenic differentiation as 
well as the spontaneous cardiogenic differentiation from this early differentiated 
mESCs and established a novel culture protocol to control specific differentiation. 
During the early stages of embryogenesis, the mesoderm gives rise to 
cardioblasts, which subsequently differentiate into cardiornyocytes. Cardiogenic 
differentiation has been considered as a primary event in mesodermal 
differentiation [Arai A 1997]. It has been reported that EB formation reproduces 
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cardiornyocyte development and allows maturation from primitive precursor cells 
to highly specialized phenotypes of cardiac tissue. Within the developing EB, 
cardiornyocytes are located between the epithelial layer and the basal layer of 
mesenchymal cells [Leahy A 1999]. Cardiornyocytes are readily identifiable due to 
their spontaneous contraction within 1 to 4 days after plating. With continued 
differentiation, the number of spontaneously beating foci increases and all the EBs 
may contain localized beating cells [Zhou X 2003]. In this chapter, we achieved 
enhanced spontaneous cardiogenic differentiation of mESCs by extending the 
CM-mESC-derived EB formation period to 5 day (CM-mESC-EB5) without the 
addition of any strong cardiogenic stimulators. Specifically, at day 16 of culture 
there was a 4-fold increase in the number of beating colonies in the long EB- 
formation, CM-mESC-EB5 group generating approximately 1.7,4.0 and 2.9 
beating colonieS/CM2 at day 11,16 and 21 of culture, respectively, as compared to 
the control E135 group. In comparison, cardiornyocyte differentiation of mESCs 
enhanced by gene mutation after 13 days of culture by plating individual 5 day- 
EBs, generated approximately 3.4 beating colonieS/CM2 [Zhou X 2003]. This 
controlled and enhanced cardiogenic differentiation was further characterised by 
cardiogenic gene, Nkx-2.5, expression and molecular, sarcomeric a-actinin and 
tropomysin, expression. Murine Nkx-2.5 is predominantly expressed in the heart 
and in cardiac progenitor cells at the early developmental stage and it is widely 
used as one of the earliest markers of the precardiac cells [Mummery C 2002]. It 
has been reported that during the early stages of differentiation, cardiornyocytes 
within EBs are typically small and round and that the nascent myofibrils are sparse 
and irregularly organized or lacking, whereas others contain parallel bundles of 
myofibrils that show evidence of Z bands [Dabiri G 1997]. With maturation, ESC- 
derived cardiornyocytes become elongated with well-developed myofibrils and 
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sarcomeres. Herein, Nkx-2.5 gene expression as well as molecular expression of 
sarcomeric (x-actinin and tropomysin were detected in the CM-mESC-EB5 and 
control EB5 groups, but not detected in both CM-mESC-EB1 and CM-mESC-EB3 
groups. These results suggest that cardiogenic differentiation can be enhanced by 
increased mesoderm formation from the primitive streak/nascent mesoderm-like 
cell population and is dependent on EB formation period. 
Whereas increasing the EB formation time resulted in enhanced 
cardiornyocyte differentiation, the extended EB formation groups, namely CM- 
mESC-EB5 and EB5, showed no significant difference and enhancement in bone 
nodule formation, AI-Pase activity, or Cbfal expression. In contrast, reducing the 
EB formation time resulted in significant enhancement of osteogenic differentiation 
in the CM-mESC-EB1 , mainly, and CM-mESC-EB3 groups. The bone nodule 
formation assay indicated that the highest bone formation was obtained in the CM- 
mESC-EB1 group, where the CM-mESCs were allowed only one day of EB 
formation, generating 34 ± 6,59 ±7 and 72 ±6 bone nodules/cm 2 at day 11,16 
and 21 of culture, respectively. A comparison with literature data shows that 
induction of osteogenic precursor cells from foetal tissue produced approximately 
8 bone noduleS/CM2 after 19 days of culture through supplementation with ascorbic 
acid and glycerophosphate [Zur Nieden NI 2003]. Despite the difficulty in 
comparing directly with literature data, our results certainly suggest that our 
methodology offers improved osteogenic differentiation in terms of culture time and 
yield. Several in vitro studies for osteogenic differentiation have demonstrated that 
the process of osteoblast differentiation is divided into three temporal phases: 
proliferation, maturation/matrix synthesis, and mineralization [Abe Y 2000]. We 
evaluated osteogenic differentiation by assessing OB cadherin expression, Cbaf-1 
expression, and the AI-Pase assay. OB cadherin is highly expressed in 
123 
osteoblastic cell lines and during mesenchymal cell differentiation including the 
osteoblastic lineage [Lecanda F 2000, Luegmayr E 2000]. OB cadherin staining 
was well developed in the periphery of neighbouring cells, which maintained 
cuboidal shapes. These results were in agreement with the bone nodule assay 
results. Specifically, OB cadherin was expressed only in the CM-mESC-EB1 and 
CM-mESC-EB3 groups at day 11 of culture, whereas it was scarcely detected in 
the CM-mESC-EB5 and EB5 groups. This corresponds perfectly with the bone 
nodule count observed for these groups. Furthermore, expression of Cbfal 
confirmed the above mentioned results. The core binding factor (Cbfal; also 
known as runt related transcription factor (Runx2)) is a member of the runt 
homology domain family of transcription factors essential for osteoblast 
differentiation and bone formation and is expressed in all osteoblasts. The Cbfal 
protein has been reported to bind to the promoters of several genes that are 
expressed predominantly in osteoblasts and has been shown to increase the 
expression of osteocalcin, osteopontin, and type I collagen genes and induce ALP 
expression [Banerjee C 2001]. Cbfal expression was only observed in the CM- 
mESC-EB1 and CM-mESC-EB3 groups and was hardly detected in the CM- 
mESC-EB5 and E135 groups at day 11, signifying the consistency of our results in 
terms of osteogenic differentiation. Finally, we also evaluated the AI-Pase activity, 
a key enzyme in osteogenic differentiation. Alkaline phosphatase (ALPase) 
belongs to a family of proteins that are anchored to the plasma membrane via a 
glycosyl-phosphaticlinositol linkage [Wuthier RE 1985]. AI-Pase is widely used as a 
marker for the osteoblast phenotype, not least because of the simplicity with which 
it can be assessed. Osteoblasts express the tissue-non specific form of the 
enzyme. High levels of AI-Pase are seen in both pre-osteoblasts and osteoblasts 
in vivo and in differentiating osteoblasts in vitro. The biological function of AI-Pase 
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is still unknown except for a role in bone mineralization. Our results indicate that 
the CM-mESC-EB1 group, which has consistently showed the most enhanced 
osteogenic differentiation, had a Vold increase in ALPase activity as compared to 
the background levels of the other groups. This is consistent with the full gamut of 
our results and the transient nature of osteogenic differentiation in vitro. 
In the parallel study to the osteogenic differentiation, chondrogenic 
capacity of the CM-mESCs was evaluated. Recently, many attempts have been 
made to induce in vitro differentiation of ESCs into the chondrogenic lineage. 
Kramer et al. have reported in 2000 that BMP-2 and BMP-4 directs ESCs to the 
chondrogenic fate when added during day 3-5 of EB differentiation [Kramer J 
2000]. Those chondrocytes isolated from the EBs possess a certain plasticity to 
undergo hypertrophy and calcify [Kramer J 2000]. In contrast, others have shown 
that skeletal lineage differentiation of ESCs is highly dependent on the type of 
growth factor or supplement, and indicated that BMP-4 acted predominantly to 
promote osteogenic differentiation and retinoic acid treatment of EBs followed by 
TGF-03 treatment of outgrowths was sufficient to induce chondrogenesis from 
ESCs [Kawaguchi J 2005]. In another report, chondrogenesis was enhanced by 
the addition of dexamethasone in intact EB cultures [Tanaka H 2004]. In a different 
approach, it has been reported that mesodermal progenitor cells, identified as 
PDGFRcc' and/or foetal liver kinase-1 (flk)' cells, were isolated from ESCs using 
FACS sorting, whereby macroscopic cartilage formation was achieved in EB 
cultures by supplying various growth factors such as IGF-I, TGF-P3, BMP-4 and 
PDGF [Nakayama N 2003]. In conclusion, the vast majority of methods for the 
derivation of the chondrogenic lineage from ESCs are based on EB culture system. 
To our knowledge, this is the first report demonstrating the derivation of 
chondrogenic cells from mESCs using enhanced mesoderm progeny and a single 
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cell unit culture system producing macroscopic cartilage formation. 
In this chapter, we demonstrate the derivation of chondrocytes from 
mESCs. Specifically, the presence of matrix components produced by 
chondrogenic cells was confirmed by the Alcian blue staining. In particular, the 
extent of Alcian blue staining was higher in the CM-mESC-EB1 group, which was 
allowed only 1 day of EB formation, consistent with the higher levels of GAG 
content proved by DMMB assay. These CM-mESCs derived chondrocytes 
organized cartilage-like nodules in two dimensional cultures showing intensive 
staining for GAG and type 11 collagen expression. In addition, an Alcian blue and 
Alizarin red S double staining confirmed that the cartilage-like nodules in the CM- 
mESC-EB1 could be attributed to the chondrocytes derived, which was in contrast 
to the results obtained from the other groups, including the control group, where 
multiple lineage differentiation, including cardiogenic differentiation, was occurring. 
Beating colonies could be easily detected in all experimental groups except the 
CM-mESC-EB1 in accordance with the results obtained from our osteogenic 
differentiation. The RT-PCR results confirmed the enhanced chondrogenic 
obtained in the CM-mESC-EB1 group with the expression of genes characteristic 
for chondrogenic differentiation such as type 11 collagen [Sandell LJ 1991], 
aggrecan [Watanabe H 1998], and sox-9 [Kulyk KM 2000] throughout whole 
culture period. It has been well established that the pre-chondrogenic splice 
variant (collagen IIA) and adult splice variant (collagen 1113) are differentially 
regulated according to the differentiation stage of chondrogenic cells and that 
collagen IIA is usually upregulated in the initial stage of chondrogenic 
differentiation and collagen 1113 is expressed highly in maturation stage of 
chondrogenic cells [Sandell LJ 1991, Hegert C 2002]. However, in our study, the 
mRNA levels of collagen IIA and 1113 were similar in CM-mESC-EB1 group 
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throughout the culture period. A possible explanation for these results is that a 
heterogeneous population with different maturation stages in the CM-mESC-EB1 
group was produced. This clearly necessitates further investigation in order to 
achieve the production of the required homogenous population at the same 
maturation stage for any future clinical applications. Therefore, our results clearly 
indicate that increasing the EB formation time results in enhanced cardiogenic 
differentiation and reducing the EB formation time results in significant 
enhancement of osteogenic/chondrogenic differentiation. 
4.6. Conclusion 
In conclusion, controlling the EB formation period of the mESCs treated with 
the conditioned medium resulted in the preferential stimulation of cardiogenic, 
osteogenic or chondrogenic differentiation, respectively. Reducing the EB 
formation time to 1 day resulted in the enhanced osteogenic or chondrogenic 
differentiation, which was superior to the conventional EB formation process. This 
could provide the basis for a new approach for the up-regulation of specific 
mesodermal differentiation pathways for ESCs that could have applications in 
bone and cartilage tissue engineering. 
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CHAPER V 
IN VITRO DIRECT OSTEOGENIC AND 
CHONDROGENIC DIFFERENTIATION OF 
MURINE EMBRYONIC STEM CELLS WITHOUT 
EB FORMATION PROCESS 
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5.1. Introduction 
In vitro differentiation of ESCs can eventually lead to clinical applications 
by generating large quantity of the desired cells or tissues suitable for bone and 
cartilage defects. Many proposed applications of ESCs for skeletal tissue 
regeneration, such as bone and cartilage regeneration, are predicated on the 
assumption that it will be possible to obtain pure populations of differentiated cells, 
such as osteoblasts and chondrocytes from ESCs. To obtain physiologically 
functional specific lineage cells from ESCs that are suitable for transplantation, 
controlled differentiation procedures must be implemented. 
Table 8: Current approaches for in vitro EB mediated osteogenesis and 
chondrogenesis 
OSTEOGENESIS CELL CULTURE STRATEGY 
Buttery et a/ EB formation (5 days) --> trypsinisation mESC (E14) 2001 --> 2D culture 
Kawaguchi et al EB formation (5 days) 
mESC (E14) 2005 Direct EB plating and culture 
Bielby et al EB formation (5 days) --> trypsinisation 
mESC (E14) 2005 --> 2D culture 
Garreta et al EB formation (8 days) --> trypsinisation 
mESC (R1) 2006 2D culture and 3D culture 
Cao et al EB formation (4-5 days) 
hESC (H9) 
2005 Direct EB plating and culture 
CHONDROGENESIS CELL CULTURE STRATEGY 
Kawaguchi et al EB formation (5 days) 
mESC (E14) 
2005 Direct EB plating and culture 
Kramer et al EB formation (5 days) 
mESC (M) 
2000 & 2005 Direct EB plating and culture 
Nakayama et al EB formation (3-5 days) --> trypsinisation mESC (E14) 
2003 --> Micromass 2D culture, Pellet culture 
Tanaka et al EB formation (5 days) -3- Prolonged EB culture in mESC (E14) 
2004 hydrogel or ---> trypsinisation -3ý Micromass 2D culture, 
Hwang et al EB formation (5 days) --> Prolonged EB culture in mESC (M) 
2006(l) hydrogel or--> Direct EB plating and culture 
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A range of approaches have been developed to achieve this. For in vitro 
osteogenic and chondrogenic differentiation, the most widely used protocol for the 
induction of spontaneous differentiation is that of embryoid body (EB) formation for 
the early differentiation of ESCs to form mesoderm or mesoderm progenitors, 
along with the two other germ layers. This spontaneously formed mesoderm 
provides potent pool of progenitors for following further osteogenic and 
chondrogenic lineage differentiation [Tanaka H 2004, Buttery LID 2001, Kawaguchi 
J 2005, Bielby RC 2005, Nakayama N 2003, Kramer J 2005, Cao T 2005, Hwang 
NS 2006(l)]. The EBs are typically replated in monolayer cultures, after around 5 
days of EB formation followed by terminal differentiation. 
Under the suspension culture system for EB formation, early differentiation 
of ESCs in EBs is processed in two phases. Within the first 2-4 days of EB 
formation, ESC aggregates give rise to simple EBs containing an outer layer of 
endodermal cells, then these cells begin to synthesize extracellular matrix 
molecules, such as laminin, and a complete basement membrane is laid down 
between the primitive endoderm cells and the remaining undifferentiated ESCs 
within EB. Shortly afterwards, the ESCs within the EB start to differentiate to 
epiblast cells and, subsequently, around day 4 some of the epiblast cells that are 
aligned against the basement membrane polarize to form a columnar epithelium, 
while the inner cells of simple EBs undergo the process of programmed cell death 
to form cystic EBs with the formation of a central cavity formed by apoptosis and 
differentiation of a columnar epithelium with a basal lamina, a process called 
cavitation. Cavitation becomes evident when the resultant cellular debris is 
phagocytosed by the cells of the epiblast derived epithelium [Coucouvanis E 1995, 
Li S 2002] (Figure 43). This cavitation by programmed cell death is an inevitable, 
spontaneous process, making control of cell death within the EBs very difficult, 
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thus resulting in loss of available cells for terminal differentiation. 
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Figure 43. Schematic illustration of cystic EB formation. 
Furthermore, despite the tremendous amount of research on ESC 
differentiation by employing EB formation, limited knowledge exists concerning the 
culture conditions and requirements of EB culture and the differentiation 
mechanism(s) and cellular interactions occurring during EB formation. Thus, little 
is known about the process guiding the development of the three germ layers and 
the specific lineage of cells within the EBs [Khoo MLM 2005]. 
Recently, attempts have been made to induce specific lineage 
differentiation of ESCs directly by completely bypassing the EB formation process. 
Lee et al reported the screening of 880 compounds for their capability to induce 
cardiogenic differentiation efficiently using established ESC clones that expressed 
EGFP under the transcriptional control of a cardiac specific promoter, (x-MHC 
promoter, and a compound, ascorbic acid, markedly increased the differentiation 
of ESCs into cardiac myocytes directly in 2D culture without EB formation process 
[Takahashi T 2003]. In addition, in their study, it was reported that monolayer 
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culture of ESCs without EB formation reduced background differentiation, other 
lineage differentiation, and enabled high-throughput screening [Takahashi T 2003]. 
For osteogenic differentiation of ESCs, Langer and colleagues demonstrated ESC 
differentiation into osteogenic lineage without the EB formation step showed a 7- 
fold increase in the number of osteogenic lineage cells and the spontaneous bone 
nodule formation after 10-12 days in the presence of an osteogenic medium in 
comparison with osteogenic differentiation through 5 days of EB formation. When 
the ESCs were allowed to form EBs and the EBs were replated following 
dissociation, bone nodules formed after 4 weeks of culture only in the presence of 
dexamethasone. This research suggests that ESC differentiation into osteogenic 
lineage cells without an EB step can be used to derive large quantities of 
functional osteogenic cells for bone tissue engineering [Karp JM 2006]. From the 
literature, it is evident that the need of novel method to control and enhance 
lineage specific differentiation more efficiently is required, and increasing the 
efficiency of deriving specific lineage cells from ESCs would likely require better 
control over the cell microenvironment. 
5.2. Objectives 
The aim of this chapter is the development of a efficient culture 
process/system for directing and enhancing direct lineage-specific differentiation of 
mESCs into osteogenic/chondrogenic lineages which consists of two culture 
phases: a) mESCs differentiation into primitive streak/nascent mesoderm-like cells 
through the use of HepG2 conditioned medium in order to acquire potent cell 
source and b) terminal osteogen ic/chond rogen ic differentiation in 
osteogenic/chondrogenic culture media directly from the primitive streak/nascent 
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mesoderm-like cell population without the EB formation process. 
5.3. Experimental Process 
Previously we have shown that mESCs differentiate into primitive 
streak/nascent mesoderm like cells by the treatment of HepG2 conditioned 
medium (Chapter 111) and that this cell population showed enhanced in vitro 
osteogenic or chondrogenic differentiation through the modulation of EB formation 
period (Chapter IV). In this chapter, direct in vitro osteogenesis or chondrogenesis 
of mESCs was achieved by removing EB formation process resulting in a novel 
culture strategy that is more efficient, controlled, reproducible, and amenable to 
automation for application to skeletal tissue engineering. Specifically, mESCs were 
plated on tissue culture plates and cultured in 50: 50 HepG2 conditioned medium 
for 3 days in order to induce early differentiation into a primitive streak/nascent 
mesoderm like cell population, followed by terminal differentiation into osteogenic 
or chondrogenic lineages by simply replacing the conditioned medium with 
osteogenic or chondrogenic media containing the appropriate supplements such 
as P-glycerophosphate, ascorbic acid and dexamethasone (osteogenesis) or 
ascorbic acid, dexamethasone and TGFpl (chondrogenesis). Thus direct 
osteogenic or chondrogenic differentiation without EB formation was assessed 
using various techniques such as, characterisation of mineralised bone nodules, 
bone nodule formation assay, alkaline phosphatase expression, cartilage nodule 
formation assay, immunocytochemical characterisation, RT-PCRI and other 
specific ECM and lineage specific enzyme activity evaluation, which detailed 
explanation was described at CHAPTER 11. The overall experimental process was 
illustrated in figure 44. 
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Figure 44. Schematic illustration of direct in vitro osteogenesis and 
chondrogenesis without EB formation process 
5.4. Results 
5.4.1. Direct osteogenic differentiation 
5.4.1.1. Bone nodule formation and quantification 
Bone development in vitro is routinely assessed via the formation of bone 
nodules [Sottile V 2003, Woll NL 2006, Zur Nieden Ni 2003, Buttery LID 2001, 
Bielby RC 2005]. The bone nodule formation assay was performed using specific 
Alizarin red S (ARS) staining and the quantification of extracted ARS from stained 
bone nodules using the cetylpyridinium chloride (CPC) extraction method [Gregory 
CA 2004]. As shown in figure 45, the stained area increased with culture time as 
differentiation progressed; distinct mineralisation was induced from day 11 of 
osteogenic culture in both groups with the conditioned medium-treated mESCs 
(CM-mESCs) showing enhanced mineralization than the control mESCs 
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throughout the culture time. Specifically, approximately 50% increase in the 
stained bone nodules formed in the CM-mESCs cultures as compared to the 
control mESCs cultures was obtained. 
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Figure 45. Alizarin red S quantification for evaluating bone nodule formation. 
mESCs: non-treated normal mESCs. CM-mESCs: HepG2 conditioned media 
treated mESCs Data are shown as mean OD ± SD (n = 6; *p < 0.05 compared to 
mESCs). 
5.4.1.2. Characterisation of mineralised bone nodule 
It has been well demonstrated that ascorbic acid is necessary for formation 
of the collagenous matrix and P-glycerophosphate for subsequent mineralisation, 
which is mainly cell mediated through alkaline phosphatase activity expressed by 
osteogenic cells [Bellows CG 1991, Bellows CG 1986]. In addition, phosphate ions 
are required for mineralisation in vitro with P-glycerophosphate being the source 
[Binderman 1 1979]. However, spontaneous non-specific mineral precipitation, 
which may not be cell-mediated, may be generated from the culture medium's 
phosphate and calcium content. Herein, in order to evaluate whether bone nodule 
formation was cell-mediated or was non-specific mineral precipitation, the 
135 
ss s 
ARA 
mineralised nodules were characterised by ALPase expression and alizarin red S 
staining. Under light microscopy, dark irregular shaped mineral deposition could 
be easily detected mainly at the central space in cell aggregations (Figure 46A), 
and AI-Pase was strongly expressed only around the mineral deposits with slight 
expression in cells (Figure 46B). Accompanied with morphological observation and 
AI-Pase expression assay, the calcium deposit on mineralised bone nodules was 
stained calcium specific alizarin red S, and figure 46C shows a strongly stained 
red spot on mineralize nodules with slightly stained region around mineral deposits. 
In addition, when the alizarin red S-stained area was exposed to filtered UV light 
(excitation at 530-560 nm and emission at 580 nm), the detection of fluorescence 
was confined only on mineral deposits, as shown in figure 46D. 
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Figure 46. Characterisation of mineralised bone nodules; (A) Morphology of bone 
nodule under light microscopy. (B) AI-Pase expression on bone nodules. (C) 
Alizarin red S stained bone nodules under light microscopy. (D) Alizarin red S 
stained bone nodules showing fluorescence. Arrow indicates mineral deposits. 
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5.4.1.3. ALPase expression and activity quantification 
In order to characterize the osteogenic differentiation stage of the control 
mESCs and experimental CM-mESCs in osteogenic medium, expression and 
time-course analysis of ALPase activity, which is widely used as a marker of 
mineralization and as a marker of the osteoblast phenotype, was evaluated. As 
show in figure 47, the gradual increase of AI-Pase expression was detected in 
both mESCs and CM-mESCs in accordance with culture time, and especially, at 
day 16, where both mESCs and CM-mESCs showed the strongest expression of 
AI-Pase, which generally concentrated on the mineral deposit, followed by week 
expression of AI-Pase thereafter. In general, in comparison with mESCs, CM- 
mESCs expressed ALPase more strongly. Furthermore, non-specific ALPase 
expression was detectable in the mESCs group (Figure 47C and C'), which might 
be derived from AI-Pase activity of other lineages. 
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Figure 47. Assessment of AI-Pase expression. A, C, E and A', C" E' ; mESCs 
culture in osteogenic media at day 11,16 and 21. B, D, F and B', D', F' ;CM- 
mESCs culture in osteogenic media at day 11,16 and 21. 
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The expression of ALPase was supported by the quantification of ALPase 
activity using a colorimetric assay. As shown in figure 48, CM-mESCs showed 
relatively lower level of AI-Pase activity in comparison with mESCs at day 0 prior to 
osteogenic differentiation. Following osteogenic differentiation, consistent with 
ALPase expression, enzyme activity showed a time-dependent behaviour with a 
marked increase at day 16 and then a decrease to background levels from day 21 
onwards in both mESCs and CM-mESC culture in osteogenic medium. Specifically, 
ALPase activity was enhanced around 1.6-fold (P<0.05) in the CM-mESC in 
comparison with the control mESC group at day 16 of the osteogenic culture, 
which were 485.3 ± 43.6 PNPýM/min/rng in the CM-mESC and 320.2 ± 24.9 
PNPýM/min/mg in the mESC. This temporal increase of AI-Pase activity in both 
CM-mESC and mESC correlates with the increased bone nodule formation. 
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Figure 48. Colorimetric assay for assessing ALPase activity. mESCs; non-treated 
normal mESCs- CM-mESCs; HepG2 conditioned media treated mESCs. Data are 
shown as mean enzyme activity ± SD (n = 6; *p < 0.05 compared to mESCs). 
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5.4.1.4. Immuno-staining for osteogenic differentiation 
Osteoblast differentiation is controlled by the extracellular environment. 
The principal role of osteoblasts in bone formation is to secrete the matrix 
framework upon which bone is built by actively synthesizing many proteins during 
their developmental and maturation stages. This matrix framework is mainly 
composed of densely packed type I collagen fibrils infiltrated by hydroxyapatite 
(HA) crystals and small amounts of distinctive non-collagenous proteins, such as 
osteopontin. Osteopontin (OPN) is a highly phosphorylated sialoprotein that is a 
prominent component of the mineralized extracellular matrices of bones [Sodek J 
2000]. In osteoblast differentiation, type I collagen and OPN are constitutively and 
regularly expressed [Zhu JX 2001, Chen Y 1992, Zhou HY 1995]. Herein, 
osteogenic differentiation was further characterized by assessing type I collagen 
and OPN expression. As shown in figure 49, at day 21 of culture type I collagen 
and OPN were very strongly expressed in the CM-mESCs cultured in osteogenic 
medium. In particular, type I collagen immunostaining was well developed in the 
periphery of neighbouring cells. Similarly, OPN immunoreactive cells could be 
observed in the CM-mESCs at day 21 of osteogenic culture. 
Figure 49. Immunocytochernical staining for type I collagen and osteopontin 
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(OPN) in CM-treated mESC-derived cultures. (A) Expression of type I collagen 
(green) and nuclear staining (DAPI; blue) at day 21 of culture in the cmES-EB1- 
derived osteogenic cells. (B) Expression of osteopontin (OPN) (green) and nuclear 
staining (DAPI; blue) at day 21 of culture in the cmES-EB1 -derived osteogenic 
cells. Inset (A') and (B') shows negative control for non-specific binding of the 
primary antibody. 
5.4.1.5. Osteogenic gene expression 
It is well known that core binding factor Cbfal/Runx2 is an essential 
transcription factor required for osteoblast recruitment and differentiation and bone 
formation [Banerjee C 2001] and that Osterix is a bone-related transcription factor 
that controls both growth and differentiation in osteoblasts and osteogenic 
differentiation of ESCs [Nakashima K 2002, Guanping T 2004]. In addition, the 
osteocalcin gene encodes an osteoblast-specific protein that is induced with the 
onset of mineralization at late stages of differentiation [Viereck V 2002]. Herein, 
the direct osteogenic differentiation of mESCs without EB formation was evaluated 
at the genetic level by examining the expression of osteocalcin, Cbfal/Runx2 and 
osterix using RT-PCR. As shown in figure 50, gene expression confirmed 
osteogenic differentiation for both mESCs and CM-mESCs derived osteoblasts. 
Specifically, Cbfal/Runx2 expression was constant throughout the culture period 
for both groups, yet a relatively stronger expression of osteocalcin and osterix was 
observed in the CM-mESCs in comparison to the mESCs. These results are in 
agreement with the bone nodule formation assay, mineralised nodule 
characterisation and type I collagen and osteopontin immunostaining results 
demonstrating the correlation between mineralised bone nodule formation and 
osteogenic marker expression and osteoblast related gene expression. 
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Figure 50. RT-PCR analysis of osteogenic gene expression. GAPDH gene 
expression was used at the housekeeping control. Lane 1-4: osteogenic culture 
of mESCs for 6,11,16 and 21 days. Lane 5-8: osteogenic culture of CM-mESCs 
for 6,11,16 and 21 days. 
5.4.2. Direct chondrogenic differentiation 
5.4.2.1. Morphological evaluation 
Herein, the control, mESCs, and experimental, Cm-mESCs, groups were 
subjected to the high cell density micromass culture with chondrogenic 
supplements, such as dexamethasone, ascorbic acid and TGF-P1 without EB 
formation. Distinct cartilage nodule-like structures could be observed in with 
different frequency in both the CM-mESCs and mESC groups, where cells formed 
three-dimensional round shaped aggregates, as seen in figure 51A and B; the 
frequency being higher in the CM-mESC group. Following 15 days of 
chondrogenic differentiation, cartilage nodules containing round-shaped 
chondrocytes were observed with the nodules exhibiting a distinct structure 
comprising of round-shaped cells separated by extracellular matrix surrounded by 
a circular arranged fibrillar matrix that was easily detected by light microscopy. 
However, in the control mESC cultures, different morphologies could be detected 
easily which might indicate other lineage differentiation (Figure 51 C and D). 
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Figure 51. Morphology of cartilage nodules and other cell lineages. (A) and (13): 
cartilage nodule. (C) and (D): Other cell lineages found in mESC group. 
5.4.2.2. Cartilage nodule formation 
When mESCs and CM-mESCs were cultured in chondrogenic conditions in 
the absence of EB formation, local condensation occurred in monolayer cultures 
and the condensed cells gradually formed cartilage nodules. These cartilage 
nodules could be easily detected by GAG specific staining, such as alcian blue 
staining. Following 15 days of chondrogenic differentiation, the cartilage nodules 
exhibited a distinct structure comprising of round-shaped chondrocytes separated 
by extracellular matrix (ECM) surrounded by a circular arranged fibrillar matrix 
[Maleski MP 1996], and positive staining of the nodules with Alcian blue, indicative 
of cartilage-like extracellular matrix accumulation. Our results indicated that the 
CM-mESCs resulted in enhanced chondrogenesis, as shown in figure 52. 
Specifically, an 1.8-fold increase (P < 0.05) in the stained areas was obtained in 
the CM-mESCs compared with the control group of untreated mESCs, with 31.89 
± 2.50 % of stained area in the CM-mESC group and 17.89 ± 2.22 % of stained 
143 
area in the mESC group, respectively. 
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Figure 52. Quantification of the Alcian blue stained areas of cartilage nodules. 
mESC: non-treated normal mESCs. CM-mESC: HepG2 conditioned media treated 
mESCs. Data shown as mean relative stained area ± SD (n=4, * P<0.05 compared 
to mESCs). 
5.4.2.3. Extracellular Matrix Synthesis 
Cartilage tissues consist of sparsely embedded chondrocytes in a 
specialized ECM. ECM has dense collagen and GAG networks that determine 
mechanical and functional properties of the tissue [Poole 2001]. Furthermore, both 
pre-cartilage condensation and cartilage nodule formation are regulated influenced 
by extracellular matrix components, such as GAG and collagen [Poole AR 2001. 
Knudson CB 2001]. For the functional evaluation of chondrogenic differentiation, 
GAG and collagen synthesis were quantified. Our results showed that GAG and 
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CM-mESC 
collagen synthesis in the CM-mESC group was much higher than the control 
mESC group as culture time progressed. Specifically, GAG content produced in 
the CM-mESC group showed around an 2-fold increase throughout the culture 
period compared with the control group of mESC, with 0.304 ± 0.052,0.306 ± 
0.057,0.503 ± 0.099 ýtg/ýtg of DNA at day 5,10 and 15 in the CM-mESC group 
and 0.147 ± 0.019,0.106 ± 0.041,0.266 ± 0.084 ýtg/ýtg of DNA at day 5,10 and 15 
in mESC group, respectively (Figure 53). 
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Figure 53. Quantification of relative matrix sulfated GAG amount produced by 
culture. mESC: non-treated normal mESCs. CM-mESC: HepG2 conditioned media 
treated mESCs. Data shown as mean relative GAG content at each culture time to 
GAG content at 0 day culture of each test group ± SID (n=6 * p<0.05 compared to 
mESCS). 
For collagen synthesis, at day 5 of culture, there was no significant 
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difference between the CM-mESC and mESC groups. However, collagen content 
in CM-mESC group showed 1.9- and 1.4-fold increase at day 10 and 15 of culture 
in comparison with the mESC group, with 1.545 ± 0.106,2.746 ± 0.541,3.463 ± 
0.194 ýtg/ýtg of DNA at day 5,10 and 15 in the CM-mESC group and 1.816 ± 0.094, 
1.403 ± 0.142,2.494 ± 0.329 ýtg/ýtg of DNA at day 5,10 and 15 in the mESC 
group, respectively (Figure 54). 
4.000 
3.500 
3.000 
2.500 
2.000 
1.500 
0 
L) 1.000 
0.500 
0.000 
Day 5 Day 10 Day15 
Culture Time 
Figure 54. Quantification of relative matrix collagen amount produced by culture. 
mESC: non-treated normal mESCs. CM-mESC: HepG2 conditioned media treated 
mESCs. Data shown as mean relative collagen content at each culture time to 
GAG content at 0 day culture of each test group ± SID (n=6 * p<O. 05 compared to 
mESCs). 
5.4.2.4. Immuno-staining for chondrogenic differentiation 
One of the most important transcription factors that is expressed during 
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early chondrogenesis is the high-mobility group (HMG) box protein Sox-9 [Kulyk 
KM; 2000]. In addition, one of the distinct ECM in the cartilaginous matrix is type 11 
collagen which plays an important role in modulating the mechanical and structural 
properties of cartilage [Poole AR; 2001]. As shown in figure 55A, at day 15 of 
culture, small islands of type 11 collagen matrix protein (green stain) were observed 
in both the control and experimental groups. In addition, Sox-9 was observed 
distinctly in a central region of the cells within cartilage nodules, which were easily 
confirmed by nuclear counterstaining with PI (Figure 55B). 
Figure 55. Immunostaining of cartilage nodules with type 11 collagen and sox-9 
antibody. (A) Expression of type 11 collagen (green) and nuclear staining (PI; red) 
at day 15 of culture in the cmES-EB1 -derived chondrogenic cells. (B) Expression 
of Sox-9 (blue) and nuclear staining (PI; red) at day 21 of culture in the cmES- 
EB1 -derived chondrogenic cells. Inset (A') and (B) shows negative control for non- 
specific binding of the primary antibody. 
5.4.2.5. Chondrogenic gene expression 
The genotypic profiling of chondrogenic markers in this study using RT- 
PCR at different culture time points is shown in figure 56. Upon chondrogenic 
differentiation, type 11 collagen, aggrecan and link protein transcript, which are 
major structural component of cartilage [Sandell LJ 1991, Watanabe H 1998, 
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Rodriguez E 2005, Neame PJ 1994], were readily detectable from day 5 of culture 
in both culture groups, and type 11 collagen mRNA expression was upregulated 
substantially higher at day 10 of chondrogenic culture in the CM-mESCs group 
and at day 15 of culture in the mESCs group, respectively. Furthermore, Sox-9 
mRNA expression, a major transcription factor controlling chondrogenic 
differentiation [Kulyk KM 2000], became detectable at day 5 of chondrogenic 
culture and appeared to be increasing with culture time during chondrogenic 
differentiation in both the mESCs and CM-mESC groups. Furthermore, Scleraxis, 
a basic helix-loop-helix (bHLH) transcription factor expressed in developing 
chondrogenic cell lineages during embryogenesis [Brown D 1999], was induced at 
day 5 of chondrogenic culture and expressed at constant levels in the CM-mESCs. 
In contrast, Scleraxis expression became detectable at low levels at day 15 of 
chondrogenic culture in the control mESCs group. 
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Figure 56. Molecular analysis (RT-PCR) of type 11 collagen, scleraxis, sox-9 
aggrecan, and link-protein gene expression with GAPDH control lanes. Lane 1,2 
and 3: mESCs were cultured in chondrogenic media for 5,10 and 15 days. Lane 4, 
5 and 6: CM-mESCs were cultured in chondrogenic media for 5,10 and 15 days. 
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5.5. Discussion 
In Chapters III and IV, we demonstrated that mESCs were induced to 
differentiate into a cell population with high capacity for osteogenic or 
chondrogenic differentiation through stimulation with the HepG2 conditioned 
medium and modulation of the EB formation period. However, for future clinical 
applications of this culture strategy to bone and cartilage tissue engineering, 
reproducibility, control, and automation are imperatives that need to be considered. 
Hence, we have demonstrated herein the direct differentiation of ESCs into the 
desired cell types in the absence of EB formation although EB-mediated ESCs 
differentiation has been widely accepted by most researchers [Tanaka H 2004, 
Buttery LD 2001, Kawaguchi J 2005, Bielby RC 2005, Nakayama N 2003, Kramer 
J 2005, Cao T 2005, Hwang NS 2006 (1)]. One of limitations in EB-mediated 
differentiation strategy is the spontaneously induced cavitation within El3s. This 
cavitation by programmed cell death is an inevitable, spontaneous process, which 
is very difficult to control resulting in loss of available cells for terminal 
differentiation even in the specialized culture conditions for lineage specific 
differentiation [Coucouvanis E 1995, Li S 2002]. In addition, the spontaneous 
formation of all three germ layers within the EBs can result in reduced yield of 
differentiation to the cell type of interest and a heterogeneous population due to 
mostly unknown precise mechanism(s) of cellular interactions within the EBs 
[Khoo MLM 2005]. From those limitations, the need of novel culture strategy by 
bypassing EB formation process is evident, considering more efficient, simple and 
easy manageable bioprocesses for tissue engineering, 
The assessment of functional osteogenic activity and quantification of the 
extent of mineralization were achieved by Alizarin red S staining. The increase in 
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the stained mineralised area with culture time was representative of normal 
osteogenesis. Furthermore, the enhanced osteogenesis in the CM-mESC group 
indicated that the HepG2 conditioned medium in the absence of EB formation 
produced superior results in both time and extent of differentiation that the 
standard protocol requiring EB formation. To discriminate between cell-mediated 
and non-specific mineral deposits, a calcium responsive alizarin red S stain was 
employed [Midura RJ 2004, Chang YL 2000] in addition to observance of 
fluorescence, indicating high density of calcium. In addition, alkaline phosphatase 
(ALPase) expression was clearly confined around mineral deposits. The AI-Pase 
has been thought to play a role in the mineralization of bone [Wuthier RE 1985] 
and as a marker of the osteoblast phenotype. Our results demonstrated that 
mineralization was cell-mediated in the experimental group (CM-mESCs), which is 
consistent with reports that cellular-derived mineral deposits are formed in vitro in 
the presence of P-g lycerop hosp hate as an additional source of phosphate ions 
[Tenenbaum HC 1982, Chang YL 2000]. It has been well documented that 
AI-Pase attached covalently to the external surface of plasma membranes is 
involved in the mineralization of hard tissues [Togari A 1993] and that AI-Pase of 
osteoblastic cells is released into the medium during maturation. Hence, the 
temporal increase of AI-Pase activity observed in our results is consistent with the 
progress of mineralization [Yoshikawa M 1999]. The enzymatic hydrolysis activity 
of AI-Pase is necessary to initiate biological mineralization by hydrolyzing p- 
glycerophosphate and promoting mineralization [Sugawara Y 2002]. In 
accordance with the quantitative data of mineralised bone nodule formation, CM- 
mESCs showed relatively higher AI-Pase activity than mESCs, indicating the 
enhanced osteogenic activity. The relatively lower AI-Pase activity in CM-mESCs 
at day 0 represents their early differentiation stage due to treatment with the 
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HepG2 conditioned medium. It has been demonstrated that undifferentiated ESCS 
show a high level of expression AI-Pase which decreases following differentiation 
[Thomson A 1998]. 
In addition to functional characterisation, osteogenic cells are known to 
express various specific markers that distinguish them from other cell types. In in 
vitro bone formation, the mineralised bone nodules consist of cuboidal osteoblasts 
embedded within the bone matrix [Malaval L 1999]. This bone matrix is mainly 
composed of dense packed type I collagen fibrils infiltrated with hydroxyapatite 
crystals and small amounts of bone specific proteins, such as osteopontin. Type I 
collagen is the most abundant protein of bone [Rossert J 2002] and is essential for 
bone growth and development. Furthermore, osteopontin is one of the major bone 
sialoproteins which is essential for the process of mineralisation [Sodek J 2000]. 
The expression of these molecules is controlled during osteogenic differentiation 
[Zhu A 2001, Chen Y 1992, Zhou HY 1995]. Our results in the expression of type 
I collagen and osteopontin in the matrix of bone nodules were in accordance to 
literature data and was further verified by the gene expression profiles of specific 
genes. Cbfal/Runx2, a transcription factor that is the earliest marker of 
osteogenesis, is expressed in early mesenchymal condensation [Ducy P 1997, 
Banerjee C 2001] and participates in mature osteoblast by controlling the 
expression of type I collagen and bone sialoproteins, such as osteocalcin and 
osteopontin [Ducy P 1997, Banerjee C 2001]. The early expression at day 5 of 
Cbfal/Runx2 in our results was in accordance to the literature data and 
demonstrated the enhanced osteogenesis in the CM-mESC group over the control 
group. These results were further supported by the robust osteocalcin expression 
in CM-mESCs, which persisted to 21 days of culture in comparison with mESCs. 
In addition, osterix, an osteoblast-specific transcription factor required for the 
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differentiation of osteoprogenitors into mature osteoblasts [Nakashima K 2002, 
Guanping T 2004], was upregulated strongly at late culture stage in CM-mESCs, 
which is consistent with a report that osterix is upregulated several days later than 
Cbfal/Runx2 developmentally [Woll NL 2006]. Finally, these results are in 
agreement with the bone nodule formation assay, mineralised nodule 
characterisation and type I collagen and osteopontin immunostaining results 
demonstrating the correlation between mineralised bone nodule formation and 
osteogenic marker expression and osteoblast related gene expression. 
Direct chondrogenesis was also achieved without EB formation, as 
demonstrated by our data. The process of chondrogenesis occurs in stages 
beginning with the aggregation of chondroprogenitor from mesenchymal cells into 
precartilage condensations. The cells in the centre of the nodules remain spherical 
and are surrounded by an abundant cartilaginous extracellular matrix. The cells in 
the periphery of the nodules acquired a discoid morphology and are surrounded by 
a sparse extracellular matrix [Hall BK 2000, Tuan IRS 2004, Kuettner KE 1982]. In 
our results, morphological cell condensations were apparent by day 5 of 
differentiation and distinct cartilaginous nodules could be observed by day 15 
which further increased in number and size. Local condensation occurred in 
monolayer cultures, and round shaped chondrocyte was observed at the centre 
area of cartilage nodules; these nodules exhibited a distinct structure comprising 
of round-shaped cells separated by extracellular matrix surrounded by a circular 
arranged matrix that was easily detected by light microscopy. For the further 
characterisation of cartilage nodules to assess functional chondrogenic activity, 
cartilage nodules in chondrogenic culture were stained by GAG specific Alcian 
blue and the relative stained area were measured, cartilage nodules, after 15 days 
of chondrogenic culture, were easily detected by positive staining with Alcian blue, 
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indicative of cartilage-like extracellular matrix accumulation, and the HePG2 
conditioned media-treated mESCs (CM-mESCs) resulted in enhanced 
chondrogenesis with a 1.8-fold increase in the stained areas in compared with the 
control group of untreated mESCs, suggesting that HepG2 conditioned media 
induced mESC early differentiation strategy generate a cell population with high 
capacity of mesodermal lineage differentiation. These accumulated extracelluar 
matrix are mainly composed of dense collagen and GAG networks that determine 
mechanical and functional properties of the cartilage tissue [Poole 2001]. In 
addition, both precartilage condensation and cartilage nodule formation are 
regulated by extracellular matrix components such as GAG and type 11 collagen 
[Poole AR 2001. Knudson CB 2001]. Under our chondrogenic condition, High 
GAG and collagen deposition was detected in highly condensed areas of cell 
growth in CM-mESCs cultures. GAG and collagen synthesis in CM-mESC group 
was much higher than mESC group in accordance with culture time. Specifically, 
GAG content produced in CM-mESC group showed around 2-fold increase for 
whole culture period compared with the control group of mESC. In collagen 
synthesis, at day 5 of culture, there was no significant difference in collagen 
content between CM-mESC and mESC, but collagen content in CM-mESC group 
showed 1.9- and 1.4-fold increase at day 10 and 15 of culture in comparison with 
mESC group. This finding was further validated by immunocytochernical analysis 
carried out on day 15 of differentiation. Chondrocyte marker proteins such as type 
11 collagen, one of major macromolecules produced by chondrocyte [Poole AR 
2001], and Sox-9, one of the most important transcription factors that are 
expressed during early chondrogenesis [Kulyk KM 2000], expression in cartilage 
nodules were evaluated. Type 11 collagen deposition in the cartilage nodules found 
predominately in both cells and the matrix synthesized by CM-mESCs, and 
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immunostaining for Sox-9 was easily detected in a central region of cells within 
cartilage nodules, indicating well defined chondrogenic differentiation. 
Chondrogenic differentiation was also characterized by distinct cellular 
phenotypes, which could be identified by specific extracellular matrix and 
transcription factor gene expression profiles. Type 11 collagen, aggrecan and link 
protein are major structural components of cartilage [Sandell LJ 1991, Watanabe 
H 1998, Rodriguez E 2005, Neame PJ 1994] and matrix network composed of 
these macromolecules determines mechanical and functional properties of the 
tissue [Poole 2001]. In addition to chondrocyte specific extracellular matrix 
macromolecules, there are specific transcription factors controlling chondrogenic 
differentiation. Scleraxis, one of major transcription factor, is expressed in 
mesenchymal progenitors and during chondrogenesis [Brown D 1999], and Sox-9 
is major transcription factor directing chondrogenic differentiation [Kulyk KM 2000]. 
The two transcription factors regulate the fate of cells that interact with each other 
during differentiation pathways. Recent research reported the presence of 
temporal and spatial association of scleraxis expression during embryonic 
development of mesenchymal precursor cells in close association with that of Sox- 
9 expression in chondrogenic cells in skeletal tissues [Asou Y 2002]. Upon 
chondrogenic differentiation, type 11 collagen, aggrecan and link protein 
transcription were induced from day 5 of culture. Especially, substantially 
upregulated type 11 collagen mRNA expression was observed in CM-mESCs group 
respectively. However, aggrecan and link protein transcripts were not expressed in 
constant level in both chondrogenic culture of CM-mESCs and mESCs, which 
might be due to heterogeneous cell population expressing them. Different from 
type 11 collagen which is expressed only in cartilaginous tissue, although aggrecan 
and link protein are distinct molecules found in cartilage tissue and expressed in 
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chondrogenic cell lineage, it was well known that aggrecan and link protein can be 
also expressed by other cell lineage and non-cartilaginous tissue [Carulli D 2007, 
Binette F 1994]. In the expression of chondrogenic transcription factor, there was 
also significant induction of Sox-9 and scleraxis genes in chondrogenic culture of 
CM-mESCs, and Sox-9 and scleraxis transcripts were upregulated as culture time 
passed. In contrast, even though Sox-9 expression in chondrogenic culture of 
mESCs showed similar pattern with CM-mESCs with relatively week intensity, 
mESCs showed relatively weak expression of scleraxis mRNA. Finally, gene 
expression analysis showed that direct chondrogenic differentiation was achieved 
under the culture condition with chondrogenic supplement from direct culture of 
mESCs without EB formation step, and was enhanced in chondrogenic culture of 
early differentiated mESCs (CM-mESCs) through preliminary treatment with 
HepG2 conditioned medium, showing the correlation between cartilage nodule 
formation, chondrogenic specific extracellular matrix production and chondrogenic 
marker expression. 
5.6. Conclusion 
The novel culture strategy for directing osteogenic and chondrogenic 
differentiation of mESCs described here is completely devoid of EB formation 
process, enabling in vitro direct osteogenesis and chondrogenesis. Removing the 
EB formation step resulted in the almost exclusive osteogenic and chondrogenic 
differentiation, which would be more efficient and easy than the conventional EB 
mediated differentiation culture method. In addition, osteogenic and chondrogenic 
differentiation could be enhanced by the use of early differentiated ESCs, which 
induced by HepG2 conditioned medium treatment. By taking advantage of the 
1,555 
ease of directing and enhancing in vitro osteogenic/chondrogenic differentiation, 
the ESCs osteogenic/chondrogenic differentiation culture described here would 
provide an efficient and easy culture strategy for applying to bone and cartilage 
tissue engineering in the context of macroscopic bone and cartilage formation. 
This culture system may lead to a better strategy for bone and cartilage repair and 
bone and cartilage tissue engineering. 
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CHAPER VI 
BIOPROCESSING FOR THREE DIMENSIONAL 
BONE AND CARTILAGE TISSUE LIKE 
CONSTRUCT FORMATION USING ALGINATE 
ENCAPSULATED MURINE EMBRYONIC STEM 
CELLS AND HARV BIOREACTORS 
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6.1. Introduction 
Recently, in the field of skeletal tissue engineering, osteogenic and 
chondrogenic construct has been fabricated by isolating various cell type including 
primary adult cells and bone marrow stem cells that are expanded in tissue culture 
flasks and cultured on or in various three dimensional scaffold which are made of 
natural or synthetic biornaterials in bench-scale [Suh H 2000, Suh H 2001, 
Ceuninck FID 2004, Hwang NS 2006(l)]. Specially, recent skeletal tissue 
engineering studies have shown the potential use of ES cells for bone and 
cartilage tissue regeneration in three dimensional scaffold systems with 
appropriate growth factors. Hwang NS et al reported that three dimensional 
scaffold culture system by encapsulating mESCs derived EBs with natural, 
synthetic and hybrid biornaterials such as poly(ethylene glycol (PEG))-based 
hydrogels, PEG hydrogel containing glucosamine, arginine-glycine-aspartate 
(RGD)-modified poly(ethylene glycol)-diacrylate (PEGDA) hydrogels and alginate 
based hydrogel provided suitable environment for chondrogenic differentiation 
resulting in three dimensional structure like neocartilage [Hwang NS 2006(l), 
Hwang NS 2006(2), Hwang NS 2006(3), Tanaka H 2004]. In other hands, in three 
dimensional osteogenic differentiation of ESCs, there has been only one tissue 
engineering based approaches in development of three dimensional bone like 
construct. The report demonstrated that mESCs derived EBs were encapsulated 
by self-assembling peptide, a synthetic nanofiber biornaterial made of 
commercially available peptides (RAD16-1 peptide, BID PuraMatrix Peptide 
Hydrogel), and induced to differentiate into osteoblast like cells in a three 
dimensional culture system, which was proved by evaluating matrix mineralization, 
collagen I synthesis, ALPase activity, and expression of the osteoblast 
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transcription factor Runx2 [Garreta E 2006]. 
However, such culture process in static culture system has some 
drawbacks even though three dimensional scaffolds are used. It has been well 
known that mass transfer limitations involved during in vitro culturing of three 
dimensional constructs result in limited cell growth into the three dimensional 
construct [Ishaug-Riley SL 1998, Holy CE 2000]. In such static culture system, cell 
growth and tissue formation are usually confined on top of surface of scaffold 
resulting in poor penetration of cells and poor three dimensional tissue formation. 
For instance, it was reported that some cells (bone marrow stem cells) which were 
initially seeded at internal part of the three dimensional porous scaffolds could 
migrate by chernotaxis towards outer surface where nutrient concentration is 
higher. The remaining cells inside of scaffold showed decreased osteogenic 
differentiation and lower expression of osteogenic specific genes [Glowacki J 
1998]. It has been well documented that transport of nutrients into the centre point 
of three dimensional scaffold mainly depends on diffusion, which can not satisfy 
the metabolic requirement of cells on three dimensional scaffolds for long culture 
period [Mueller SM 1999]. These results might be due to potential mass transfer 
limitations including external and internal mass transfer limitation with respect to 
the supply of oxygen and medium components. However, these mass transfer 
limitations can be reduced by the use of bioreactors. 
Bioreactors become essential in tissue engineering, not only because they 
provide an in vitro culture system mimicking in vivo conditions for the growth of 
cells to form three dimensional tissue substitutes, but also because they enable 
systematic studies of the responses of living tissues to various mechanical and 
biochemical cues. In addition, bioreactors can drastically reduce the amount of 
space and handling steps involved and increase the volumes of tissue-engineered 
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product in comparison with in vitro the flasks based culture strategy which might 
provide a limit in their productivity due to limited cell expansion that can be 
supported by a given surface area for cell growth, and handling for culture 
maintenance makes the process labour intensive. In recent years, among various 
types of bioreactors, Rotating Wall Vessel (RWV) bioreactors such as High Aspect 
Ratio Vessel (HARV) bioreactor have been widely used in the culture of cells 
seeded on scaffolds or microcarriers or without scaffold in cartilage [Ohyabu Y 
2006] and bone [Qiu QQ 1999, Botchwey EA 2001] tissue formation in vitro. The 
RWV bioreactor is designed to optimize to produce laminar flow and minimize the 
mechanical stresses on cell aggregates in culture by minimizing shear and 
turbulence, and is a device that creates a unique environment, while providing 
adequate nutrition and oxygenation, ideal for mammalian cell culture, that supports 
three dimensional tissue growth [Hammond TG 2001]. Oxygenation is provided by 
a permeable silicon rubber membrane through the stationary inner cylinder, 
allowing the passive exchange of gases to and from the medium, whereas the 
outer cylinder is impermeable and rotates at a controlled rate. The free falling of 
the microcarrier inside the bioreactor as a result of gravity can be balanced by the 
centrifugal forces due to the rotation of the outer-cylinder, thus establishing 
suspension culture environment for microcarrier [Pollack SIR 2000, Hammond TG 
2001]. (Figure 57) 
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Figure 57. RV\IV bioreactor and influencing factor diagram for particle move. 
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Accompanied with bioreactor system, another important factor in three 
dimensional culture system could be the selection of microcarrier for cell growth 
and three dimensional tissue formation. In skeletal tissue engineering, various 
biornaterials such as natural or synthetic polymers and hydrogels have been used 
as supporting matrix for cell growth and differentiation [Suh H 2000, Suh H 2001, 
Ceuninck FID 2004]. In case of natural and synthetic polymers, porous scaffolds 
have been favoured by most of researchers for constructing three dimensional 
bone and cartilage like structure in vitro. However, porous structure and non- 
homogenous shape like cylindrical or disc type may give rise to very complex 
motion in bioreactors, which could be very difficult to model and evaluate the 
influence of mechanical stress to the scaffolds, resulting in poor consistency in 
data. Hence, hydrogels with spherical shape could be considered as another 
candidate, because their simple shape like sphere may make it easier relatively to 
expect their motion and the effect of environmental condition in bioreactors, and 
extensive studies have been processed about model and experimental validation 
of such particles motion in bioreactors to optimize suspension culture [Pollack SIR 
2000, Hammond TG 2001]. In various biomaterials forming hydrogel, alginate has 
been widely used for cell encapsulation, drug or growth factor delivery and tissue 
engineering [Ceuninck FD 2004, Masuda K 2003, Gu F 2004] due to its great 
biocompatibility (low undesirable immune response), significant mechanical 
resistance, and an interesting biodegradability [Becker TA 2000, King A 2001 ]. 
Alginate is a polysaccharide extracted from seaweed composed of 
homopolymeric regions of 1,4-linked b-D-mannuronic acid (M-blocks) and a-L- 
guluronic acid (G-blocks) residues in varying proportions and arrangements 
interspersed with MG-blocks. Divalent cations, such as Ca 2+ , cooperatively 
bind 
between the G-blocks of adjacent alginates chains, creating ionic interchain 
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bridges and subsequent gelling of aqueous alginate solutions [Martinsen A 1989]. 
The constitution of alginate gel networks is a complex phenomenon. The different 
gel network structures have been well demonstrated by Bienaime et al [Bienaime 
C 2003]. The gel network of alginate bead is mainly composed of a superficial 
crust, a subsurface, cavities, shafts and shaft clusters, a medium gelled zone, and 
a weak gelled zone, which formed by the heterogeneous distribution of calcium 
inside the gel matrix (Figure 58). The gelation process are as follows; After 
formation of a superficial crust layer with the highest calcium and alginate 
concentration, which make the gel bead be tightened, the volume of gel bead is 
gradually reduced due to the tightening of the superficial crust by water expulsion, 
and then alginate molecules in the centre of the gel bead which still is not 
crosslinked with calcium ion gradually moved to the boundary space with high 
calcium content. Finally, during this cascade of reaction-diffusion processes, micro 
fractures, shafts and cavities are formed. 
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Figure 58. Schematic representation of the different gel network structures of a 
Ca-alginate hydrogel. 
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Such simple and reproducible gelation process and good biocompatibility 
makes alginate widely used as biomedical materials for various applications, and 
can provide suitable matrix for cell growth and function in three dimensional 
culture system using a bioreactor. 
6.2. Objectives 
The aim of this study was to develop single step culture process for direct 
osteogenic and chondrogenic differentiation of mESC, finally develop three 
dimensional bone and cartilage tissue like construct, using alginate encapsulation 
and HARV bioreactors and by applying previously established differentiation 
strategy, resulting in efficient and reproducible culture system for bone and 
cartilage tissue engineering applications. 
6.3. Experimental Process 
Finally, in this study, each previous culture strategies were integrated into 
single-step culture process using alginate encapsulation and HARV bioreactor for 
developing three dimensional bone and cartilage like tissue formation. mESCs 
were encapsulated with alginate solution including gelatin through reaction with 
calcium, and then placed in the vessel of HARV bioreactor. For first 3 days, 
encapsulated mESCs were cultured in 50% HepG2 conditioned media in order to 
induce early differentiation of mESCs into primitive streak/nascent mesoderm like 
cells, and then encapsulated cells were subjected to differentiate into osteogenic 
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and chondrogenic lineage cells by changing the conditioned media with 
osteogenic or chondrogenic media including osteogenic supplements such as P- 
glycerophosphate, ascorbic acid and dexamethasone or including chondrogenic 
supplements such as ascorbic acid, dexamethasone and TGF-P1. Finally, the 
single step 3D osteogenic and chondrogenic differentiation was investigated using 
various techniques; live/dead assay, morphological observation, histological 
staining, immunohistochemical staining, and RT-PCR, which detailed explanation 
was described at CHAPTER 11. In brief, the overall experimental process was 
illustrated in figure 59. 
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Figure 59. Experimental process for single step 3D osteogenesis and 
chondrogenesis in a HARV bioreactor 
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6.4. Results 
6.4.1. Alginate beads and HARV bioreactor system 
For the single step osteogenesis and chondrogenesis, mESCs were 
encapsulated by 1.1% alginate including 0.1% gelatin, and the cell + alginate 
beads were placed in 50 ml bioreactor vessels, and then these vessels were 
rotated at the speed of 25 rpm. The morphology and pictures of alginate beads 
and a HARV bioreactor system was shown in figure 60. Figure 60 portrays alginate 
beads encapsulating mESCs with approximate diameter from 2 mm to 2.5 mm. 
Al, 
Figure 60. Alginate beads and HARV bioreactor system. (A) and (B) Morphology 
of spherical alginate beads and encapsulated mESCs within alginate beads. (C) 
HARV bioreactor equipped with four vessels containing around 500 alginate beads 
and media. 
6.4.2. In vitro single step 3D osteogenesis in a HARV bioreactor 
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6.4.2.1. Observation of cell viability 
Time course cell viability of CM-mESCs within alginate beads in 3D 
osteogenic culture was visualized using a two-colour fluorescence cell viability 
assay that is based on the simultaneous determination of live and dead cells that 
measure intracellular esterase activity and plasma membrane integrity. Calcein AM 
is cleaved by intracellular esterases to label live cells brightly with green 
fluorescence. Ethidium homodimer (EthD-1) enters cells that have lost plasma 
membrane integrity, producing bright red fluorescent labelling of dead cells. As 
shown in figure 61, at early stage of osteogenic culture, most of cells within 
alginate beads showed intensified green fluorescence indicating live cells with very 
few yellow or orange fluorescence, and as culture time passed, population of dead 
cells was gradually increase, but the size of cell aggregation with tissue like 
structure was also increased. 
M, 
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Figure 61. Live/dead assay and morphology of cells within alginate beads in 3D 
osteogenesis. A and B; CM-mESCs in alginate beads at day 0 of osteogenic 
culture in HARV bioreactor. C and D; CM-mESCs in alginate beads at day 11 of 
osteogenic culture in HARV bioreactor. E and F; CM-mESCs in alginate beads at 
day 16 of osteogenic culture in HARV bioreactor (X200 magnifications). 
6.4.2.2. Bioprofiling 
Following live and dead assay, in order to evaluate the growth kinetics of 
CM-mESCs within alginate beads indirectly, the consumption of nutrient in the 
osteogenic media in a HARV bioreactor was evaluated by measuring time-course 
concentration of glucose, lactate and ammonia, and by detecting pH of media 
during whole culture. In this study, the osteogenic media was refreshed every two 
days just after measuring the concentration of nutrients in cultured media using a 
bio-profiler. In pH kinetics, even though the fresh medium was supplied every two 
days, pH of Medium gradually decreased from 7.5 to 7.2 as culture time passed 
(Figure 62A). In glucose consumption kinetics, glucose concentration in medium 
was also reduced rapidly from 5.4 mM to around 0.15 mM even at day 2 of culture, 
followed by further reduction to 0 mM. In an opposite pattern with pH and glucose, 
ammonia and lactate concentration went up to 4.00 mM from 2.75 mM and up to 
11.75 mM from 0 mM in medium, indicating ammonia and lactate production and 
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release though metabolism of cells within alginate beads into medium. 
(A) 
7.550 7.503 
7.500 
7.438 
7.450 7.423 
- 7.405 
7.400 i 
7.350 
7.300 
7.250 
7.200 
(C) 
4.50 
4.00 
3.50 
jý 3.00 
0 E 2.50 
E 
+ 2.00 
z 1.50 
1.00 
0.50 
0.00 
7.384 
1 
7.388 
7.369 
7.306 
, 
7.321 
7.330 7.295 
-2 02468 10 12 14 16 18 20 22 
Culture Time (Day) 
3.953.90 4.054.00 
3.35 3. f 
55 
31 65 
2.95 3.10 
2.75 
f 
0.15 
(B) 
6.000 - 
5.450 
ýT 5.000 
0 4.000 
LU 3.000 
W 
0 
6 2.000 
1.000 
0.150 
0.000 11t0. -00.0 
0-. 0 O. 
'o 
0,0 0; 0 0: 0 010 0. 
-0 
-2 02468 10 12 14 16 18 20 22 
Culture Time (day) 
(D) 
14 
11.300 11.750 12 11.150 
10-100 10.150 11.750 
11.300 11-500 10 
0 10.100 10.250 E 
E8 
uj i- 6 
L) 
'4 j4 
2 
0 
ItIIIIIIjII101111jIIIIII 
-2 02468 10 12 14 16 18 20 22 -2 02468 10 12 14 16 18 20 22 
Culture Time (Day) Culture Time (Day) 
Figure 62. The change of pH, glucose, ammonia and lactate concentration in 
medium in accordance with culture time during 3D osteogenesis. (A) pH change, 
(B) Change of glucose concentration, (C) Change of ammonia concentration, (D) 
Change of lactate concentration. 
6.4.2.3. Osteogenic gene expression 
Following the evaluation of cell growth and metabolic activity in HARV 
bioreactor culture system, osteogenic differentiation was also characterized by 
distinct cellular phenotypes, such as a component of specific extracellular matrix 
and transcription factor gene expression profiles. In this study, direct osteogenic 
differentiation of mESCs by bypassing EB formation process was evaluated by 
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osteogenic gene expression level. Characterisation of osteogenic differentiation 
was performed by examining expression of osteocalcin, Cbfal/Runx2, osterix 
using RT-PCR. As shown in figure 63, these gene expression indicating 
osteogenic differentiation was clearly detected in 3D osteogenic culture. Especially, 
osteocalcin and Cbfal/Runx2 transcripts were induced to express in mESCs after 
culture in HepG2 conditioned medium for 3 days, and expressed at steady state 
levels through whole osteogenic culture period in osteogenic medium, but osterix 
mRNA expression was not detected in the culture under HepG2 conditioned 
medium. Different from the pattern of osteocalcin and Cbfal/Runx2 expression, 
expression of osterix transcript was upregulated by 11 day of osteogenic culture in 
osteogenic media, followed by consistent expression for further culture. In addition, 
to confirm their differentiation stage, Oct4 expression was evaluated for whole 
culture period, showing the strong expression of Oct4 transcript of mESCs before 
culture in HepG2 conditioned medium and osteogenic medium and the distinct 
down-regulated expression over osteogenic culture, which indicates the 
progressive differentiation. 
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Figure 63. RT-PCR analysis of osteogenic gene expression in 3D osteogenesis. 
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6.4.2-4. Staining and immuno-staining 
In our previous study, early differentiated mESCs (CM-mESCs) formed 
mineralised bone nodules in vitro in 2D culture system without EB formation 
process. Therefore, we addressed whether the CM-mESCS were also capable of 
forming mineralised bone nodule in 3D culture system using alginate beads and a 
HARV bioreactor. The encapsulated mESC were subjected to be cultured in 
HepG2 CM in order to induce early differentiation into specific cell population with 
high osteogenic capacity and then to differentiate directly into osteogenic lineage 
in replaced osteogenic medium in suspension culture system within bioreactor. 
The H&E staining showed well developed three dimensional tissue formation 
within alginate beads with size variation, which some of large tissues represents 
200-300 ýtm in diameter or length, after 21 days of osteogenic culture (Figure 64 
A-D). In addition, in order to confirm whether these tissues were mineralised bone 
tissue by osteogenic differentiation, Alizarin red S (ARS) staining was done for the 
characterisation of calcium deposit in tissues. AIRS staining represents mineralised 
areas that stained dark-red with ARS, which became noticeable around centre 
region of tissues, indicating bone nodule-like mineralised matrix accumulation, and 
the other areas showed weak AIRS staining (Figure 64 E-H). In addition, when the 
ARS-stained area was exposed to filtered UV light (excitation at 530-560 nm and 
emission at 580 nm), only mineralised area represented fluorescence as shown in 
figure 64 I-L. For further confirmation, the sections were stained with anti-type I 
collagen as well as an anti-osteocalcin antibody (Figure 64 M-T). Most of the areas 
that stained with AIRS expressed both type I collagen and osteocalcin. Especially, 
type I collagen was expressed markedly at peripheral region around cells and 
tissues, and osteocalcin immuno-staining was also found at similar region with 
type I collagen with relatively weak intensity. 
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Figure 64. Various staining and immuno-staining for mineralised bone nodules 
and osteogenic differentiation. A-D: H&E staining, E -H: ARS staining, 1: negative 
staining of ARS, J: positive staining of mouse bone tissue, K: positive staining of 
AIRS and L: AIRS positive staining representing fluorescence. M: type I collagen 
immuno-staining of mouse bone tissue, N: negative staining for type I collagen, 0 
& P: type I collagen immuno-staining of 3D bone construct. Q: Osteocalcin 
immuno-staining of mouse bone tissue, R: negative staining for Osteocalcin, S&T 
Osteocalcin immuno-staining of 3D bone construct. All alginate bead 
encapsulating cells were allowed to direct osteogenic differentiation for 21 days in 
HARV bioreactors. 
6.4.2.5. Physicochernical characterisation of alginate beads 
6.4.2.5.1. The micro attenuated total reflection -Fou He r transformed infrared 
(ATR-FTIR) analysis of mineralised nodules 
4, #11 
In order to characterise the mineralised nodules within alginate beads, 
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alginate beads encapsulating cells were collected to evaluate mineral components 
of mineralised nodules after 21 days of osteogenic culture using ART-FTIR 
analysis method in combination with a focal plane array (FPA) detector. Firstly, 
FTIR images were collected with this system, and FTIR imaging showed distinct 
presence of phosphate only in the sample of cells plus alginate bead directing 
osteogenic differentiation (Figure 65 C), not in pure alginate beads (Figure 65 A) 
and cells plus alginate beads (Figure 65 B) when the images were plotted by the 
integrated absorbance Of P04 (between 970 cm-1 and 1035 cm-) and amide I 
(between 1565 and 1500 cm-1). The FTIR spectrum of mineralised bone nodules 
showed characteristic functional groups of phosphate moieties. Phosphate peaks 
were observed between 970 cm-1 and 1035 cm-1. This ATR-FTIR analyses of the 
mineralised nodules suggested that they are apatitic since the characteristic P04 
(at 1016 cm-1) vibrations were observed (Figure 66 E), which are typical of apatitic 
minerals [Granja PL 2005, Aparicio S 2002, Sandeep GH 2006]. Furthermore, two 
major additional peaks such as hydroxyl and H20peak, centred at around 1650 
cm-1 and 3250 cm-1 were observed in FTIR spectrum (Figure 65 E), which could 
be derived from control alginate beads and media in sample evaluation (Figure 65 
D). Another interesting bands in this evaluation was amide I (between 1565 and 
1500 cm-) regarding whether the mineralised nodule was derived from cellular 
origin, but the amide I peak was not characterised due to shielding effect by high 
peak of H20 from sample media. In addition, another minor peak that can be 
considered as carbonyl 
(C03 2-) peak regarding its peak band [Aparicio S 2002], 
indication biological mineralisation of bone tissue. It has been well proved that in 
the biological mineralization of bone tissue, hydroxyl ions and P04 3- is substituted 
in the apatite structure byC03 2- or HP04 2- [Sandeep GH 2006]. 
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Figure 65. The FTIR images and ATR-FTIR spectra of cell + alginate construct; 
generated by plotting the integrated absorbance Of P04 (between 970 cm-1 and 
1035 cm-1) and amide I (between 1565 and 1500 cm-) over the imaged area; the 
colour scale bar shows the value of the integrated absorbance. (A) Chemical 
image of pure alginate beads. (B) Chemical image of alginate beads encapsulating 
cells. (C) Chemical image of alginate beads encapsulating cells directed into 
osteogenic differentiation. (D) ATR-FTIR spectra of pure alginate beads analysed. 
(E) ATR-FTIR spectra of alginate beads encapsulating cells directed into 
osteogenic differentiation analysed. 
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6.4.2.5.2. Scanning Electron Microscope (SEM) and Energy Dispersive 
spectroscopy (EDS) analysis of mineralised bone nodules 
When viewed by SEM, many mineralized deposit were observed within 
alginate hydrogels encapsulating cells after osteogenic culture. In the X-ray 
analysis observation, SEM pictures showed the presence of non-stoichiometric 
mineralised deposits, and mineralised bone nodules within alginate hydrogels 
were mainly composed of calcium and phosphorous, proved by EDS analysis 
(Figure 66). The EDS spectrum of mineralised nodules showed specific Ca and P 
peaks. In addition, in the spectrum, minor magnesium and sodium were also 
detected as one of component. A relatively higher peak of carbon and oxygen 
might be due to the cellular component or alginate component. In addition, the 
Ca/P molar ratio of the calcium phosphate formed, as analysed by EDS 
microanalysis, was about 1.23. 
ftý 
i 
0 
Figure 66. SEM and EDS microanalysis spectra for the composition of mineralised 
bone nodules formed within alginate beads in the osteogenic culture of mESCs 
after 21 days. (A): Low magnified SEM observation and its EDS analysis. (B): High 
magnified SEM observation and its EDS analysis. 
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6.4.2.5.3. Mechanical property of 3D bone like construct 
The mechanical property of bone like construct was characterised by 
compression testing. The compressive modulus was measured for each test 
materials including controls, and the bone constructs, which were formed by the 
osteogenic culture of mESCs for 21 days in HARV bioreactor following alginate 
encapsulation, was stiffer than the controls, pure alginate beads and alginate bead 
encapsulating undifferentiated mESCs with same cell density as bone construct 
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Figure 67. Mechanical strength of bone like construct. Bone construct: 21 days 
osteogenic culture of mESCs encapsulated with alginate. Alginate: pure alginate 
bead without cells. Alginate + Cells: Alginate bead encapsulating undifferentiated 
mESCs with same cell density as Bone construct. 
6.4.3. In vitro single step 3D chondrogenesis in a HARV bioreactor 
6.4.3.1. Observation of cell viability 
As shown in figure 68, at day 5 of chondrogenic culture, most of cells 
within alginate beads showed intensified green fluorescence indicating live cells 
with very few yellow or orange fluorescence, and as culture time passed, 
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population of dead cells was gradually increase, but the size of cell aggregation 
with tissue like structure was also increased. In addition, comparing with cell 
viability within alginate beads in HARV bioreactor, the cells within alginate bead in 
static culture condition at day 5 of culture showed much higher population of dead 
cells (Figure 68G). 
Figure 68. Live/dead assay and morphology of cells within alginate beads. A, B 
and C; CM-mESCs in alginate beads at day 5, day 10 and day 15 of chondrogenic 
culture in HARV bioreactor. G: CM-mESCs in alginate beads at day 5 of 
chondrogenic culture in 2D static culture condition. 
6.4.3.2. Bioprofiling 
Following live and dead assay, in order to evaluate the growth kinetics of 
CM-mESCs within alginate beads indirectly, consumption of nutrient in the 
chondrogenic media in a HARV bioreactor was evaluated by measuring time- 
course concentration of glucose, ammonia, and lactate and by detecting pH of 
media during whole culture. In this study, the chondrogenic media was refreshed 
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every two days just after measuring the concentration of nutrients in cultured 
media using a bio-profiler. In pH kinetics, even though the fresh medium was 
supplied every two days, pH of Medium gradually decreased from 7.6 to 7.0 as 
culture time passed. In glucose consumption kinetics, glucose concentration in 
medium was also reduced rapidly from 22 mM to around 10 mM even at day 2 of 
chondrogenic culture without further reduction in concentration for following culture 
period. In an opposite pattern with pH and glucose, ammonia concentration went 
up rapidly from 0.55 mM to 1.65 mM even at day 2 of chondrogenic culture and 
increased finally up to 2.45 mM at day 15, and lactate concentration went 
gradually from 0 mM up to 22.6 mM in medium, indicating ammonia and lactate 
production and release though metabolism of cells within alginate beads into 
medium. (Figure 69) 
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medium in accordance with culture time during 3D chondrogenesis. (A) pH change, 
(B) Change of glucose concentration, (C) Change of ammonia concentration, (D) 
Change of lactate concentration. 
6.4.3.3. Chondrogenic gene expression 
For the validation of 3D chondrogenesis, chondrogenic differentiation were 
characterised by genotypic profiling of chondrogenic markers in this study using 
RT-PCR at different culture time points, as shown in figure 70. Upon chondrogenic 
differentiation, type 11 collagen, aggrecan and link protein transcript, which are 
major structural component of cartilage [Sandell U 1991, Watanabe H 1998, 
Rodriguez E 2005, Neame PJ 1994], were readily detectable during chondrogenic 
culture. These expressions except aggrecan were not detected in normal mESCs, 
but, when mESCs were cultured in HepG2 conditioned medium for 3 days, 
aggrecan and link-protein was upregulated. Furthermore, Sox-9 mRNA expression, 
a major transcription factor controlling chondrogenic differentiation [Kulyk KM 
2000], become detectable from day 5 of chondrogenic culture, and appeared to be 
upregulated with culture time during chondrogenic differentiation. In particular, 
Scleraxis, a basic helix-loop-helix (bHLH) transcription factor to be expressed in 
developing chondrogenic cell lineages during embryogenesis [Brown D 1999], 
transcript were also induced from day 5 of chondrogenic culture and expressed in 
constant level through whole culture period. In addition, to confirm their 
differentiation stage, Oct4 expression was evaluated for whole culture period, 
showing the strong expression of Oct4 transcript of mESCs before culture in 
HepG2 conditioned medium and chondrogenic medium and the distinct down- 
regulated expression over chondrogenic culture, which indicates the progressive 
differentiation. 
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Figure 70. RT-PCR analysis of chondrogenic gene expression in 3D 
chondrogenesis. 
6.4.3.4. Staining and immuno-staining 
In our previous study, early differentiated mESCs (CM-mESCs) formed 
mineralised bone nodules in vitro in 2D culture system without EB formation 
process. Therefore, we addressed whether the CM-mESCs were also capable of 
forming cartilage like tissues in 3D culture system using alginate beads and a 
HARV bioreactor. The encapsulated mESC were subjected to be cultured in 
HepG2 CM in order to induce early differentiation into specific cell population with 
high chondrogenic capacity and then to differentiate directly into chondrogenic 
lineage in replaced chondrogenic medium in suspension culture system within 
bioreactor. The H&E staining showed well developed three dimensional tissue 
formation within alginate beads with size variation, which some of large tissues 
represents 200-400 ýtm in diameter or length, after 15 days of chondrogenic 
culture (Figure 71 B-D). When the chondrocytes secrete their extracellular matrix, 
they become trapped within the matrix. In a histological preparation the 
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chondrocytes may shrink, thereby revealing the small spaces, called lacunae, in 
which they reside, which can be a distinct characteristic of histological section of 
cartilage tissue. These lacunae structure could be observed in H&E staining. In 
addition, Alcian blue and Safranin 0 staining were done for the characterisation of 
cartilage tissues. These staining represent represents overall area that stained 
dark-blue with Alcian blue and dark-red with Safranin 0, which became noticeable 
throughout whole area of the tissues, indicating an extensive deposition of GAG 
that are one of the major ECIVI in cartilage. In addition, chondrocyte-like lacunae 
structure was evident in the sections and could be detected with Alcian Blue and 
Safranin 0 (Figure 71G-L, O-P). For further confirmation, the sections were 
stained with anti-type 11 collagen (Figure 71Q-T). Most of the areas expressed 
abundant extracellular immunoreactivity for type 11 collagen. 
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Figure 71. Various staining and immuno-staining for 3D cartilage like construct. A: 
H&E staining of mouse cartilage tissue. B-D: H&E staining of cartilage like 
constructs. E&F: Alcian blue staining of mouse cartilage tissue. G-L: Alcian blue 
staining of cartilage like construct, M&N: Safranin 0 staining of mouse cartilage 
tissue. 0&P: Safranin 0 staining of cartilage like construct, Q: type 11 collagen 
immuno-staining of mouse cartilage tissue. R: negative staining for type 11 collagen 
S&T type 11 collagen immuno-staining of cartilage like construct. U: H&E staining 
(Low magnification). V: Alcian blue staining (Low magnification). X: Safranin 0 
staining (Low magnification). All alginate hydrogels encapsulating cells were 
allowed to direct chondrogenic differentiation for 15 days in HARV bioreactors. 
6.5. Discussion 
Tissue engineering, a new field that enables tissue equivalents to be 
created from cells in combination with biornaterials and bioreactor culture vessels, 
185 
potentially can provide a basis for systematic, controlled in vitro Studies of tissue 
growth and function. To dates, there have been extensive researches for 
developing three dimensional bone and cartilage tissue like construct by studying 
various cell sources and three dimensional biomimic scaffold in 2D culture system 
in laboratory scale [Suh H 2000, Suh H 2001, Ceuninck FID 2004, Hwang NS 
2006(l)]. However, the 2D culture system has not been successful for constructing 
3D tissue equivalent due to some limitations of nutrient mass transport and of 
controlling mechanical forces to induce differentiation and growth. To overcome 
these limitations, recently bioreactor culture system has been developed to 
enhance and develop three dimensional growth of cells in proper culture condition. 
Therefore, we developed a culture system to create three-dimensional bone and 
cartilage like tissues based on mESCs, alginate bead, and HARV bioreactor. As 
far as we know, this is the first study demonstrating the three dimensional bone 
and cartilage like tissue formation from individual cell suspension of mESCs in a 
bioreactor system, and, thus, could have widespread applications in bone and 
cartilage tissue engineering. 
In this study, mESCs were prepared in suspension and encapsulated with 
1.1% alginate mixed with 0.1% gelatin, and then the encapsulated mESCs were 
placed to culture in suspension environment within vessels of HARV bioreactors, 
a kind of Rotating Wall Vessel (RWV) bioreactor, whereas the bioreactor maintains 
controlled in vitro culture conditions that permit tissue growth and development. 
This RWV bioreactor optimize suspension culture circumstance by producing 
laminar flow and minimizing shear and turbulence which can be the stresses on 
cells in culture, while providing sufficient nutrition and oxygenation that supports 
three dimensional tissue growth [Hammond TG 2001]. In our study, live and dead 
assay showed increased cell aggregation size in accordance with culture time and 
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finally well developed tissue formation within alginate beads in both osteogenic 
and chondrogenic culture. In addition, in brief comparison study with static culture 
of mESCs within alginate beads, 3D culture system using a bioreactor showed 
much higher cell viability. The relatively lower cell viability in static culture system 
in comparison with 3D culture system might be due to potential mass transfer 
limitations including external and internal mass transfer limitation with respect to 
the supply of oxygen and medium components, which transport of nutrient in static 
culture mainly depends on diffusion, which can not satisfy the metabolic 
requirement of cells on three dimensional scaffolds for long culture period [Mueller 
SM 1999]. This difference can be explained by that mass transfer limitations 
involved during in vitro culturing of three dimensional constructs result in limited 
cell growth into the three dimensional construct [Ishaug-Riley SL 1998, Holy CE 
2000]. 
Tissues constructs formed by cell growth within alginate beads consisted of 
viable and metabolically active cells, which were evaluated by measuring pH 
change, glucose consumption, lactate and ammonia production in osteogenic and 
chondrogenic medium during cultures. It has been well reported that these 
metabolites profile and pH can provide a kind of metabolic parameters to be used 
to modulate cell metabolism such as ECM synthesis and tissue growth and 
morphology for developing optimal culture condition for cell growth [Obradovic B 
1999]. Mammalian cells utilize glucose and glutamine as one of major energy 
sources. Glucose uptake was from culture medium and then is converted to lactate 
as a by-product through glycolysis under anaerobic condition, yielding 2 mol of 
adenosine triphosphate (ATP) per mole of glucose, or toC02and H20through the 
tricarboxylic acid (TCA) cycle in aerobic condition, yielding 36 mol of ATIP per mole 
of glucose. Lactate is mostly produced by glYcolysis of glucose, and only a small 
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amoun is derived from glutamine [Glacken 1986, Zielke 1980]. Glutamine is 
utilized by catabolism through the TCA cycle, producing ammonia as a by-product. 
The amount of ammonia can be used as an indicator of glutamine utilization and 
TCA cycle activity [Miller 1987, Siano 1991]. In our study of 3D osteogenesis and 
3D chondrogenesis, glucose consumption kinetics showed rapid decrease in 
glucose concentration in medium, implying rapid cell growth and active 
metabolism in cells. Furthermore, rapid reduction of glucose concentration to 
ground level in osteogenesis might be due to initial low concentration of glucose in 
osteogenic medium, and the glucose was consumed to constant level at 10 mM in 
chondrogenesis, which might be due to relatively much higher initial concentration 
of glucose in chondrogenic medium. Lactate and ammonia profile showed fast 
decline in their concentration at day 2 of culture in both 3D osteogenesis and 3D 
chondrogenesis, but, in 3D osteogenesis, lactate was consumed to constant level 
at around 10 or 11 mM for further culture period, and, in 3D chondrogenesis, the 
lactate concentration in medium was increased gradually up to 22.6 mM, which 
might be related with the difference in initial concentration of glucose in osteogenic 
and chondrogenic medium, and the accumulation of lactate matches the decrease 
of glucose, and ammonia production might be from the metabolism of glutamine 
contained in medium ((x-MEM) as basal concentration, 2mM. In addition, medium 
pH is another key parameter in cell culture as it affects cell viability, cell growth, 
and metabolic activity. In our study, the pH in osteogenic and chondrogenic 
medium decreased with culture time and with increasing lactate and ammonia 
concentration, which is consistent with that ammonia and lactate production alters 
intracellular and external pH in medium [Barngrover D 1985]. However, the pH 
change was within the proper pH range (7-0-7-4) of cell culture media, implying no 
strong influence on cell growth and function. From these results, we suggests that 
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the more concise control of culture condition should be necessary for achieving 
optimal culture system in regard of nutrient consumption profile and cellular 
metabolism in a bioreactor. 
Recently, there have been tissue engineering based approaches in 
development of three dimensional bone and cartilage like construct using mESCs, 
three dimensional scaffold systems and appropriate growth factors in static culture 
system, showing the potential use of ESCs for bone and cartilage tissue 
regeneration [Hwang NS 2006(l), Hwang NS 2006(2), Hwang NS 2006(3), Tanaka 
H 2004, Garreta E 2006]. In most these current researches, mESCs were allowed 
to form EBs, then mESCs derived EBs were encapsulated with synthetic 
hydrogels, and cultured in 2D static culture environment with various osteogenic 
and chondrogenic supplements, showing successful achievement of bone and 
cartilage like structure. However, in spite of these successful approaches for 3D 
osteogenic and chondrogenic differentiation of ESCs, attempts to direct the 
differentiation of ESCs into desired cell types though intermediate EB formation 
have been limited. To dates, limited knowledge exists concerning the culture 
conditions and requirements for culturing EBs and differentiation mechanism and 
cellular interactions within EB, resulting in difficulty to control homogenous 
differentiation. In other words, little is known about the process guiding the 
development of three germ layers and specific lineage of cells within the EB. 
Current approaches for the differentiation through intermediate EB formation give 
rise to a mixture of different cell types due to spontaneously formed three germ 
layers [Khoo MLIVI 2005]. It has been well proved that ESC differentiation into 
osteogenic lineage cells without an EB step can be used to derive large quantities 
of functional osteogenic cells for bone tissue engineering [Karp JM 2006]. 
Therefore, to develop more efficient culture system for skeletal tissue engineering 
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application, our culture system was designed to induce early differentiation of 
mESCs encapsulated with alginate and subsequent osteogenic and chondrogenic 
differentiation by the culture in HepG2 conditioned medium and osteogenic and 
chondrogenic medium in a HARV bioreactor, for achieving 3D bone and cartilage 
like construct. 3D osteogenesis and chondrogenesis was characterised at a gene 
expression level by examining expression of osteocalcin, Cbfal/Runx2, osterix, 
type 11 collagen, aggrecan, link protein, scleraxis, sox-9 and Oct4. These 
osteogenic, osteocalcin, Cbfal/Runx2, osterix, and chondrogenic, type 11 collagen, 
aggrecan, link protein, scleraxis, Sox-9, gene expression showed substantial level 
throughout whole osteogenic and chondrogenic culture period, indicating well 
developed in vitro osteogenic and chondrogenic differentiation, which progressive 
differentiation was confirmed by the gradual downregulated expression of Oct4 
transcript for osteogenic and chondrogenic culture which strongly expressed in 
undifferentiated mESC. Interestingly, the mESCs culture in HepG2 conditioned 
media for first 3 days prior to culture in osteogenic medium also showed relatively 
weak expression of osteogenic maker, osteocalcin and Cbfal/Runx2. It has been 
well reported that Cbfal/Runx2, a transcription factor that is the earliest marker of 
osteogenesis, is expressed in early mesenchymal origin [Ducy P 1997, Banerjee C 
2001], and osteopontin (OPN), a specific protein expressed in osteogenesis with 
similar function with osteocalcin (OCN), can be also expressed in undifferentiated 
or early differentiated ESCs through coordinated action with other molecules 
controlling undifferentiation stage of ESCs, Oct4 and cd9 [Koestenbauer S 2006, 
Oka M 2002, Botquin V 1998]. However, further researches for their expression in 
early differentiated mESCs are needed. In addition, aggrecan or link protein 
transcript were also expressed in relatively low level in both undifferentiated and 
early differentiated mESCs, which might be related with that aggrecan and link 
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protein can be also expressed by other cell lineage and non-cartilaginous tissue 
[Carulli D 2007, Binette F 1994]. In spite of these finding, the distinct expression of 
osteogenic and chondrogenic specific gene, such as osterix, an osteoblast-specific 
transcription factor required for the differentiation of osteoprogenitors into mature 
osteoblasts [Nakashima K 2002, Guanping T 2004], type 11 collagen, one of major 
macromolecules produced by chondrocyte [Poole AR 2001], Sox-9, one of the 
most important transcription factors that are expressed during early 
chondrogenesis [Kulyk KM 2000], and scleraxis, one of major transcription factor, 
is expressed in mesenchymal progenitors and during chondrogenesis [Brown D 
1999], represents well developed osteogenic and chondrogenic differentiation in 
our 3D culture system. 
Finally, for further validation of 3D osteogenesis and 3D chondrogenesis, 
the 3D cell plus alginate construct after osteogenic and chondrogenic culture was 
characterised by histological and immuno-staining. Histological staining of 
sectioned 3D construct in 3D osteogenesis showed well distributed tissue growth 
with a few hundreds ýtrn in size within alginate beads, and ARS staining indicated 
mineral deposition on those tissues, and mineral deposits that stained strongly 
with AIRS and showed fluorescence was shown to be formed mainly at centre area 
of tissues. Immuno-staining of these tissues represented type I collagen and 
osteocalcin accumulation at peripheral region. In further physicochernical 
characterisation of mineralised deposit, mineral deposits formed by osteogenic 
cells within alginate hydrogels were evaluated by ATR-FTIR analysis, SEM-EDS 
microanalysis and mechanical analysis. ATR-FTIR analysis showed distinct peaks 
of phosphate and carbonyl, indicating the presence of hydroxyapatite 
(Ca, O(PO4)6(OH)2) like mineral deposits within alginate hydrogels, which is major 
component of bone mineral [Hunter GK 1983], within alginate hydrogels. 
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Previously, it has been reported that mineral deposits are formed in vitro by P- 
glycerophosphate as an additional source of phosphate ions [Chang YL 2000], 
and it was also reported that phosphate ions were made available in places where 
ALPase was present, thereby reducing the possibility of non-specific mineral 
precipitation, suggesting that a controlled mineralization process is operating by 
osteogenic cells in proper culture condition [Tenenbaum HC 1982], which is 
consistent with our result that mineralised deposit formation was confined only 
within tissues in histochernical studies. Mineralisation could also be confirmed by 
SEM-EDS microanalysis, showing distinct mineral morphology and around 1.23 in 
the Ca/P molar ratio of the mineral deposit. The morphology and Ca/P molar ratio 
might indicate the formation of calcium phosphate-based minerals, regarding that 
Ca/P molar ratio of the representative calcium phosphate minerals is 1.00 in 
Dicalcium phosphate dihydrate, 1.33 in octacalcium phosphate, 1.50 in tricalcium 
phosphate and 1.67 in hydroxyapatite [Campbell AA 1996, Wang H 2002, 
Rodriguez-Lugo V 2005]. This mineral deposit formation within the 3D constructs 
influenced their mechanical properties, as shown by the compression strength 
testing. The Youngs modulus of the 3D bone constructs, formed by the osteogenic 
culture of mESCs for 21 days in HARV bioreactor following alginate encapsulation, 
was much higher than the controls, pure alginate hydrogels and alginate hydrogel 
encapsulating undifferentiated mESCs with the cell density of approximate 
1,800,000 cells, which are almost identical to the cell number in 3D bone construct 
after 21 days of osteogenic culture, indicating much higher stiffness of the 3D bone 
constructs. It is therefore concluded that these mechanical experiments confirm 
the presence of mineralised tissue with superior mechanical properties formed by 
the osteogenic culture of mESCs in the alginate hydrogels. 
In 3D chondrogenesis, histological analysis represented well-developed 
192 
and distributed tissue growth with various sizes within alginate hydrogels after 15 
days of chondrogenic culture. Clusters of cells were surrounded by significant 
amounts of extracellular matrix that stained strongly with alcian blue and safranin 
0, and tissues formed within alginate hydrogels showed a lacunae structure which 
is typical cartilage tissue structure. In addition, immuno-staining of these tissues 
represented type 11 collagen accumulation on tissues. Finally, these histological 
characterisation and physicochemical characterisation demonstrated the formation 
of well-developed 3D bone and cartilage like construct by the osteogenic and 
chondrogenic culture of mESCs in alginate hydrogel and HARV bioreactors. 
6.6. Conclusion 
The bioprocessing for directing 3D osteogenic and chondrogenic 
differentiation of mESCs in alginate hydrogels and HARV bioreactors described 
here enabled the formation of 3D bone and cartilage-like constructs. Osteogenic 
and chondrogenic differentiation could be directed from the early differentiated 
mESCs, which induced by HepG2 conditioned medium treatment, and by the 
culture in osteogenic and chondrogenic environment. Alginate based cell 
encapsulation and HARV bioreactor culture system provided suspension culture 
environment suitable for 3D cell and tissue growth. In addition, removing the EB 
formation step in directing 3D osteogenesis and chondrogenesis resulted in more 
efficient and easy bioprocess than the conventional EB mediated differentiation 
culture method. This culture system described here would provide an efficient and 
easy culture system for applying to bone and cartilage tissue engineering in the 
context of macroscopic bone and cartilage formation. 
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CONCLUSIONS 
In this thesis, we have developed a novel culture strategy for deriving in 
vitro osteogenesis and chondrogenesis from murine ESCs and a bioprocess for 
the formation of 3D bone- and cartilage-like constructs for application to skeletal 
tissue engineering. For the application of ESCs to bone and cartilage tissue 
engineering, the efficient derivation of osteogenic and chondrogenic lineage cells 
from pluripotent ESCs is a prerequisite. Regarding ESCs early differentiation 
strategy into three germ layers; encloderm, mesoderm and ectoderm, well- 
organised induction of mesoderm formation from undifferentiated ESCs is an 
important intermediate step for further terminal differentiation into osteogenic and 
chondrogenic lineage cells. Hence, early differentiation of mESCs was induced by 
the treatment with conditioned medium from the HepG2 cell line (human 
hepatocarcinorna) with similar biological function with visceral endoderm, which 
plays a key role in mesoderm formation during embryogenesis since it induces 
and enhances mesoderm formation. mESC stimulation by the HepG2 conditioned 
medium produced a cell population with a similar gene expression profile to 
primitive streak/nascent mesoderm, which was signified by the increased 
expression of brachyury, cripto and goosecoid transcripts. Furthermore, the gene 
expression profile during EB formation showed relatively enhanced and rapid 
induction of mesoderm formation in comparison with normal mESCs. Finally, the 
HepG2 conditioned medium-treated cells demonstrate the capacity of reversible 
differentiation into the undifferentiation stage in certain culture conditions. 
Following enhanced early differentiation of mESCs into mesoderm, mESCs were 
allowed to form EBs for 5 days, and then dissociated EB-derived cells to 
differentiate into osteogenic lineage cells in the presence of osteogenic 
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supplements. However, increased beating colony formation in the HepG2 CM 
treated mESCs, which was probably due to spontaneous cardiogenic 
differentiation, was observed that was accompanied by bone nodule formation with 
no significant difference in comparison to the untreated mESCs, suggesting the 
need to modulate culture condition for enhancing osteogenic and chondrogenic 
differentiation. Hence, we have designed new culture strategy to enhance 
osteogenic and chondrogenic differentiation selectively and reduce spontaneous 
cardiogenic differentiation. Controlling the EB formation period of the mESCs 
treated with HepG2 conditioned medium resulted in the preferential stimulation of 
cardiogenic, osteogenic and chondrogenic differentiation, respectively. Specifically, 
reducing EB formation time resulted in the distinct reduction of cardiogenic 
differentiation and simultaneously the almost exclusive osteogenic and 
chondrogenic differentiation, which was superior to the conventional EB formation 
process. 
Following the control of skeletal lineage differentiation of mESCs, the need 
to develop a more efficient culture method led to the investigation of direct 
differentiation of mESCs by bypassing EB formation, which was suggested from 
the finding that HepG2 conditioned medium-treated mESCs showed early inducted 
gene expression profile for mesoderm. Therefore, mESCs early differentiation was 
induced by culture in HepG2 conditioned medium. Subsequently, osteogenic and 
chondrogenic differentiation was induced by osteogenic or chondrogenic media 
without EB formation. Removing the EB formation step resulted in the almost 
exclusive osteogenic or chondrogenic differentiation. This novel approach 
represents a more efficient and less time- and labour-intensive process than the 
conventional EB-mediated differentiation method. Finally, using this novel 
differentiation strategy, direct 3D osteogenesis or chondrogenesis of mESCs 
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through encapsulation in alginate hydrogels and culture in HARV bioreactors was 
achieved which enabled the formation of 3D bone or cartilage-like constructs. This 
novel bioprocess would provide an efficient, integrated, and easily scalable and 
automatable culture system for applying to bone and cartilage tissue engineering 
for potential therapeutic applications. 
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FUTURE WORK 
In this thesis, a novel culture strategy and bioprocess was established for 
mESC differentiation. However, from a therapeutic point of view, application of this 
culture strategy and bioprocess for bone and cartilage tissue engineering and 
regenerative medicine requires further characterization and development. 
First, the HepG2 conditioned medium requires to be characterized, which 
would enable the identification of the active factors that trigger ESC differentiation 
and enhance mesoderm formation. Since cell line-derived conditioned media may 
cause transmission of pathogens and vary in the quality depending on the cell 
passage number as well as the cell's physiological status, it is imperative to 
identify the biological molecules in order to produce a defined medium, thus 
rendering its utilisation clinically relevant. The combination of two-dimensional 
electrophoresis coupled to mass spectrometry with matrix-assisted laser 
desorption ionization (MALDI) has become as a powerful tool in the differential 
analysis of proteoms. Therefore, characterization of the active factors in the 
HepG2 conditioned medium using proteornics is essential in developing a novel, 
defined medium that contains the active factors able to enhance mesoderm 
formation. 
Second, cell purification through cell sorting in order to purify osteogenic 
cells or chondrogenic cells specifically from the heterogeneous cell population may 
be required. Specifically, Fluorescence Activated Cell Sorting (FACS) could be 
applied. FACS selects the desired cell type from a heterogeneous population 
based upon the intensity of fluorescence which desired cells emit. This requires 
the generation of suitable monoclonal antibodies can be selectively used to 
identify the desired cell type. In particular, specific markers and antibodies relating 
198 
to the ESC differentiation stage are required, because, to date, only OB cadherin 
(Cadherin 11) has been available to identify and select cells with mesenchyme 
origin. 
Finally, for the practical application of this culture system, which 
established using mESCs, to human ESC (hESC)-based biotechnology, this 
culture strategy and system should be tested and modified in terms of the 
difference in culture condition between mESCs and hESCs. Generally, hESC 
culture is based on the use of feeder cell layers with mouse origin and FIBS free 
environment. Preliminary, HepG2 growth was tested in the FBS-free condition in 
comparison with FBS-containing condition, and there is no significant difference in 
HepG2 growth between FBS-free and FBS-containing culture condition (Appendix 
8), suggesting the potent use of FBS-free HepG2 conditioned medium in hESC 
early differentiation with slight modification. In addition, feeder cell layer free 
culture system will be developed to remove the possibility of cross-contamination 
between human origin and mouse origin for the final purpose of medical 
application, and more concise culture condition will be developed to derive and 
control hESC differentiation into osteogenic and chondrogenic lineage, and finally 
hESC derived 3D bone and cartilage tissue construct will be fabricated by the use 
of our established integrated bioprocess with slight modification. 
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APPENDIX 
22,5 
APPENDIX 1 
A standard curve was generated by measuring the level of the endogenous 
mitochondrial dehydrogenase of mESCs after 4 hrs of seeding in accordance with 
serial cell seeding density using the Celffiter 960 AQueous non-radioactive cell 
proliferation assay according to previously described method in the section of 
2.3.1. 
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APPENDIX 2 
A calibration curve was generated using standard p-nitrophenol solution 
(Sigma, UK). The absorbance for serially diluted p-nitrophenol, ranged from 0 to 
500 ýM, was read at 405 nm. 
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APPENDIX 3 
Calibration curves were generated using serially diluted bovine serum 
albumin (Sigma, UK) and Bio-Rad DC protein assay kit (Bio-Rad, USA) or BCA TM 
protein assay kit (Pierce, USA) according to the manufacturer's instruction. 
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APPENDIX 4 
A calibration curve was generated using the serially diluted chondroitin 
sulfate solution (Sigma, UK), and other procedure was done according to 
previously described method in the section of 2.4.2.5. Measurement of sulfated 
GAG content (1,9-Dimethimethylene Blue (DMMB) assay) and DNA content, and 
the OD650of the solution was measured. 
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APPENDIX 5 
A calibration curve was generated using highly polymerised calf-thymus 
DNA (Sigma, UK) and other procedure was done according to previously 
described method in the section of 2.4.2-5. Measurement of sulfated GAG content 
(1,9-Dimethlmethylene Blue (DMMB) assay) and DNA content. An aliquot (100ýtl) 
of the solution was then read using a microtiter plate fluorometer (MFX, Dynex 
Technology, Finland) with the excitation wavelength being at 365 nm and the 
emission wavelength at 460 nm. 
Hoechst 33258: DNA content: Standard Curve 
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APPENDIX 6 
A calibration curve was generated using the supplied reference collagen 
standard solution (Sircol Collagen Assay S 1000, Biocolor Ltd, Ireland), and other 
procedure was done according to previously described method in the section of 
2.5.2.6. Measurement of collagen content and DNA content 
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APPENDIX 7 
As a preliminary experiment, mESC (TG2a) growth was evaluated in 
accordance with initial cell seeding density for achieving optimal cell density for 
further researches. mESCs were seeded onto the plates at various concentration 
of 1.0 X 104 cel IS/CM2 , 
2.0 x 
104 cel IS/CM2 and 3.0 x 104 cel IS/CM2 , and cultured 
for 1, 
21 3,4, and 5 days in standard mESC maintenance culture medium at 37'C in a 
5% C02 humidified incubator. Unattached cells were removed by thoroughly 
washing 3 times with 1X PBS. Cell growth were evaluated using the CeIlTiter 960 
AQueous non-radioactive cell proliferation assay according to previously described 
method in the section of 2.3.1. mESCs, with initial cell seeding density of 3.0 x 104 
cel IS/CM2 , reached almost 
90% confluence and showed higher growth rate at early 
culture period. From this previous experiment, the cell density of 3.0 x 
104 
ce IIS/CM2 was used for further studies. 
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APPENDIX 8 
For the further researches about the application of our developed cell 
culture system to human ESCs, as a previous experiment, we evaluated HepG2 
cell growth in FIBS free culture condition. HepG2 cells were seeded on culture 
plate with initial cell seeding density of 5X 104 cel IS/CM2 and cultured in HepG2 
maintenance media containing FIBS and in HepG2 maintenance media without 
FIBS for 1,3, and 5 days. Cell growth were evaluated using the CeIlTiter 960 
AQueous non-radioactive cell proliferation assay according to previously described 
method in the section of 2.3.1. As shown in below figure, there was no significant 
difference in HepG2 growth between FBS containing medium and FIBS free 
medium, suggesting that the FIBS free conditioned medium from HepG2 culture 
can be applied to hESCs early differentiation. 
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